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ABSTRACT
Although leucocytes are a normal constituent of human semen, the concentration can vary. 
About 20% of infertile men have leucocytopsermia (leucocytes lxl06/ml) with granulocytes 
being the most common leucoyte present. There has always been a poorly defined 
correlation between the role of leucocytes and male infertility. Leucocytospermia has been 
shown to be associated with poor semen quality by several studies. However, other studies 
have stated that leucocytes and leucocyte subpopulations in semen have no role to play 
either in reducing the sperm fertilising capacity or in decreasing sperm quality.
Cytokine levels are significantly elevated in seminal plasma exhibiting bacterial or 
mycoplasma infections in the urogenital tract, but their role in male infertility is 
controversial. Cytokines may influence sperm motility directly or indirectly as they have 
been shown to negatively correlate with the number of progressively motile sperm, resulting 
in reduced mucosal penetration properties. Similarly, cytokines have been shown to 
decrease the sperm penetration capacity of zona-free hamster eggs. However, other studies 
have been unable to find any significant differences in the cytokine content between fertile 
and infertile men.
A prospective cohort study of the leucocyte subpopulations and cytokine content of seminal 
fluid of different categories of infertile men as well as men attending an IYF programme 
was undertaken. This study was aimed to identify the role of leucocytes and cytokines in 
male infertility. The study will help to clarify a much debated issue.
Semen samples were obtained from normal fertile donors, men being referred to the 
andrology and IVF clinics in Liverpool Women’s Hospital and to the seminology laboratory
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for routine semen analysis. Patients were placed in the followings groups namely 1) 
Normospermia 2) Asthenospermia 3) Oligospermia mild 4) Oligospermia severe 5) 
Oligoasthenospermia mild 6) Oligoasthenospermia severe 7) Azoospermia (obstructive) 8) 
Azoospermia (germ cell damage). These groups were determined according to the sperm 
count and sperm motility. These patients were also subdivided into two further groups 
depending on their antisperm antibody status as tested by the mixed antiglobin reaction 
(MAR) for IgA and IgG antibodies.
Samples were produced by masturbation after three to five days of sexual abstinence and 
collected in sterile containers. Swabs for bacteriological cultures including Gonococcus, 
Trichomonas, Chlamydia, Ureaplasma, Mycoplasma and general bacterial and fungal 
growth were taken. Leucocytes were identified using an immunohistocytochemical 
technique. The size of the total leucocyte population was assessed using monoclonal 
antibodies directed against the common leucocyte antigen. The remainder of the sample was 
used to identify cytokines using enzyme linked immunosorbent assay (ELISA) techniques.
Most of the studies looking into the role of leucocytes in infertility have concentrated on one 
or two of the leucocytes subpopulations. Similarly, the commonly reported cytokines with 
relation to infertility such as interleukin IL-1, IL-6, IL-8, tumour necrosis factor alpha and 
interferon gamma have been either studied individually or in combination. However, an 
extensive study to look into all the leucocyte subgroups and the various cytokines to 
determine their significance in male infertility and their effects on fertilisation and 
implantation rates in an IVF programme has not been performed. This study aimed to 
identify these particular' leucocyte subgroups and cytokines.
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ACTH Adrenocorticotrophic hormone
ADCC Antibody dependent cellular cytotoxicity
AGIF Adipogenesis inhibitory factor
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ASA Antisperm antibody
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BSA Bovine serum albumin
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C Complement
CD Cluster of differentiation
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FasL Fas ligand
FC Fragment crystallisable
FSH Follicle stimulating hormone
ys lymphocytes Gamma lymphocytes
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GM-CSF Granulocyte macrophage colony stimulating factor
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Hsp Heat shock protein
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IFN Interferon beta
IkB Inhibitory kappa B protein
IL Interleukin
IL-R Interleukin receptor
IL-RA Interleukin receptor antagonist
IUI Intrauterine insemination
IVF In vitro fertilisation
IVF-ET In vitro fertilisation- embryo transfer
JAK Janus kinase pathway
LIF Leukemia inhibitory factor
LGL Large granular lymphocyte
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LIF Leukaemia inhibitory factor
LH Luteinising hormone
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MAPK Mitogen activated protein kinase
MC5b-9 Membrane bound terminal complement complex
MC Complement membrane attack complexes
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MHC Major histocompatibility complex
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mRNA Messenger ribo nucleic acid
NASP Nuclear autoantigenic sperm protein
NF~Kb Transcription factor kappa B protein
NHS Normal human serum
NK Natural Killer
NKkB Natural killer kappa B
PBS Phosphate buffered saline
PBMC Peripheral blood mononuclear cell
PGE2 Prostaglandin E
PMN Polymorphonuclear
ROS Reactive oxygen species
RPM Revolutions per minute
SCF Stem cell factor
SMT Sperm migration test
SpAbs Sperm antibodies
SPSS Statistical package for social sciences
STAX Signal transducers and activation of transcription pathway
TATA Sequence of nucleotides
TBS Tris buffered saline
TCE Tumour necrosis factor converting enzyme
TCR T cell receptors
TGF Transforming growth factor
Th T helper cells
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TLR Toll like receptor
TNF Tumour necrosis factor
TNFR Tumour necrosis factor receptor
UreG Urease complex component UreG
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Cell Mediated Immunity in Male Infertility
CHAPTER 1: MALE INFERTILITY
1.1 Infertility
Infertility has been defined as a failure to conceive after a year of unprotected intercourse 
with the same partner. Use of this time period, while arbitrary, was based upon a study of 
5574 British and American women engaging in unprotected intercourse who ultimately 
conceived between 1946 and 1956. Among these women, 50 percent conceived within three 
months, 72 percent within six months, and 85 percent within 12 months1. If a pregnancy 
does not occur by three years, persistent infertility is very likely in the absence of medical 
intervention2. Studies indicate that one in six couples around the world have difficulties in 
conceiving at some point in their lives, adding up to 50-80 million people3. The available 
information indicates that about 15% of all couples in the western world are infertile4.
Infertility depends on both male and female factors, as more than one factor may coexist in 
both partners. In the past decade the WHO has indicated that a male cause may be present in 
about 43% of infertile couples5. Recent epidemiological studies in the UK have indicated that 
abnormal semen6 or defective sperm function7 may be the most common single defined cause 
of infertility in approximately 25% of couples investigated. Historically, the workup for the 
infertile couple focused primarily on the condition of the female. However, the birth of 
Louise Brown, the first successful in vitro fertilisation, heralded a major step forward in 
dealing with one of the causes of infertility: tubal infertility8. This has motivated interest in 
assisted reproduction techniques such as controlled ovarian stimulation, intra-cytoplasmic 
sperm injection to help overcome male factor infertility and many others. Thus, assisted
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reproduction technology has allowed a better understanding of the process of human embryo 
development and has opened up avenues of research into the causes and cures of infertility. 
The trend has now shifted, such that the male partner in an infertile liaison may be 
investigated first. If an abnormality is detected in the seminal analyses, the couple can then be 
referred to a clinical andrologist rather than a gynaecological infertility clinic to avoid 
unnecessary female investigations.
Male infertility, internationally, has been noted to vary, depending on various factors such as 
social habits, environmental conditions and genetics. However, recent studies have 
demonstrated that there is poorer semen quality, reduced sperm numbers and reduction of 
fertility in men today as compared to that of fifty years ago9'11.
1.2 Male Infertility
Studies cited earlier have indicated that the male factor accounts for approximately 30% of 
the cases of infertility12. Many factors can interfere with the process of sperm production. It 
could be deficiencies in the main hormones leading to sperm production classified as pre- 
testicular’ infertility. Testicular* infertility could include factors damaging the sperm producing 
cells. Mechanical blockage of the outlet system for ejaculation and failure of erection and 
ejaculation is termed as post-testicular infertility. Table 1.1 summarises the distribution of the 
main aetiological causes of male infertility.
The unexplained forms of male infertility may be caused by several factors such as chronic 
stress, endocrine disruption due to environmental pollution, reactive oxygen species and 
genetic abnormalities. Table 1.2 gives the standard values for semen analysis according to the 
1999 WHO criteria13.
18
Table 1.1: Aetiology and distribution (%) of male infertility among 7057 men.
Adapted from guidelines on male infertility 200514.
Aetiology Distribution (%)
Sexual factors 1.7
Urogenital infection 6.6
Congenital anomalies 2.1
Acquired factors 2.6
Varicocele 12.3
Endocrine disturbances 0.6
Immunological factors 3.1
Other abnormalities 3.0
Idiopathic abnormal semen (OAT 
syndrome) or no demonstrable cause
68.0
Table 1.2: Overview of standard values for semen analysis according to the 1999 
WHO criteria13.
Parameters Values
Volume > 2ml
pH 7.0-8.0
Sperm concentration > 20 million/ml
Total number of spermatozoa >40 million/ejaculate
Motility > 50% with progressive motility or 25% 
with rapid motility within 60 mins after 
ejaculation
Morphology* > 14% of normal shape or form
Viability >50% of spermatozoa
Leucocytes <1 million/ml
Immunobead test <50% spermatozoa with adherent particles
MAR test** <50% spermatozoa with adherent particles
*Assessment according to Kruger and Menkfeld criteria.
**MAR= Mixed antiglobulin reaction.
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WHO revised these criteria in 2010. In accordance to the new WHO criteria, over 15 million
sperm per millilitre is considered to be normal for sperm count, 40% for motility and 4% or 
more of the observed sperm have normal morphology15. If the semen analysis is initially 
normal according to the mentioned WHO criteria, one test should be sufficient. However, 
further andrological investigation is only indicated if the results are abnormal in at least two 
tests. There are several causes of male infertility. The causes of male infertility are elaborated 
as shown in Table 1.3.
1.3 Immunological Factors in Infertility
A recently recognised class of infertility is immunological infertility, most often characterised 
by the presence of antisperm antibodies (ASA) in one or both partners (semen, blood, 
cervical mucous or follicular fluid).
1.3.1 Antisperm Antibodies
The presence of antisperm antibodies in infertile men was first reported in 1954 . The 
incidence of sperm autoimmunity in infertile couples is 9-36% in contrast to 0.9-4% in the 
fertile population. Males may resorb senescent sperm and females may adsorb sperm from 
coitus, thereby producing low litres of sperm antibodies seen in fertile couples .
The incidence of detection of sperm antibodies in the infertile male is up to 21% and in the 
female up to 23%19. An immunological aspect may contribute to 5-15% of male infertility 
causes. Antisperm antibody (ASA) can be defined as immunoglobulins of the IgG, IgA and / 
or IgM isotype that are directed to various aspects of the spermatozoa (head, tail, midpiece or 
combination thereof).
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Table 1.3: Causes of male infertility. Adapted with permission from British Journal of
16Hospital Medicine .
Primary testicular failure
Congenital disorders
Klinefelter's syndrome (XXY) and its variants (XXY/XY; XXXY)
Cryptorchidism
Myotonic dystrophyFunctional prepubertal castrate syndrome (congenital anorchia)
Varicocele (congenital weakness of the mesenchyme of the blood vessels)
Androgen insensitivity syndromes 
5-alpha-reductase deficiency 
Y chromosome deletions
Acquired disorders
Viral orchitis (mumps, echovims, arbovirus)
Granulomatous orchitis (leprosy, tuberculosis)
Epididymo-orchitis (gonorrhea, chlamydia)
Drugs (e.g., alkylating agents, alcohol, marijuana, antiandrogens, ketoconazole, spironolactone, histamine receptor antagonists)
Ionizing radiation
Environmental toxins (e.g., dibromochloropropane, carbon disulfide, cadmium, lead, mercury, environmental estrogens and phytoestrogens) 
Hyperthermia
Immunologic disorders, including polyglandular autoimmune disease
Trauma
Torsion
Castration
Systemic illness (e.g. renal failure, hepatic cirrhosis, cancer, sickle cell disease, amyloidosis, vasculitis, celiac disease)
Secondary testicular failure (Hypothalamic-pituitary disorders)
Congenital disorders
Congenital GnRH deficiency (Kallmann syndrome)
Hemochromatosis
Multiorgan genetic disorders (Prader-Willi syndrome, Laurence-Moon-Beidl syndrome, familial cerebral ataxia)
Acquired disorders
Pituitary and hypothalamic tumors (macroadenoma, craniopharyngioma)
Infiltrative disorders (sarcoidosis, histiocytosis, tuberculosis, fungal infections)
Trauma, postsurgery, postirradiation 
Vascular (infarction, aneurysm)
Hormonal (hyperprolactinemia, androgen excess, estrogen excess, cortisol excess)
Drugs (opioids and psychotropic drugs, GnRH agonists or antagonists)
Systemic disorders
Chronic illnesses 
Nutritional deficiencies 
Obesity
Extra testicular disturbances
Epididymal dysfunction
Radiation
Drugs
Infection- Mumps, Mononucleosis, Hepatitis, TB, Gonorrhoea, Mycoplasma, Candida, Trichomonas, Reiters)
Young's syndrome (functional obstruction at the level of the caput epididymis)
Abnormalities of the vas deferens
Congenital absence
Infection
Vasectomy
Ejaculatory dysfunction
Cerebral and spinal cord disease
Autonomic dysfunction- drugs, diabetes and surgery
Premature ejaculation, retrograde ejaculation and anorgasmy,
Spinal and peripheral nerve injuries
Idiopathic______________________ ____________ __ _______________________________
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In other words, it is an immunoglobulin with antibody activity against the sperm antigen that 
plays a role in infertility. However, not every antibody that binds to the sperm surface 
influences sperm function20. Immunoglobulin M is too large a molecule to cross into the 
semen from the systemic circulation. ASA concentration may be of importance in affecting 
sperm function. Hence there are some protective mechanisms against the development of 
ASAs and the most important amongst them is the blood testis barrier to which the immune 
privilege of the testis was originally attributed to. Figure 1.1 describes the blood testis barrier.
Protective mechanisms preventing ASA production - The blood-testis barrier (BTB) and 
the tight junctions between Sertoli cells appear' to play a major role in keeping the developing 
spermatozoa and immune system separate. It prevents those testicular* cells expressing 
"foreign" antigens from coming into contact with lymphoid tissue and immunocompetent 
cells from entering the seminiferous tubules. This creates favourable conditions for 
spermatogenesis and sperm survival in the testicular' fluid, and sperm maturation in the 
epididymal fluid. It also prevents the occurrence of autoimmunity after puberty. Therefore, 
alteration of the blood-testis barrier and the epididymal blood-epithelium barrier allows the 
production of ASAs and, hence, may lead to infertility. The BTB is commonly breached by 
physiological leakage of normally sequestered sperm antigens. Also the tight junctions do not 
protect all intratesticular sperm autoantigens from the immune system that lie below the tight 
junctions in the basal compartment of the seminiferous tubule. Recent research has shown a 
previously unknown level of complexity with a multitude of factors both physical and 
immunological necessary for the establishment and maintenance of immunotolerance in the 
testis22.
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Blood-testis barrier 
(tight junction) 
Sertoli cell nucleus
Basement membrane
Blood capillary 
Leydig cell
SPERMATOGENIC CELLS 
Sperm cel or spermatozoon ( 
Late spermatid (n)
t
Early spermatid (n) 
Secondary spermatocyte (n)
Primary spermatocyte (2n) 
Spermatogonium (2n) (stem c
Figure 1.1: Microscopic anatomy of the seminiferous tubules, (a) Transverse 
section of several seminiferous tubules. The blood capillaries are within the 
interstitium. (b) Transverse section of a portion of a seminiferous tubule. The 
blood-testis barrier is located in the seminiferous tubule between the Sertoli cells.
Reprinted from Tortora and Grabowski (editors) with permission from John Wiley & 
Sons, Inc 21.
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Besides the blood testis barrier and the diminished capability of the large testicular resident 
macrophage population to mount an inflammatory response, it is the constitutive expression 
of antiinflammatory cytokines in the testis that represents an essential element for local 
immunosuppression.
Other protective mechanisms besides the blood-testis barrier and the blood-epithelium barrier 
have also been identified. Immunosuppressive substances have been found in semen and 
follicular fluid. Moreover, T lymphocytes in the human immune system, which partially 
mediate the normal state of immunologic unresponsiveness toward sperm autoantigens 
through cytokines, also play an important role in preventing the autoimmune response. 
Components of seminal plasma and polymorphonuclear neutrophils in semen could eliminate 
nonviable sperm or debris .
Some of the proposed mechanisms of immune protection are:
1. Immunologic tolerance induced by low grade "leakage" of sperm antigens;
2. Immunomodulatory mechanisms within testis e.g. steroids, macrophages, 
suppressor cells which may prevent activation of immune response; and
3. Immunomodulation distal to the testis (T lymphocytes mediated cytokine 
production in the epididymis and immunosuppressive activity of seminal plasma).
Crude sperm protein preparations are highly immunogenic in all species. There is 
considerable evidence that under normal circumstances some interaction occurs between 
sperm and the immune system within both the testis and epididymis and that 
immunomodulatory mechanisms act to prevent SpAb formation. There is also clear evidence 
for the presence of immunosuppressive cytokines in the testis and seminal fluid24,25. The 
formation of SpAb is influenced by a number of factors including:
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1. flushing of sperm from the genital tract;
2. degradation of sperm antigens by extra-cellular enzymes;
3. phagocytosis of sperm by somatic cells and macrophages;
4. immunopotentiation by other foreign antigens in the genital tract;
5. paternal lymphocytes present in semen; and
6. seminal immuno-suppressive factors.
SpAbs are rare in fertile couples implying, but not proving a role for SpAbs in infertility24,26.
1.3.2 Factors leading to ASA production
Chronic Infection: Antisperm antibodies were found in 25-56% of men with chronic 
prostatitis27. It has been suggested that the female’s isoimmunity to sperm is associated with 
sperm autoimmunity in their husbands18. Women with pelvic infection have a higher 
incidence of sperm immunity (up to 59%). Antibody production is linked to Chlamydia 
trachomatis, Mycoplasma species and Ureaplasma urealyticum infections. It has been 
reported that Heat-shock protein (Hsp) 60 in human seminal fluid was associated with the 
formation of AS As28. Hsp 60 is associated with a humoral immune response to C. 
trachomatis or other infection agents, indicating that genital infection could be an important 
factor causing ASA production .
The possible relationship between ASA production and Ureaplasma urealyticum infection 
was also investigated. It was confirmed that U. urealyticum and human sperm membrane 
proteins share cross-reactive antigens (61, 50 and 25 kDa)29. Among the cross-reactive 
antigens, the urease complex component UreG of U. urealyticum was discovered. 
Furthermore, the cross-reaction between human NASP (nuclear autoantigenic sperm protein) 
and UreG was verified. Both anti-rUreG antibodies and antiserum against synthetic peptide 
NASP393-408 inhibited mouse sperm-egg binding and fusion. After immunisation with
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rUreG or synthetic peptide, 81.2% and 75% of female mice became sterile, respectively . 
These findings proved that the cross-reactive antigens shared in sperm and microorganisms 
induce ASA production and infertility.
Vasectomy and Vasovasostomy: More than 50-70% of men develop ASAs after a 
vasectomy, and there is limited success in the regaining of fertility, even after successful 
surgical reanastomosis by vasovasostomy. This has been attributed to the presence of 
ASAs30. The highest incidence of titres is one year after vasectomy, but titres can be found 
as early as six months or as late as 20 years post-operatively. These ASAs are causative 
factors in infertility, because disappearance of ASAs causes return of fertility. However, 
considerable disagreement remains as to whether antibodies are the primary causative agent. 
No significant changes were observed in the prevalence of the antibodies over the period 
following vasectomy, and in patients with and without postoperative sperm granulomas . 
Sperm antigens are in abundant supply in vasectomised men as a result of the continuous 
resorption of spermatozoa after vasectomy. Therefore, it is possible that undetectable 
antibody titres reflect high levels of ASAs circulating as immune complexes.
Other factors: Heavy metals can also adversely influence reproduction since in sensitive 
individuals they are able to alter the immune responses including autoantibody production, 
which can then cause infertility32. For example, after mercury stimulation, less IFN-y and 
more ASAs were produced by the lymphocytes of patients33. This suggested that the release 
of metal ions from dental materials can be one of the stimulating factors that may adversely 
affect fertility. Testicular cancer and testicular torsion patients also have a markedly high 
incidence of ASAs34. The former may be related to radiation therapy and severe damage of 
seminiferous tubules. Torsion causes a breakdown of the blood testis barrier (sympathetic 
orchiopathia) and studies in rats have shown the production of ASA after torsion . In
29
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addition, a high ASA rate (43.1%) was observed among prostitutes36. It may be related to 
repeated inoculations with multiple sperm antigens and / or microorganisms.
The possible effects of immunologic reaction to fertility are:
1. Disordered spermatogenesis resulting in oligospermia and azoospermia;
2. Binding of antibodies to post testicular spermatozoa and inhibiting their effective 
transport in the male reproductive tract;
3. Auto agglutination of ejaculated spermatozoa;
4. Sperm cytotoxicity mediated by sperm antibodies;
5. Direct immobilising effect of sperm antibodies on spermatozoa in the female tract;
6. Enhancement of phagocytic clearance of spermatozoa by macrophages;
7. Inadequate spermatozoal penetration of cervical mucus;
8. Disorders of sperm capacitation and acrosome reaction;
9. Blockage of sperm-ovum interaction;
10. Induction of sperm immunity in the female; and
11. Post fertilisation reproductive failure and occult abortion.
1.3.3 Role of Antisperm antibodies in infertility
Antibodies directed towards various sperm antigens can result in reduced fertility in men. 
Immunological infertility is probable if more than 50% sperm are bound to IgG or IgA 
antibodies37. As the level of antibodies increases, sperm function can be impaired, and the 
chance of spontaneous pregnancy declines. Results from several large studies on the presence 
of sperm agglutinins in fertile and infertile men indicate a high correlation between sperm 
agglutinins and complement dependent immobilising antibodies. AS As can bind to antigens 
on sperm membranes, but subcellular structures cannot be reached by AS As in living cells. 
Therefore, it is speculated that the function of transmembrane proteins may be altered by the
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ASAs concerned. Another possible explanation is via complement-mediated membrane 
damage. ASAs could inactivate human sperm motility in the presence of complement, 
showing that complement-dependent inactivation of sperm motility might be the biological 
mechanism of female infertility .
IgG- and C3-bound motile sperm are adhered to human neutrophils in vitro at the acrosomal 
region of the sperm head. This adhesion potentiates the localised release of oxygen radicals 
along with activated C3 fragments, leading to sperm-motility loss39 as high as (43-87%) and 
ultimately leading to sperm lysis40. GDI lb / GDIS glycoprotein complex (CR3) have also 
been implicated in ASA- and complement-mediated immune destruction of motile sperm by 
neutrophils41. A receptor on the sperm surface has been identified which increases its 
susceptibility to immobilisation42. Evidence exists that sperm reactive autoantibodies may 
impair sperm penetration into cervical mucus from seminal plasma. This can be shown both 
clinically at postcoital testing and in vitro. Spermatozoa obtained from known fertile donors 
and previously shown to be able to penetrate human cervical mucus have failed to do so 
following incubation with antibodies in vitro43.
The presence of ASAs in cervical secretions is not frequent but nevertheless when present it 
is a severe cause of infertility44. In the genital tract, IgA has been observed to be primarily 
present in semen, cervical mucus or follicular fluid, since the production of IgA is closely 
associated with mucosal immunity. It was reported that infertile men had more IgA and other 
secretory components in semen than controls, and that IgA was considered responsible for the 
reduced penetration of spermatozoa into cervical mucus and for the 'shaking phenomenon' 
(jittering in situ) seen when sperm actually enter the mucus45. Impairment of sperm 
penetration into the cervical mucus appeal's to be of consequence in the following 
mechanisms: the activation of the complement cascade by immunoglobulins attached to the
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sperm surface, at the end of which cell lysis and initiation of the phagocytic process of the 
sperm may take place. The complement induced cell lysis in the female reproductive tract 
depends on the immunoglobulin class of the antibody. IgM is far more effective than IgG, 
while some IgA subclasses are unable to interact with the early complement components. 
During then" residence in the cervical mucus, sperm are exposed to complement activity. The 
complement activity in cervical mucus is approximately 12% of that of serum46. Thus, it may 
take longer for sperm immobilisation to occur. There appears to be some reaction between 
the cervical mucus and the Fc region of the antibody causing binding of the sperm to the 
cervical mucus47. This process could contribute to the binding of spermatozoa to the antibody 
and the immobilisation of this complex by the cervical mucus that is seen in immunological 
infertility.
Antibody-coated sperm may activate lymphocytes, thus leading to the production of ASAs. 
This may be an additional mechanism that leads to infertility. Mononuclear cells, including 
lymphocytes, monocytes and macrophages, may play a role in infertility caused by ASAs. 
Cytokines secreted by these mononuclear cells may also have roles; however, these are 
unclear at present. It has been reported in one study that no significant difference was found 
in the concentration of leucocytes or subpopulations of these cells (monocytes, lymphocytes 
and granulocytes) between fertile, sterile without ASAs and immunological sterile groups . 
It is possible that both the presence of ASAs and the increase of leucocytes in semen are 
manifestations of an immunological response or a common etiological factor of genital tract 
infections, and they are not interrelated. In contrast, a significant increase in large granular 
lymphocytes (LGL) was detected in semen samples from immunological sterile patients 
when compared with fertile ejaculates and sterile ejaculates without ASAs .
29
The LGLs form the population responsible for antibody-dependent cellular cytotoxicity 
(ADCC). An expansion of these cells is reflected by an increase in ADCC effector cells. 
Immunoregulation by ADCC induces the disappearance of the antigens recognised by each 
antibody. Thus, the appearance of AS As in an ejaculate could generate the expansion and 
activation of LGLs to decrease ASA production by B lymphocytes. Nevertheless, LGL 
activity may be a specific cellular mechanism operative in limiting the fertilising ability of 
these spermatozoa. Antisperm cell-mediated immunity (CMI) has been associated with 
infertility in men and women. Sperm antigens can specifically induce CMI factors that have 
detrimental effects on sperm motility and preimplantation embryos. Despite the observation 
of antisperm CMI responses in all individuals of the following groups: infertile men and 
women, fertile women, virgin women, oligozoospermic men, and men with andrological 
disorders, the role of antisperm CMI in reproductive processes is still unclear.
Fertilisation is significantly reduced (pcO.OOl) only if both IgA and IgG antibodies are 
present in semen but there is no reduction if either class is present alone49. High levels 
(>80%) of ASA bound sperm were less likely to fertilise. In patients with low levels of 
antibodies, ASA-free sperm might contribute to higher fertilisation rates in IVF50, The 
presence of both IgG and IgA in the seminal plasma was associated with poor post coital test 
results and a reduced rate of fertilisation of human oocytes51. Lower fertilisation rates and a 
lower number of transferred embryos were found in couples with ASA on the spermatozoa of 
couples undergoing IVF when IgG was the major immunoglobulin involved52.
Antisperm antibodies can also impair the fertilisation process at the level of the acrosome 
reaction, of the zona pellucida recognition and penetration, and of the sperm vitellus 
interaction53. ASA binding to the sperm head influences the acrosome reaction54. A number 
of spontaneously occurring ASAs were shown to enhance the number of acrosome reacted
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sperm55. In addition, there is evidence that some surface bound antibodies may not interfere 
with fertilisation but with subsequent embryo cleavage of fertilised ova56. It was reported that 
the fertilisation rate in the antisperm antibody group (61.3%) was significantly lower than 
that in the control group (76.8%)57. Although sperm-immobilising antibodies prevent sperm- 
egg interactions, they do not seem to have any adverse effects on the likelihood of 
pregnancy57. Interestingly, active immunisation with many of these molecules does not 
inhibit fertility in vivo58. Moreover, the occurrence of a cellular or humoral immune response 
against sperm seems to augment the uterine receptivity for the implantation of fertilised ova 
or blastocyst, and to be favourable for a successful pregnancy by the IVF-embryo transfer 
(ET) procedure59.
In spite of the difficulty to explain these contradictory results, it was generally accepted that 
most autoantibodies occurring in biological fluids do not cause autoimmune diseases54. It has 
been reported that there was no statistically significant difference in the pregnancy rate 
between those women with and without AS As60. These conflicting studies about the effects 
of ASAs on fertilisation could be due to inadequate experimental approaches in evaluating 
antisperm immunity 61.
1.3.4 Indications for antisperm antibody testing
The indications of antibody testing are:
1) Abnormal semen analysis- Clumping / agglutination, low motility, poor sperm 
viability and shaking of sperm in cervical mucus rather than proper motility;
2) Abnormal postcoital test- Low number of sperm in mucus, poor motility and 
shaking in place of motility; and
3) Identifiable risk factors such as:
• Abnormal in vitro cervical mucus penetration tests;
31
• Abnormal sperm penetration assay;
• Failed or low fertilisation in IVF;
• Unexplained infertility after couple’s evaluation.
Methods of ASA Testing- These are the commonly used methods to test for ASA
1) Sperm agglutination tests;
2) Sperm immobilisation test;
3) Immunobead test and mixed antiglobulin reaction;
4) Immunofluorescence assay (very inaccurate);
5) Enzyme-linked immunosorbent assay (very inaccurate);
6) Radiolabeled antiglobulin assay;
7) Flow cytometry;
8) Immunoblotting;
9) Affinity chromatography.
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The ASAs detected by different methods are not identical. Comparative investigations using 
various assays to detect levels of antibodies to human spermatozoa have produced widely 
varying results. A possible explanation for the observed wide variation in results from 
different methods to detect ASAs may be the different target antigens used in assays. 
Although there is reason to accept antibody-mediated antisperm immunity as a cause for 
subfertility, the routinely used methods are not reliable for the detection of specific ASAs. 
The methods described so far* have been hindered by co-detection of undesired non- 
specifically bound antibodies.
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1.3.5 Treatment Modalities
There have been a wide range of treatments proposed for ASA:
1. Condom therapy- Is no longer advised as it was once thought that decreasing the 
antigenic load may be beneficial in the infertile female. However, it is likely that the 
antibody titres will rise once the therapy has been stopped.
2. Immunosuppressive therapy- The method of immunosupression most commonly used 
is steroid therapy. Different regimes have been used in the past with varying results. 
Low dose continuous therapy using 5mg of oral prednisolone for three to twelve 
months improved the sperm count and a pregnancy rate of 14% was achieved. 
However, the sperm antibody titres remained significantly high . Steroids suppress 
macrophages and T cells and thus inhibit antibody production by B cells and 
proliferation of B cells clones. It also suppresses proinflammatory cytokine 
production by down regulating the T-helper-type-1 cells (Thl)64. Vitamin D3 acts by 
inhibiting monocyte derived cytokines and T cell activation. Combined treatment 
regime of Vitamin D3 with dexamethasone has shown not alone to improve sperm 
motility and viability but also to decrease ASA levels65. Most of the steroid studies 
are not controlled trials and hence makes it difficult to evaluate outcomes and come to 
a meaningful conclusion whether steroid therapy is effective in immunoinfertility.
3. Assisted reproduction- There are three important assisted reproduction techniques.
IUI (intrauterine insemination) - Intrauterine insemination has been found to 
be useful for treatment of female and male immunoinfertility. Sperm passage 
through the female genital tract and the cervical canal is facilitated by IUI. 
Washing of the sperm may also help in removing some of the IgG bound to 
the sperm surface66.
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GIFT (gamete intrafallopian transfer-) - GIFT was able to achieve 43% 
pregnancy rates per couple and 24% per cycle in patients with 
immunoinfertility .
IVF and ICSI (intracvtoplasmic sperm injection) - IVF can help in cases of 
female immunoinfertility but not male immunoinfertility as albumin is used 
instead of the female partner’s serum in the insemination medium. ICSI was 
able to achieve almost equal fertilisation rates and cleavage rates in the 
ASA+ve group compared to the ASA-ve group. However, there was increased 
pregnancy loss in the immunoinfertile group68.
4. Semen manipulation - Different techniques have been tried to either decrease the 
binding of ASA to sperm or remove the bound ASA from sperm69. However, the 
various techniques mentioned such as sperm washing, swim-up, dilution, 
cryopreservation, immunomagentic sperm separation, immunobead incubation and 
proteolytic enzyme treatment etc. have had only limited success.
5. Fertilisation antigen-1 treatment - Immunoadsorptiontechnique using humansperm 
FA-1 antigen would help remove autoantibodies from the surface of sperm cells of 
ASA+ve men and thus increase their fertilising capacity. A study has shown that 
sperm motility and acrosome reaction rates were improved by this technique and this 
treatment did not have any deleterious effect on the foetus .
6. Soluble complement receptor treatment may be beneficial in treating complement 
mediated sperm damage39.
7. Fab fragments treatment - Studies in rabbits have been suggested that in vitro 
treatment of sperm with Fab fragments may help to protect it from immune attack71 in 
vivo.
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8. Chvinotrypsin treatment (incubation of sperm with chymotrypsin) appeared to
72improve fecunditiy rates when compared with non treatment .
9. Plasmapheresis and hemosorption - A study has shown that this technique helped to 
improve sperm parameters and subsequent ART and pregnancy outcomes by 
decreasing ASA levels and normalising humoral and cellular immunity73.
10. Miscellaneous - Acupuncture, Chinese herbal treatment, monoclonal antibody therapy 
and zinc therapy have also been tried with varying success74'76.
Despite various treatment modalities being available with regards to male immunoinfertility, 
most of them have met with only limited success.
1.4 Infection
It has long been appreciated that chronic inflammation and systemic infection are associated 
with decreased reproductive capacity. Infections account for almost 15% of cases of male 
infertility seen in infertility clinics77. Inflammatory diseases have been established as hazards 
to male reproductive function and fertility. General acute and chronic infections are 
associated with disorders in steroidogenesis and spermatogenesis resulting in temporary or 
permanent male infertility77. Urethritis, prostatitis, orchitis and epididymitis have been 
described as male accessory gland infections (MAGI) by the WHO.
Infections of the male accessory glands have been considered as causes of male infertility for 
decades. MAGI appeal* to affect reproductive function as indicated by decreased number, 
density, and motility of spermatozoa and alterations in seminal plasma markers78'80. Different 
pathophysiological concepts have been established describing the effects of MAGI on the 
reproductive system, and spermatozoa respectively.
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These concepts involve direct effects exerted by pathogenic microorganisms in the testis, 
accessory glands, and spermatozoa81, alterations in male accessory gland function due to 
general or local infections59’78 and immunological events resulting from the immune defense 
of the body against invading microorganisms82. However, substantive data is lacking to 
confirm that these diseases have a negative influence on sperm quality .
Nevertheless, infections of the male genito-urinary tract may contribute to infertility by 
adversely affecting sperm function, causing anatomical obstruction to the efferent ducts of 
the testis or initiating a leucocyte response. The majority of infertile males, due to infection, 
are asymptomatic. However, an elevated seminal leucocyte count, pyospermia, can be 
associated with male infertility and may reflect an infectious or inflammatory disorder and 
can present with urinary symptoms and even epididymal and testicular' pam .
The current literature defining the role of infection in male infertility is inconsistent and the 
mechanism by which seminal leucocytes and microorganisms may impair fertility remains 
controversial. Amongst many studies conducted in this field, one study has reported increased 
total leucocyte, granulocyte, monocyte and CD8+ T cell levels in men with infertility and 
pyospermia, causing an adverse effect on sperm concentration, velocity and motility .
Another study has reported that the strongest correlation with an abnormal sperm penetration 
assay was the increased presence of leucocytes in semen, but here too no correlation between 
semen bacterial culture results and sperm penetration scores was noted85. Two other studies 
have found that the semen parameters that correlated most significantly with a reduced ability 
to fertilise oocytes were a slow rate of forward progression of sperm and an elevated number 
of leucocytes in semen 86,87.
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Macrophage activation occurs most effectively by the combination of exposure to microbial 
products (through the receptors) and cytokines particularly IFN-y. The complete activation of 
the macrophages, including the ability to kill intracellular microbes, is helped by IFN-y. IFN- 
yis so potent becauses it enhances several microbicidal pathways, including both the 
respiratory burst and the generation of nitric oxide.
Figure 1.2 shows an overview of T cell mediated immunity to bacteria and fungi. The ThlT 
cells provide both IFN-y and B cell help to produce IgG subclasses for opsonization of 
bacteria. CD8+ cytotoxic T lymphocytes (CTL) can release intracellular organisms by killing 
the infected cell. Even macrophages may be targets of CTLs because when infected with 
intracellular bacteria they can become refractory to activation and less able to kill the 
organism themselves.
CDS T cells are activated by peptides presented via MHC class molecules, primarily derived 
from microorganisms that reside in the cytoplasm, such as viruses and some intracellular 
bacteria that escape the phagosome such as Listeria species. Other pathogens that do not 
escape the phagosome (such as Mycobacterium tuberculosis) can still induce CDS T cell 
responses via cross-priming, in which infected and apoptotic host cells release antigenic 
fragments that are taken up by dendritic cells (DCs).
Figure 1.4 shows that the effector CDS T cells (CTL) provide protection by releasing 
proinflammatory and macrophage-activating cytokines and killing infected host cells via 
perforin release and Fas. In some cases, the release of granulysin from the CTL can also 
result in killing of the pathogen. As we can see from Figure 1.3, chemokines like TNF are 
released which cause an increase in the inflammatory cell recruitment.
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Immunological events include the migration of white blood cells to the site of infection due 
to chemotaxis and the secretion of cytokines that are necessary for the communication 
between immune-competent cells. Cytokines appear to be responsible for most 
pathophysiological events associated with infection and are the decisive factors that 
determine the pathology of an infectious disease.
Several early reports have suggested a relationship between a genital infection and the 
production of sperm autoantibodies88. Furthermore, a sexually transmitted disease also 
appears to predispose men to the development of sperm antibodies89. Other studies have 
shown that in non-symptomatic men under fertility investigation, a previous history of 
prostatitis or urethritis was associated with a marked increase in the incidence of sperm 
antibodies90.
Circumstantial evidence points towards chronic inflammatory conditions in the male 
reproductive tract as a major cause of disturbances in sperm quality. However, a greater 
acknowledgement of its contribution to male infertility needs to be ascertained. Hence 
screening for male genital tract infections is important.
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Overview of CD4* T cell-mediated immunity to bacteria and fungi
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Figure 1.2: Optimal activation of macrophages is dependent on Thl CD4 T cells. 
The most important source of IFN-y during adaptive immune response to 
intracellular bacteria is from Thl CD4+ T cells91. Adapted from Immunology, 
Male D, Brostoff J, Roth D, and Roitt I (editors), with permission from Elsevier Ltd, 
2006.
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Figure 1.3: CDS T cell activation leads to release of chemokine TNF which causes 
inflammatory cell recruitment. Adapted from Immunology91, Male D, Brostoff J, 
Roth D, and Roitt I (editors), with permission from Elsevier Ltd, 2006.
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There are immune consequences of male genital tract infections which include :
1. Induction of an autoimmune response to spermatozoa;
2. Release of proinflammatory cytokines;
3. Activation of yS T lymphocytes;
4. Release of reactive oxygen species; and
5. Immune sensitisation to crossreacting antigens also expressed in spermheat shock 
protein.
1.5 Leucocytes in Male Infertility
Leucocytes are a normal constituent of semen irrespective of the fertility status of the male. 
The human ejaculate invariably contains cellular elements other than spermatozoa. These 
include epithelial cells from the reproductive tract and round cells; namely a mixture of 
immature germ cells and leucocytes. Advances in immunocytochemistry, using monoclonal 
antibodies, have made it possible to accurately differentiate leucocytes and their constituent 
subpopulations from other cells in semen. Such techniques make it possible to asses the role 
of leucocytes as an independent group of round cells in semen, including immune related 
infertility. Male germ cells develop and are sequestrated from the immune system in the testis 
by the blood testis barrier. Thus the male gamete resides for set periods of time in an 
immunologically privileged milieu. However, in the rete testes and epididymis no such 
barrier exists, and immunological and inflammatory responses are mounted against millions 
of spermatozoa stored in this organ.
Leucocytes in fertile ejaculate
Fertile men have leucocytes, in some cases with values considered as pathological, but 
without any effect on the seminal quality and fertility93. A previous study has shown that
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every ejaculate from fertile and infertile men studied, contained granulocytes (the 
predominant leucocyte type), and monocytes / macrophages94. Around two thirds of all 
samples contained lymphocytes. The regular occurrence of leucocytes in the fertile ejaculates 
suggests that they play an important role in the normal function of semen. Certain 
components of semen may act as chemo-attract ants for leucocytes. These may include 
products leaking from dead cells, complement components and bacterial products. In semen, 
leucocytes have an important phagocytic function, destroying necrotic spermatozoa and 
invading microorganisms. This ensures that the ejaculate contains predominantly healthy, 
viable spermatozoa. Distal portions of the male reproductive tract are not sterile, and the 
average ejaculate contains between five-six different species of bacteria95. To prevent 
bacterial colonisation at this site, leucocytes have an important role in immune surveillance at 
these sites, recognising and destroying invading microorganisms. Granulocytes and 
macrophages, bind to, endocytose and destroy factors with particular receptors including 
antibodies, complement factors and bacterial polysacchaiides. No significant difference was 
found in the concentration of leucocytes or subpopulations of these cells (monocytes, 
lymphocytes and granulocytes) between fertile and sterile patients without ASA and 
immunological sterile groups (patients with genital tract infections excluded from the 
study)48. In a study by Gil and co-workers there was a predominance of macrophages / 
monocytes within the population of seminal leucocytes. No statistically significant difference 
was found in the absolute number of T and B lymphocytes between the three groups 
studied48.
Leucocytes in infertile ejaculates
It is estimated that the frequency of leucocytospermia is between 10% and 20% among male 
infertility patients. A variation in leucocyte concentrations is a typical feature of human
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semen, although it is considered pathological when it exceeds a concentration of >lx 106 
WBC/ml semen, defined as leucocytospermia13. This concentration, however, represents only 
a minimal percentage of cells (0.4-4%) when compared to the normal number of 
spermatozoa, ranging from 25 to 250 million/ml96. In general, granulocytes represent 50% to 
60% of all leucocytes in semen, macrophages 20% to 30% and T lymphocytes (CD4+ and 
CD8+) only 2% to 5%. Plasma cells and B lymphocytes are found rarely in semen94. 
However, another study found that macrophages were the predominant cell type in the 
infertile patients with or without leucocytopsermia97. In general, it is difficult to identify 
effects produced by a specific leucocyte type because there is always a mixture of different 
leucocyte populations in semen.
The incidence and significance of leucocytospermia amongst infertility patients is a much 
debated topic. Numerous studies in the past have found elevated concentrations of leucocytes 
to have a positive correlation with infertility. Using monoclonal antibodies, the first evidence 
was provided of a significant relationship between elevated leucocyte concentrations, their 
sub-types and a reduction in total number of spermatozoa, percentage motility, sperm 
velocity and total number of motile spermatozoa. When comparing infertility patients with 
and without leucocytospermia, men with many leucocytes in semen showed significant 
reductions in total sperm number, percent sperm motility, sperm velocity, motility index and 
total number of motile sperm. This was statistically significant in the high WBC / ejaculate 
group >3xl06/ml82.
Men with a high concentration of monocytes / macrophages were found to have a lower 
seminal volume, men with a high number of T cells were found to have a lower sperm 
velocity (although analysis of samples with elevated CD4+ T helper (>5xl04/ml) or CD8+ T
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cytotoxic lymphocytes (>5xl04/ral) did not yield significant differences in any semen 
parameter, possibly because of low numbers of positive individuals), and men with a high 
granulocyte elastase concentration which is an indirect evidence for a high number of 
granulocytes, had a lower ejaculate volume, total sperm number and total motile sperm 
number98. The authors concluded that leucocytospermia may occur in male infertility patients 
and that high levels of leucocytes in semen are associated with poor semen quality.
A significant inverse relationship was found between the number of granulocytes in semen 
and a successful hamster ovum penetration test and increased leucocyte numbers were 
associated with reduced sperm concentrations85. Granulocytes in semen was found to inhibit 
sperm hyperactivation, an important step toward capacitation and acrosome reaction99 and the 
number of leucocytes in semen was a strong predictor of IVF-ET failure .
The percentage of suboptimal semen specimens as defined by the IVF criteria (<107 total 
motile sperm per ejaculate) significantly increased with increasing seminal granulocyte 
concentrations. A twofold increased prevalence in such suboptimal semen specimens was 
observed at the leucocytopsermia threshold of 2xl06 granulocytes/ml100. However, other 
studies found no significant difference in leucocyte count between fertile and infertile 
ejaculates. Another study even argued that semen from fertile men contained significantly 
more leucocytes than subfertile men101.
The exact cause of leucocytospermia may determine its effect on fertility. For example, 
declining frequency of ejaculation will lead to an increased proportion of ageing spermatozoa 
in the male reproductive tract. Spermatozoa will only be stored in the epididymis for up to a 
month, after which they are degraded by phagocytic leucocytes.
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Increased numbers of granulocytes and macrophages infiltrate the reproductive tract for this 
function, and will be present in the following ejaculate. Such an ejaculate will be 
characterised as leucocytospermic, although the increased number of phagocytic leucocytes is 
actually the factor maintaining the quality of the ejaculate. Without this immune function, the 
ejaculate could contain an increased proportion of ageing spermatozoa, which are more likely 
to be functionally impaired, and / or carry genetic mutations.
Leucocytospermia is often described as the best indicator of genital tract inflammation, which 
itself is often clinically silent. It has been reported that 68% of leucocytopsermic patients 
with unexplained infertility were found to have clinically silent prostatitis. The level of the 
area affected is significant as it determines the amount of time leucocytes spend in contact 
with the sperm. Inflammation of the more proximal areas, including the epididymis, are likely 
to have increased significance, as the spermatozoa will be in prolonged and direct contact 
with leucocytes.
An indication of leucocytospermia as one of the causes of male infertility has come from 
studies on the role of oxidative stress in compromising the functional competence of human 
spermatozoa. Activated granulocytes can liberate large amounts of reactive oxygen species 
(ROS), proteases and cytokines which are important mediators of sperm damage in male 
genital tract inflammation , Spermatazoa are particularly susceptible to such stress because 
of their high content of unsaturated fatty acids and they exhibit a highly specialised capacity 
for generating ROS including superoxide anion and hydrogen peroxide .
A number of retrospective analyses have indicated that the excessive generation of ROS is 
associated with defective sperm function particularly in oligozoospermia104. However, the
44
source of the high levels of ROS observed in cases of male infertility is unresolved and 
clinically significant. The washed human ejaculate contains, in addition to spermatozoa, a 
variable number of leucocytes particularly granulocytes which are powerful generators of 
ROS. Phagocytic leucocytes present in sperm suspensions can produce large amount of 
ROS105. If infiltrating leucocytes, rather than defective spermatozoa, are responsible for the 
oxidative stress observed in cases of male infertility, this will clearly have an impact on the 
therapeutic strategies that might be considered.
Since the influence of reactive oxygen species (ROS) on human spermatozoa was first 
reported in 1943, it is now widely accepted that oxidative stress is associated with male 
infertility. These highly reactive molecules cause lipid peroxidation of the polyunsaturated 
fatty acids present in sperm membranes which results in a dramatic loss of sperm oocyte 
fusion. At least 100 times more ROS are produced by leucocytes, particularly granulocytes 
than by spermatozoa106.
ROS are considered to be responsible for much of the target cell and / or tissue damage 
induced by leucocytes. ROS induce lipid peroxidation within the cell membrane. When such 
lipid peroxides are exogenously added to sperm suspensions, an irreversible arrest of sperm 
motility occurs. ROS can also damage protein and nucleic acids107. There is good evidence 
that ROS generated by leucocytes can damage sperm motility , the sperm acrosome 
reaction109, reduce fertilisation rates achieved by IYF110 and correlates with reduced sperm 
function111.
The great amount of energy necessary for the sperm journey is derived from mitochondria. 
Mitochondria possess their own genetic material which, unlike cellular DNA, is naked
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(unprotected by histones and DNA binding proteins) and lack an efficient DNA repair 
mechanism. Thus the mitochondrial DNA is especially prone to damage elicited by the free 
radicals and ROS which are continuously generated by mitochondria during normal aerobic 
metabolism. A deletion in mitochondrial DNA would impair the synthesis of mitochondrial 
proteins necessary for mitochondrial function resulting in a subsequent decline in sperm 
motility112.
The classical view of leucocytes was that only macrophages and polymorphonuclear' 
neutrophils could initiate a respiratory burst to generate the superoxide needed for killing 
microorganisms. Evidence suggests that components of the oxidase system responsible for 
initiation of the burst and superoxide generation may also be present in both T and B 
lymphocytes113. There was no evidence that spermatozoa were the principal source of ROS 
production in any of the oligospermic samples examined114.
Immunological causes of infertility have been associated with an increased production of 
ROS115. The purpose of the oxidase system in the B cell is unclear but it has been suggested 
that superoxide may play a role in the regulation of gene expression or digestion of the 
antigen. Semen samples that have ASAs present are likely to have increased numbers of B 
lymphocytes114. This means that increased ROS production is likely. Increased ROS 
production by semen samples in which ASAs are present may decrease fertility further.
Currently it is difficult to predict the impact of ASAs on fertility. Some men achieve 
fertilisation despite high semen antibody titres, whilst lower antibody titres may be the only 
abnormality detected in couples with prolonged infertility. Investigations into the extent of 
ROS induced damage, such as lipid peroxidation, may help to distinguish those patients who
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are likely to experience complete failure of fertilisation. High levels of ROS production were 
associated with impaired sperm mucus penetration in vitro. As the level of ROS production 
increased, the number of progressively motile spermatozoa that were present in the mucus 
after both 15 min and 1 h was reduced111. It is unclear whether this was due to a direct effect 
of ROS on sperm function or if it was due to the fact that high ROS producing samples 
tended to have a lower sperm concentration.
Generally it appears that samples with increased ROS production tend to have poor semen 
quality together with reduced performance in a number of sperm function tests that are 
commonly used as a first step in male subfertility investigations. It is unclear if the poor 
performance can be accounted for by low sperm numbers or if this is exacerbated by 
oxidative damage that takes place in the epididymis or semen111. There was no relationship 
between the presence of antisperm antibodies and the production of ROS .
The results of the sperm recovery and motility maintenance test emphasise that spermatozoa 
are more vulnerable to ROS once they are denied the antioxidant defenses in seminal plasma 
and this needs to be taken into account during sperm preparation for assisted conception116. 
Leucocytes can be identified in sperm by using monoclonal antibodies through 
immunohistocytochemistry. The different leucocyte subsets can be identified using various 
cell surface markers or monoclonal antibodies. Table 1,4 outlines the cell surface markers 
used in this thesis.
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Table 1.4: Human leucocytes can be identified by the following cell surface 
markers used in this thesis. Adapted with permission from Biochemical Society
, 117
Transactions .
CD Description Leucocyte expression
CD3 Part of the T cell receptor complex T cells
CD4 Ligand for class IIMHC Helper T cells (Th), macrophages
CDS Ligand for class I MHC Cytotoxic T cells (Tc)
CD 14 Lipopolysaccharide-binding protein Monocytes, macrophages
CD16 Receptor for complexed IgG Neutrophils, NK cells,
Monocytes, Macrophages
CD56 Neural cell adhesion molecule (N- NK cells, LGL
CAM) isoform
CD69 C- Type lectin protein Activated T and B Lymphocytes
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1.6 Cytokines in Male Infertility
Inflammatory disease has been long known to affect male reproductive function and is known 
to be associated with elevated levels of proinflammatory cytokines. Cytokines are 
polypeptides (regulatory proteins) usually smaller than 35 kDa, involved in haematopoiesis, 
immune cell development, inflammation and immune responses. Several cytokines have 
direct effects on testicular cell functions, and a number are produced within the testis even in 
the absence of inflammation or immune activation events. There is compelling evidence that 
cytokines, in fact, play an important regulatory role in the development and normal function 
of the testis. There are two major roles that cytokines play in testis: the first is as mediators of 
pathophysiological outcomes of immune-endocrine interactions during inflammatory 
disease; the second is as growth and differentiation factors that help orchestrate cellular 
interactions during normal physiological functions.
1.6.1 An overview of cytokines discussed in this thesis
Table 1.5 gives an overview of major cytokine families including the source, their principal 
targets and the principal effects.
The cytokine milieu is critical for determining the outcome of an immune response following 
B cell T cell interaction. Thl cells are CD4+ that produce IL-2 and IFN-g and are chiefly 
responsible for delayed type hypersensitivity responses. Th2 cells are CD4+ that produce IL- 
4, IL-5, IL-10 and IL-13 and are very efficient helper cells for the production of antibodies, 
especially IgG and IgE. Figure 1.4 outlines the different cytokines which are produced by 
Thl and Th2 cells. These cytokines also play a role in B cell development.
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Table 1.5: Description of the major cytokines. Adapted from the Cytokine 
Handbook. Thomson AW & Lotze MT (editors), permission from Elseiver Ltd 2003.
The Major Cytokines
Cytokine immune system source Other cells
Principal
targets Principal effects
IL-6 T cells, B cells fibroblasts,macrophages
B cells, 
aepatocytes
B cell differentiation, induces acute phase 
proteins
IL-8 monocytes fibroblasts
neutrophils, 
basophils, T 
cells,
keratinocytes
chemotaxis, angiogenesis, superoxide 
release, granule release
IL-10 T cells TH1 cells inhibition of cytokine synthesis
IL-11
bone marrow 
stromal cells, 
Fibroblasts
hemopoietic
progenitors,
osteoclasts
osteoclast formation, colony stimulating 
factor, elevates platelet count in vivo, inhibits 
proinflammatory cytokine production
IL-12 monocytes T cells induction of Thl cells
TNF-a
macrophages, 
mast cells, 
lymphocytes
macrophages, 
granulocytes, 
tissue cells
activation of macrophages, granulocytes and 
cytotoxic cells, leukocyte/endothelial cell 
adhesion, cachexia, pyrexia, induction of 
acute phase protein, stimulation of 
angiogenesis, enhanced MHC class I 
production
IFN-y T cells, NK cells epithelia,fibroblasts
leukocytes, tissue 
cells, Th2 cells
MHC class I and II induction, macrophage 
activation, | endothelial cell/lymphocyte 
adhesion, M0 cytokine synthesis, antiviral 
state, antiproliferative (Thl cells)
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Cytokines and B cell development
Figure 1.4: Cytokine secretion from CD4+ T cells controls B cell proliferation 
and differentiation. AFC- antibody-forming cell (B cell), APC-antigen presenting 
cell91. Adapted from Immunology. Male D, Brostoff J, Roth D, and Roitt I (editors), 
with permission from Elsevier Ltd, 2006.
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Spermatogenesis is a complex process regulated by endocrine and testicular paracrine / 
autocrine factors. Gonadotrophin releasing hormone (GnRH), which is released from the 
hypothalamus, affects the release of leutinizing hormone (LH) and follicular stimulating 
hormone (FSH) from the hypophysis. LH induces Leydig cells to produce testosterone, which 
under high levels negatively affect LH production (through the hypothalamus or hypophysis). 
On the other hand, FSH affects Sertoli cells in the seminiferous tubules to produce various 
autocrine / paracrine factors such as transferrin, androgen-binding protein, cytokines and 
inhibin. Under high levels, these factors (mainly inhibin) negatively affect FSH production 
through the hypophysis, hi addition, LH and FSH could affect, directly or indirectly, the 
production of various paracrine / autocrine factors from testicular’ cells of the interstitial and 
seminiferous tubule cells (Figure 1.5).
Gonadotropins are involved in the regulation of several testicular paracrine factors, mainly of 
the IL-1 family and testicular* hormones. Testicular* cytokines and growth factors (such as IL- 
1, IL-6, TNF, IFN-y, LIF and SCF) have been shown to affect both the germ cell proliferation 
and the Leydig and Sertoli cells functions and secretion118. These cytokines also control the 
secretion of the gonadotropins and testosterone in the testis. Under* pathological conditions 
the levels of proinflammatory cytokines are increased and negatively affect spermatogenesis. 
Autocrine and / or paracrine factors affect testicular* functions and also regulate the secreted 
levels of endocrine factors. Under pathological conditions, such as systemic or* testicular- 
infection / inflammation, the levels of proinflammatory cytokines in the testicular* tissue 
could be increased and thus disrupt the balance and normal levels of these cytokines in the 
testis and also the levels of the secreted endocrine factors (Figure 1.6).
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Figure 1.5: Endocrine control of spermatogenesis. Reprinted with permission from 
Asian Journal of Andrology118.
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Figure 1.6: Cytokine influence on spermatogenesis. Reprinted with permission 
from Asian Journal of Andrology118.
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Cytokines also affect testicular function via the hypothalamic-pituitary-adrenal pathway. 
Neuroimmune endocrine interactions are evident during stress related events and have been 
demonstrated in experimental models that utilise local application of cytokines to the brain. 
Another neural mechanism directing function of testicular cells involves autonomic nerves in 
the testis that appear to influence steroidogenesis and spermatogeneis directly or via vascular 
function. Inhibitory effects of the neuroimmune-endocrine pathway occur over a longer 
period of time course, while the autonomic nerves in the testis appear to be responsible for 
immediate alterations in testicular function119.
The male reproductive tract is an immunologically dynamic tissue capable of initiating both 
humoral and cell-mediated immune responses. Sperm cells express unique differentiation 
antigens capable of eliciting autoimmune responses. These cellular immune responses are 
mediated by cytokines. There is considerable evidence that cytokines play a role in 
immunological infertility. APC are a specialised group of cells termed antigen presenting 
cells which link the innate and adaptive immune systems by producing cytokines. These cells 
carry antigens in a form that can stimulate lymphocytes (Figure 1.7).
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Antigen-presenting cells (APCs) in the immune system
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Figure 1.7: APCs link the innate and adaptive immune systems91. Adapted from 
Immunology. Male D, Brostoff J, Roth D, and Roitt I (editors), with permission from 
Elsevier Ltd, 2006.
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1.6.1.1 Interleukin-6 (IL-6)
Interleukin-6 (IL-6), a 30 kDa glycoprotein, is part of a family of cytokines that act through 
the gp!30 receptor, and is an extremely important cytokine in the regulation of inflammation 
and immunity that is present at low levels in the circulation of healthy adults 
Synthesis and regulation: Many cells including T and B cells, macrophages, fibroblasts and 
endothelial cells produce IL-6. In the testis, IL-6 is produced by Sertoli cells in response to 
stimulation by FSH, testosterone, neuropeptides, and residual bodies * . Leydig cells also
express IL-6 after LH stimulation in vitro ’ .
Receptors and signalling: IL-6 binds to a plasma membrane receptor, IL-6 receptor. The IL-6 
receptor is expressed on activated B cells, plasma cells, T cells, monocytes, epithelial cells, 
fibroblasts, hepatocytes and neural cells. Soluble forms of IL-6Ra and gp!30 are found in 
human serum may play a role in modulating the response to IL-6126.
Actions:
T and B cells: IL-6 acts synergistically with IL-1 and TNF-a to induce T cell proliferation 
and differentiation. It also stimulates B cells to differentiate into plasma cells. This 
proinflammatory role may be important in chronic infections in order to lead to the 
development of specific humoral and cellular immune responses127.
Testis: IL-6 has a number of effects on seminiferous epithelial function, including stimulation 
of transferrin production by Sertoli cells128, and inhibition of meiotic DNA synthesis in pre- 
leptotene spermatocytes129. Both LPS and IL-1 stimulate IL-6 production by Sertoli and 
Leydig cells indicating that both cytokines are increased within the testis under inflammatory 
conditions123'125.
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1.6.1.2 Interleukin-8 (IL-8)
Synthesis and regulation: IL-8, a 77 amino acid glycoprotein dimer, is synthesised as a 99 
amino acid precursor by activated monocytes, lymphocytes, fibroblasts, epithelial cells and 
hepatocytes. It can be induced by IL-1 (3, TNF-a, LPS and viral RNA. LPS is particularly 
effective in inducing production of IL-8 by monocytes. IFN-y inhibits the production of IL-8. 
Receptors and signalling: IL-8 acts through two high affinity G-protein coupled receptors, IL-
i of)
8 receptor type A and IL-8 receptor type-B
Actions: IL-8 is important for cell-mediated response to infection. It is a chemotactic 
cytokine that activates neutrophils, leading to degranulation and release of collagenase and
1 o 1
elastase containing granules .
1.6.1.3 Interleukin-10 (IL-10)
IL-10 is an important deactivating, immunosuppressive and anti-inflammatory cytokine. 
Synthesis and regulation: EL-10, a 18.5kDa homodimer of two polypeptide chains is produced 
by macrophages, T and B cells and various other cells such as mast cells and keratmocytes . 
LPS, catecholamines and glucocorticoids are known to increase IL-10 secretion .
Receptors and signalling: The EL-10 receptor has two subunits which are members of the 
cytokine receptor family type 2134 and signals via a JAK kinase pathway.
Actions:
Monocytes and macrophages: IL-10 inhibits the production of proinflammatory cytokines 
such as IL-1 (3, IL-6, IL-8, and TNF-a by activated monocytes and macrophages135. IL-10 
inhibits the production of prostaglandin E2 (PGE2) through downregulation of 
cyclooxygenase-2 (COX-2) expression. This in turn reduces the expression of the enzymes 
involved in cervical changes (matrix metalloproteases), which are regulated by a PGE2- 
cAMP pathway. IL-10 has been shown to down regulate MHC class II molecules at the
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monocyte cell surface through post translational effects136. IL-10 inhibits the transport of 
MHC class II molecules to the cell surface.
Neutrophils: IL-10 inhibits the LPS induced production of IL-1 p, IL-8 and TNF-cc by 
neutrophils. IL-10 blocks the gene transcription of these proinflammatory cytokines by 
inhibiting NF/:B activation. It also suppresses the killing of phagocytosed bacteria and 
enhances the production of IL-RA137.
T and B cells: IL-10 enhances expression of MHC class II molecules on B cells. It also 
increases antibody production and B cell survival. IL-10 strongly inhibits CD4+ cytokine 
production, whilst stimulating CD8+ cells into cytotoxic activity and proliferation.
1.6.1 A Interleukin-11 (IL-11)
IL-11 is a multifunctional cytokine first isolated in 1990 from bone marrow derived stromal 
cells. It is a key regulator of multiple events in hematopoiesis, most notably the stimulation of 
megakaryocyte maturation. It is also known under the names adipogenesis inhibitory factor 
(AGIF) and oprelvekin.
In reproduction:
IL-11 and leukaemia inhibitory factor (LIF) are produced by the endometrium and are 
absolutely required for implantation in mice. Both cytokines increase adhesion of primary 
human endometrial epithelial cells to fibronectin and collagen IV. A study demonstrated that 
targeting IL-11 and LIF may be useful in regulating fertility by either enhancing or blocking 
implantation138. Defects in IL-11 signalling in mice result in trophoblast over-invasion and 
fetal loss139.
IL-11 has been shown to be significantly higher in oligo-terato-asthenozoospermic infertile 
patients. A study also found that a combined determination of IL-6, IL-8 and IL-11 in the
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seminal plasma of men with genital infection and oligo- terato- asthenozoospermia may 
provide clinically useful information for the diagnosis of male accessory gland infection140.
1.6.1.5 Interleukin-12 (IL-12)
IL-12, a heterodimeric protein, enhances Thl immunity and is important for defence against 
intracellular pathogens.
Synthesis and regulation: IL-12 is produced by B cells and dendritic cells, in response to 
stimulation by T cells and antigens or bacteria. It is also produced in response to LPS 
stimulated macrophages, microglia, neutrophils and astrocytes.
Receptors and signalling: The IL-12 receptor is a high affinity receptor with 2 chains, |3 1 and 
[3 2. IL-10 inhibits production of IL-12 by monocytes
Actions: IL-12 acts in synergy with IL-2 to induce IFN production by T cells and NK cells141. 
It enhances NK cell activity and costimulates blood lymphocyte proliferation. It also 
stimulates the proliferation and activation of Thl cells .
1.6.1.6 Tumour Necrosis factor alpha (TNF-ct)
TNF-a is a proinflammatory, cytotoxic cytokine with a trimeric structure, which acts via 
receptors that mediate a cell-death signal (Figure 1.8).
Synthesis and regulation: TNF-a can be produced by many cells including monocytes, T and 
B cells, neutrophils, glia, neurones and smooth muscle cells, but is mainly secreted by 
activated macrophages143. Production of TNF-a can be stimulated by a variety of chemical, 
biological and physical factors. Viruses and bacterial products such as endotoxin, cytokines 
such as IL-1, IFN-y, GM-CSF, X-ray radiation, trauma and ischaemia can all induce TNF-a 
production. The synthesis of TNF-a is tightly controlled. In the normal healthy human, it is 
produced in very small quantities so that there is virtually no TNF-a detectable. However, it
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is one of the first cytokines to be produced in response to stimulation such as sepsis or
144trauma .
TNF-a has been found in pachytene spermatocytes and round spermatids145, and in activated 
macrophages isolated from the testis146. TNF-a exists in two forms. Most biological activity 
of TNF-a is attributed to the soluble form but the membrane bound form TNF-a does have 
some activity and is more able to activate TNF receptor 2147. TNF-a production is regulated 
during transcription (NFfcB promotes148 and corticosteroids and IL-10 inhibits), translation 
and at a post-translational stage, TNF-a is secreted as a prohormone and is proteolytically 
cleaved by TNF-a coverting enzyme (TCE).
Receptors and signalling: There are two TNF high affinity receptors, found on most cell types 
apart from red blood cells. TNFR1 is thought to be responsible for most TNF-a biological 
activity. TNFR2 is thought to potentiate the effects of TNFR1, promote the proliferation of T 
cells and in oligodendrocyte regeneration143,149,150.
Actions;
Systemic: TNF-a produces fever and anorexia due to its effects on the hypothalamus. It also 
leads to release of acute phase proteins from the liver. TNF-a is a procoagulant and increases 
permeability and MHC class I expression of vascular endothelium which can lead to 
disseminated intravascular coagulation and shock.
Monocytes and macrophages: TNF-a acts synergistically with IFN-y in inducing production 
of IL-1, IL-6, IL-8, GM-CSF, IFN-y and TGF-fh It also induces further release of TNF-a. 
TNF-a causes degranulation, superoxide release and increased adhesion in granulocytes,
T and B cells: In B cells, TNF-a induces superoxide production. In T cells it induces 
cytotoxic invasiveness.
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TNFot is a cytokine with many functions
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Figure 1.8: TNF-cc; has several functions in inflammation. It is prothrombotic 
and promotes leukocyte adhesion and migration (top). It has an important role 
in the regulation of macrophage activation and immune responses in tissues 
(centre), and it also modulates hematopoiesis and lymphocyte development 
(bottom)91. Adapted from Immunology. Male D, Brostoff J, Roth D, and Roitt I 
(editors), with permission from Elsevier Ltd, 2006.
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Testis: Similar to IL-1, TNF-a inhibits Leydig cell steroidogenesis151, and its localisation to 
the post-meiotic germ cells also indicates possible involvement in the process of 
spermatogenesis. For example, TNF-a might play a role in controlling the efficiency of the 
spermatogenic process, inhibiting germ cell apoptosis by regulating the level of type 2 
transmembrane protein Fas ligand (FasL)152. hi pathology, TNF-a has been implicated as a 
major causative agent in the development of autoimmune orchitis .
1.6.1.7 Interferons
Interferons (IFN) are a very large family of cytokines with potent anti-viral actions, which are 
classified as type I (IFN-a or IFN-(3) or type II (IFNy) (Figure 1.9). IFN-y is normally 
produced by T lymphocytes and plays an immunoregulatory role by stimulating antigen 
specific immune responses154. Both type I and type II IFNs have been found in the testis, and 
are stimulated by viral infections, particularly in Sertoli and Leydig cells155,156.
Interferons have been shown to inhibit Leydig cell steroidogenesis in vitro, through inhibition 
of StAR expression157. IFN-y exerts its inhibitory effects on testosterone production at the 
level of cholesterol transport into the mitochondria and expression of both P450scc 
(cholesterol side chain cleavage enzyme) and P450cl7 (cytochrome enzyme involved in 
steroid synthesis)158. Moreover, IFN-y has been implicated in the onset of many autoimmune 
diseases, including autoimmune orchitis159. Furthermore, there exists a complex interaction of 
cytokines produced by Thl and Th2 cells in the regulation of macrophage activation and 
stimulation of B lymphocytes. Figure 1.10 highlights these interactions.
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Interferons
Figure 1.9: Interferon-a (IFN-a) and/or interferon-p (IFN-p) secreted by the 
virus infected cells and interferon-y (IFN-y) secreted by the TH1 cells are 
involved in protecting the testis by inducing resistance against viral infections91.
Adapted from Immunology. Male D, Brostoff J, Roth D, and Roitt I (editors), with 
permission from Elsevier Ltd, 2006.
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M (editors), Churchill Livingstone.
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Figure 1.11: The role of cytokines in Humoral & Cell mediated Immunity161'162. 
Reprinted with permission from Mucosal Immunology. Ogra PL, Mestecky J, Lamm 
ME, Strober W, Bienenstock J, McGhee JR (eds). San Diego: Academic Press.
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Cytokines also have a role to play in humoral immunity and Figure 1.11 shows the interaction 
of cytokines in cell mediated immunity and humoral immunity. Cytokines are detrimental to
murine embryonic development in vitro and IFN and TNF have inhibitory effects on human
1 £0
sperm motility as well as performance in sperm penetration assays . These cytokines, if 
present, may adversely affect sperm cell function and the reproductive process. Additional 
efforts are needed to clarify the effects of cytokines on fertility.
1.7 Immune disorders & Reproductive failure
Taking into consideration the various immune system disorders, they may lead to 
reproductive failure at different stages of the reproductive process: unexplained infertility, 
recurrent IVF or ICSI failures and recurrent miscarriages. Two immune cells have been 
associated with infertility, recurrent implantation failures and recurrent miscaniages. These 
are CD56+ natural killer cells164;165 which produce cytokines including TNF-a and CD19+ (B 
cells) which produce antibodies to hormones such as HCG, progesterone etc.
Cytokines are released by various immunocompetent cells in the male urogenital tract. They 
play an important role in cell signalling and perform broad pleomorphic activities . Studies 
have reported that cytokines may be mediators of oxidative stress and have the potential to 
alter the redox (reduction-oxidation reaction) equilibrium167'169. A study in patients with 
genital tract inflammation reported that cytokines may modulate pro-oxidant and anti-oxidant 
activities in the male genital tract170. Cytokines are also capable of influencing sperm 
function and fertility ’ . Chronic urogenital infections or humoral immune responses have
been suggested to play a role in reduced sperm quality and fertility154. Tissue damage caused 
by microbial pathogens is also associated with the secretion of proinfLammatory cytokines172. 
Regulatory factors released in the reproductive tracts are able to influence sperm function
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directly or indirectly. Cytokines produced by activated neutrophils were found to adversely 
affect sperm motility and sperm fertilising ability in the hamster ovum penetration test . The 
same group also reported that IFN-y and TNF-oc significantly reduced sperm motility in vitro.
Controversy exists over the role of cytokines in reproductive failure as studies have shown
that TNF-a in vitro does not affect human sperm motility, hamster ova penetration, mouse in
vitro fertilisation and embryo development173, high concentrations of TNF-a and IL-2 are not
related to sperm parameters or to the presence of bacterial agents174 and IFN-y, TNF-a or IL-
8 has no effect on the calcium ionophore challenged acrosome reaction in vitro . The total
number of motile spermatozoa is considered a clinically important parameter with regards to
fertilisation rates in IVF programmes176. It has been suggested that IL-1, IL-6 and TNF-
a might influence sperm motility via direct or indirect effects such as reduced mucosal
penetration properties and therefore reduced male fertility177. These cytokines may result in
decreased sperm motility and therefore, in reduced ova-penetrating properties. Positive
correlations have been demonstrated between sperm motility and sperm morphology and
fertilisation rates in IVF which are significant factors in predicting both fertilisation and
pregnancy rates110’178. However, some studies have shown that IL-6 provides a positive signal
in enhancing the fertilising capacity of human sperm by increasing capacitation leading to the
acrosome reaction179. Recently, seminal plasma has been found to regulate endometrial
180cytokine expression, leucocyte recruitment and embryo development in the pig
Considerable research over the past 10 years has helped to identify a role for several 
cytokines in the regulation of the male reproductive tract, particularly within the testis. This 
apparent overlap between testicular and immune regulatory mechanisms could provide the
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key to understanding both the processes leading to inflammation-mediated damage of 
testicular* function and the phenomenon of immune privilege in the testis.
Regardless of the importance of their role in normal testicular physiology, it is evident that 
several cytokines are shared by the immunological and testicular* systems. As a result, 
activation or failure of the immune system can result in perturbation of testicular* function at 
least partially through cytokine-mediated effects. For example, up-regulation of IL-1 and IL- 
6 by inflammation in either the circulation or within the testis itself would undoubtedly 
disrupt the ability of these cytokines to play a role in the fine control in the regulation of the 
spermatogenic cycle. Similarly, the production of IFNs or* TNF-ot during a viral or bacterial 
infection could suppress steroidogenesis, due to the specific effects of these cytokines on 
Ley dig cells. Consequently, excessive production of cytokines within the testis may be an 
important cause of the impairment of spermatogenesis and steroidogeneis that usually occurs 
during inflammation, illness and injury. Figure 1.12 highlights the complexity of the cytokine 
regulatory network within the testis, and the overlap with cytokines produced by immune 
cells as wellas somatic cells during immune and inflammatory responses.
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IMMUNE CELLS
Figure 1.12: Diagrammatic representation of cellular relationships and sites of 
production and action of key cytokines within the mammalian testislsl. Reprinted 
with permission from Journal of Reproductive Immunology.
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1.8 Summary
Application of newly developed molecular techniques to the field of male infertility has made 
the delineation of subtle causes of infertility—an unapparent genital tract infection, immune 
system activation within the genital tract, mutations in sperm mitochondrial or chromosomal 
DNA, alterations in sperm components involved in receptor-ligand interactions, and 
production of sperm autoantibodies—all increasingly amenable to clinical analysis. 
Continued investigations at the cellular and molecular level of the causes of male infertility 
will also lead to novel treatment regimens as well as development of new methods of fertility 
regulation.
Investigations on the potential role of ASAs in infertile couples have been performed 
extensively during the past three decades. However, questions about the underlying 
mechanisms of ASA in reproduction, testing methods, the relationship between ASAs and 
infertility, and the treatment of ASA-mediated human infertility still remain. In fact, research 
on ASA-related infertility is limited. In conclusion, sperm antigens and ASAs appeal* to have 
both adverse and favorable effects, with some even having no effect on fertility. But when do 
they act on fertility, and to what extent do they affect fertility? This study aims to answer 
some of these questions.
Leucocytospermia is said to occur in 10-20% of infertile patients. It has been considered to 
be a significant cofactor in poor semen parameters. The relationship between leucocyte 
concentrations in semen and abnormal semen parameters has not been clearly established. 
The clinical significance of leucocytospermia has been questionable particularly if the 
patients are asymptomatic. Some authors have even concluded that the threshold of clinically 
significant leucocyte count in semen should be estimated at a higher level than the current 
WHO recommendations100. If leucocytospermia was considered to be secondary to infection
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then one would have anticipated that antibiotic treatment would reduce the leucocyte count 
and improve sperm parameters. However, there was no beneficial effect of antibiotic 
treatment on semen parameters nor were there a statistically significant reduction in the 
leucocyte count amongst both the leucocytospermic and the non leucocytospermic 
individuals . However, other authors have suggested that semen parameters including 
progressive motility rate and sperm concentrations were significantly lower in the 
leucocytospermic group compared with the control group. Other semen parameters were not 
affected by the presence of leucocytes183.
ICSI outcome, including fertilisation (82% vs. 87%) and embryo development rates (79% vs. 
86%) were significantly lower in the leucocytospermic group compared with the control 
group although there were no statistical differences for embryo quality, embryo cleavage and 
pregnancy rates183. These results indicate that some semen parameters and the outcome of 
ICSI were negatively affected by the presence of leucocytospermia. In contrast to the above 
study, another study reported fertilisation rates of 63.4% (range 44.4-87.5%) in 
nonleukocytospermic couples and 64.3% (range 45.3-100.0%) in leukocytospermic couples, 
and the corresponding pregnancy rates were 34.5% and 50%, respectively. These results 
show that leukocytospermia may not necessarily have a negative effect on outcome after 
either in vitro fertilisation or intracytoplasmic sperm injection184.
Even though biologically active cytokines are found in abundance in seminal plasma and 
have been shown to be secreted by spermatozoa, the function of the cytokine network in 
relation to the fertilising capacity of the sperm has never been evaluated. Furthermore, the 
role of the cytokine network in male subfertility is also poorly understood. In most studies, 
only a few cytokines (up to four) in seminal plasma have been measured, and the
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pathophysiological effect of these cytokines on fertilisation rates and pregnancy outcomes 
remain largely unexplored.
1.9 Project Aims
Given the controversy that exists about the role of leucocytes and cytokines in male 
subfertility, the main hypothesis of this thesis was that neither leucocytospermia on its own 
nor individual cytokines have any significant role to play in male subfertility. However, the 
combination of leucocytospermia in the presence of the cytokine network may adversely 
affect sperm parameters and lead to male subfertility. In this study, leucocytes and seven 
cytokines have been analysed at the same time in the seminal plasma of both subfertile men 
and in men attending for IVF. This was used to determine if either leucocytospermia or 
individual cytokines had an influence on sperm parameters / fertilisation rates and pregnancy 
outcomes in an IVF cycle.
Chapter 2, the materials and methods chapter, discusses the various methodological aspects 
of the study ranging from ethical approval, patient recruitment, immunohistocytochemistry 
and ELISA techniques and statistical analysis.
Chapter 3, the leucocyte chapter, has been subdivided into subsections 3.1- 3.7. Each of the 
subsections aims to answer particular questions with regards to leucocyte subsets and their 
role in male subfertility:
3.1- To determine if ASA+ve patients exhibit leucocytospermia and if so, if there is 
any differential attraction of leucocyte subpopulations and compare them to the 
ASA-ve patients and controls.
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3.2- To determine if microbiologically culture positive patients exhibit 
leucocytospermia and if so, if there is any differential attraction of leucocyte 
subpopulations between patient groups or in specific infections.
3.3- To determine if oligospermic patients exhibit leucocytospermia and to analyse 
the effect of seminal leucocyte subpopulations on various sperm parameters (count, 
motility, morphology and migration test) with particular emphasis on the sperm count.
3.4- To determine whether asthenospermic patients exhibit leucocytospermia and if 
there is a relationship between various leucocyte subpopulations and sperm motility.
3.5- To determine if oligoasthenospermic patients exhibit leucocytospermia and to 
show the effect of various leucocyte subpopulations on sperm parameters with 
particular’ emphasis on sperm count and motility.
3.6- To determine if azoospermic patients exhibit leucocytospermia and to which and 
at what levels the various leucocyte subpopulations are present in azoospermia.
3.7- To determine if poor fertilisers exhibit leucocytopsermia and the true effect of T 
and B cell subpopulations on the fertilisation rates in an IVF cycle.
Chapter 4, the cytokine chapter, has been divided into subsections 4.1-4.4. Each of the 
subsections aims to answer particular* questions with regards to cytokines and their role in 
male subfertility:
4.1- To determine if there is an elevation of cytokines in the ASA+ve patients and 
whether cytokine mediated sperm damage could explain the subfertility in this group 
of patients.
4.2- To determine if microbilogically culture positive patients exhibit elevated levels 
of cytokines and if so whether this could explain their subfertility due to cytokine 
mediated sperm damage.
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4.3- To determime the presence of a repertoire of seminal cytokines IL-6, IL-8, IL-10, 
IL-11, IL-12, TNF-a, and IFN-y and to evaluate their role in male subfertility and 
identify any possible networks that may exist.
4.4- To determine the presence of a network of cytokines within the seminal plasma 
and whether this network may influence fertilisation rates either directly or indirectly.
Chapter 5, the combined leucocyte and cytokine chapter, had the aim to confirm the presence 
of cell mediated response in the seminal plasma and to identify any correlations between the 
different leucocyte subpopulations and the individual cytokines and their combined effect on 
sperm parameters.
Chapter 6, the concluding chapter, draws on all aspects of the study including limitations, 
future projects and final summary conclusions.
To my knowledge, no previous studies of a similar nature have been carried out.
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CHAPTER 2: MATERIALS AND METHODS
2.1 ETHICAL APPROVAL
A literature review was conducted to ensure that the research had not been performed 
previously and the relevant patient information sheets and consent forms were written 
(Appendices 1 and 2; pages 249 & 251 respectively). A formal application to the Local 
Research Ethics Committee (LREC 1998/023) based at Liverpool Women’s Hospital was 
submitted. Ethical approval for the project was subsequently granted and patients were 
recruited to the study. Patients were recruited at the Liveipool Women’s Hospital from July 
1999 to July 2001. Patients were asked first verbally if they would be interested in 
participating in such a study. It was emphasised that this was a voluntary study and their 
participation did not affect their treatment or success rate of an IVF programme. They were 
then given the patient information sheet (Appendix 1) which contained further information 
with regards to the purpose of the study, how will the study be conducted, who will conduct 
their study, and the confidentiality with regards to the findings of the study. Once the 
information was read, understood, all questions answered in person, a prospective written 
informed consent was obtained from all patients participating in the study, using the consent 
form in Appendix 2.
2.2 GROUP 1: MEN ATTENDING THE SUBFERTILITY CLINICS
Semen samples were obtained from men attending the Liverpool Women’s Hospital for 
infertility investigation. Semen was obtained by masturbation after three to five days of 
sexual abstinence. The samples were collected in a sterile, wide mouthed, non toxic 
container (Sterilin 60ml container, WA products, Essex) and processed in the laboratory 
within 1 hour of ejaculation. Samples did not get exposed to extremes of temperature.
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They did not come in contact with either lubricants or latex products. All the samples 
underwent semen analysis in the laboratory in accordance with the 1999 WHO laboratory 
manual13 for the examination of human semen and the study was performed using these 
reference values. Men were divided into the different subgroups according to the results of 
two consecutive semen analyses six weeks apart. Given the wide variability between 
ejaculates, two samples were taken to confidently define an individual’s phenotype. The 
seminology laboratory at the hospital carried out standard seminal analysis on each sample, 
including details on sperm number, motility, and the presence of bound antisperm 
antibodies, as detailed by WHO13. A sperm migration test was also performed on these 
samples185. The anti-sperm antibodies were detected by the sperm MAR test and evaluated 
the presence of both IgG and IgA. Parameters obtained from the semen analaysis report are 
shown in Appendix 3. These men had no other illnesses nor did they take any medication.
Sperm migration test : A 50/rf aliquot of liquefied semen was required for each test. It was 
taken from a well mixed ejaculate specimen at 30 minutes after ejaculation. The microscope 
objective fields were calibrated so that the numbers of spermatozoa per field could be 
converted to numbers per unit area. A BEEM® capsule was used as a semen reservoir with a 
hole in the capsule’s cap to take the capillary tube. The semen was placed carefully in the 
bottom of the reservoir which was held upright in a rack and the cap then closed. The open 
end of the hylauronate capillary tube was inserted into the semen reservoir so its open end 
was immersed in the semen. After a period of 60 minutes of incubation at 37 C the capillary 
tube was removed from the sperm reservoir, wiped clean of any residual semen at its open 
end and then transferred to a slide for counting. The depth and degree of sperm penetration 
into the hyaluronate column was assessed microscopically using a magnification of 200- 
250X. The number of spermatozoa present was counted in each of two microscopic fields at
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each of the upper and lower glass faces of the tube at each of the mm distances (e.g. 10mm, 
20mm etc.).
The average number of spermatozoa present per field at each distance along the hyaluronate 
column was calculated and then corrected to give the number per unit area using the known 
microscope field area. A log-linear regression using millimetre distances along the 
hyaluronate capillary as the x-axis values and the log transformed numbers of spermatozoa as 
the y-axis was performed. The vanguard sperm migration distance was calculated . A 
normal semen sample shows a vanguard migration distance of at least 20mm188.
Papanicoloau staining technique was used to assess sperm morphology as it is the 
recommended technique according to the WHO manual83. This technique allows good 
staining of the spermatozoa and the other cells. Also this technique enables one to study the 
acrosomal and post acrosomal areas of the head, cytoplasmic droplet; mid piece and tail areas 
well as all these areas are amenable to the stain. The assessment of sperm morphology and 
migration distance was carried out by the laboratory technician in the Assisted Conception 
Unit at Liverpool Womens Hospital in July 2001.
Sperm motility is divided into four different grades-
• Grade 4: Sperm with progressive motility. These are the strongest and swim fast in a 
straight line. This is equivalent to WHO motility grade a.
• Grade 3: (Non-linear motility): These also move forward but tend to travel in a 
curved or crooked motion. This is equivalent to WHO motility grade b.
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• Grade 2: These have non-progressive motility because they do not move forward 
despite the fact that they move their tails. This is equivalent to WHO motility grade c.
• Grade 1: These are immotile and fail to move at all. This is equivalent to WHO 
motility grade d.
All the samples underwent testing for genito-urinary infections such as Ureaplasma, 
Mycoplasma, Chlamydia trachomatis, Trichomonas vaginalis and other organisms such as 
Enterococcus, Streptococcus etc. The swabs were taken directly from semen and sent to the 
microbiology laboratory for culture. The samples were transported to the Royal Liverpool
o
University Hospital and processed with 24 hours to avoid being frozen to -70 C.
Direct culture of semen is ideally the best practice method to detect male genital tract 
infection as it is 100% specific. However, these are technically demanding, needing cold 
chain particularly for Chlamydia trachomatis to preserve specimen viability in transport and 
are not readily available. Furthermore, the results can take up to eight days. However, these 
tests were done almost nine years ago and now Nucleic Acid Amplification Tests (NAAT) 
may be more applicable as they are both highly sensitive and specific (95%) . The results of
NAAT are received within a few hours. Thus, NAAT is replacing culture as the tests of 
choice in detecting male genital tract infections. However, to date there are no commercial 
NAAT tests available.
After routine semen analysis, samples were centrifuged at 300g for 10 minutes and the 
supernatant removed and stored at -20°C until assayed for cytokines as described in section 
2.6.2 to prevent the effect of proteases on the individual cytokines. The samples were assayed 
in the same run to reduce inter assay variability. The remainder of the sample underwent
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immunocytochemical staining, the established method for accurately detecting leucocyte 
subpopulations102.
2.3 GROUP 2: PARTNERS OF WOMEN ATTENDING THE IVF CYCLE
An embryologist prepared the fresh sperm sample for IVF and the remainder of the sample 
was then used for the analysis of cytokines. None of the samples were discarded. Different 
grading schemes are used for embryos when they reach the blastocyst stage (around day three 
of their development). For this study an in house grading system of Grades 1-4 was used. 
Although grading systems vary slightly from one unit to another, they all produce similar 
results.
The embryo grading used the following criteria as shown in Figure 2.2 190:
• The number of cells present;
• How fast the cells are dividing;
• Whether the division is even;
• Whether there are any fragments of cells present.
The embryo is of high quality if it has an optimal cell number, the cells are fairly regular in 
size, even cell division and there is no fragmentation and is thus referred to as Grade 1. If the 
embryo has even cell division and small fragmentation then it is Grade 2. If the embryo is 
moderately fragmented and has unevenly sized cells (blastomeres) then it is Grade 3. This 
embryo is expected to have a significantly lower chance of implantation. If the embryo is 
severely fragmented and has unevenly sized cells then it is Grade 4. This embryo probably 
does not have much chance to implant and become a viable pregnancy.
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Most of the published embryo grading studies are small and generally from single centres, 
and likely to be subjective and potentially vary between operators and laboratories. Thus the 
Association of Clinical Embryologists in conjuction with the British Fertility Soceity came up 
with a cleavage stage embryo grading system in 2008, based on blastomere number, 
blastomere size and fragmentation191.
2.4 PREPARATION OF SEMINAL LEUCOCYTES 
Preparation of the slides:
Details of preparation of the slides are shown in Appendix 4.
Semen samples were diluted to 10ml with phosphate buffered saline (PBS), and washed by 
centrifugation for 10 minutes at 300g at room temperature. The clear supernatant was 
discarded. The final cellular* pellet was resuspended in 2ml of PBS/BSA (containing 0.1% 
BSA w/v). An aliquot of this suspension was mixed 1:1 in Trypan blue (which stains non- 
viable cells). Using a haemocytometer, the cellular* concentration and percentage viability 
was assessed. By altering the dilution factor of the suspension, the total round cell 
concentration (including non-viable cells) was adjusted to 1 x 106/ml in PBS/BSA. The round 
cells were leucocytes and germ cells.
Constantly mixing to ensure an even suspension of cells, 50/./1 was applied to each spot on 
Teflon-coated slides. Slides were air dried overnight, before fixing for 10 minutes in acetone. 
Wrapped in foil, slides were stored at -20°C until staining.
2.5 IMMUNOHISTOCYTOCHEMISTRY
World Health Organisation recommends peroxidase staining as the standard method and 
immunocytochemistry using monoclonal antibodies as the gold standard for the detection of
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leucocytes. Although the sensitivity of peroxidase test for the detection of leucocytospermia 
currently could be considered low192, at the time of this study no commercial flow cytometry 
methods were approved. Immunohistological staining employing monoclonal antibodies 
against all specific WBC subpopulations is expensive, time consuming and not 
standardised193.
In the past 10 years, flow cytometry technology has been used for sperm analysis194. One 
study has shown that flow cytometry using monoclonal antibodies is a simple and 
reproducible method for detecting semen leukocytes and that the correlation between 
peroxidase test and flow cytometry results is good but not absolute195. This technique, when 
used alongside monoclonal antibodies, allows a rapid, multiparameter analysis of particles 
and is suitable for counting and typing seminal leucocytes.
Mouse IgG (Coulter, Luton, UK) in a 1:100 dilution was used as a control for the immuno- 
histochemistry as it has no specificity.
2.5.1 Staining of seminal leucocytes
Materials required:
-Primary monoclonal antibodies as required (Dako Ltd. High Wycombe, UK.)
-BSA
-Rabbit anti-mouse IgG (Dako Ltd. High Wycombe, UK - Code Z 259)
-Normal human serum (NHS), heat inactivated
-Alkaline phosphatase: anti-alkaline phosphatase complex (APAAP, Dako Ltd. High 
Wycombe, UK - Code D651)
-Fast Red TR salt (Sigma-Aldrich. Gillingham, UK)
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-Haemalum stain (BDH. Poole, UK)
-0.45|im filter 
-Humidified slide box 
-Dako pen
-Aquamont (BDH. Poole, UK) 
-Tris buffered saline (TBS);
Tris 50mM 6.0g/l
NaCl 150mM 8.7g/l
Made up to 1 litre with distilled water, and adjusted to pH 7.6 using HC1
-Alkaline phosphatase substrate:
Napthol AX-MX phosphate (Sigma) lOmg
Dimethyl formamide 1.0ml
0.1 M Tris buffer pH8.2 50mls
Levamisole 1.0M solution 50/rl
Stock solution prepared in a glass bottle and stored at 4 C.
Slides were removed from the freezer and allowed to reach room temperature. Areas to be 
stained were marked with a Dako pen to separate adjacent wells. The primary monoclonal 
antibodies were diluted to the working ratios as shown in Table 2.2 in tris buffer saline (TBS) 
and 0.5% BSA (working dilution is the amount necessary for binding to all target antigens, 
without non-specific binding). 50/il of each antibody was added to wells, and incubated for 
30 minutes at room temperature, in a humidified chamber (to prevent drying of the samples). 
Slides were rinsed in TBS and then washed twice for five minutes in TBS. Rabbit anti-mouse 
immunoglobulin (Dako, High Wycombe, UK) was diluted 1:25 in TBS and 5% NHS, and 
50^/1 of this was added to each well, and incubated as above for 30 minutes. Following this,
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the rinse and two washes in TBS were repeated. Alkaline phosphatase: anti-alkaline 
phosphatase complex (APAAP) (Dako, High Wycombe, UK) was diluted 1:50 in TBS and 
added 50 jul to each well and incubated for 30 minutes. The rinse and two washes in TBS 
were repeated. Antibody binding was enhanced by repeating the addition of Rabbit anti­
mouse immunoglobulin and APAAP solutions (with intervening washes), incubating for just 
10 minutes each time. Slides were washed twice in TBS, then incubated for 20 minutes with 
filtered Alkaline Phosphatase substrate and Fast Red (50 /il per well). Slides were washed 
once in TBS then once in distilled water, before counterstaining with Haemalum (BDH. 
Poole, UK) for 15 seconds (stains nuclei blue). Slides were washed thoroughly in tap water 
and mounted in Aquamount (BDH. Poole, UK).
2.5.2 Antibodies used in the study
The following monoclonal antibodies were used in the study as shown in Table 2.1.
2.5.3 Counting of Leucocytes
The number of positively stained (red-pink) leucocytes for each antibody were counted in ten 
high power fields (HPF = x320 magnification) using a light microscope fitted with a 
graticule. Mean values of the ten counts were calculated, and used for an average value per 
HPF. This method of quantification of leucocyte subpopulations was achieved using original 
sperm concentration, according to the method of Wolff and Anderson 198894. A manual 
count was performed as there were no standardised instrument methods at the time when the 
study was performed. Ten high power fields were used as the average counting method for 
leucocytes as suggested by published studies at the time94;98;196. The specificity of each 
antibody (the type of leucocyte it binds to, resulting in red-pink staining) is given in Table 
2.1. CD45 binds to a common leucocyte antigen, thus staining all leucocytes.
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Table 2.1: Details of the monoclonal antibodies used in this study (antigenic 
markers: CD-cluster of differentiation, Ig-immunoglobulin).
ANTIBODY
to
SPECIFICITY DILUTION CLONE
Obtained from
CD3 All T-lymphocytes 1:100 UCHT1; Serotec,
Oxon, UK.
CD4 Helper T-lymphocytes 1:50 MT310; Dako,
High Wycombe,UK
CDS Cytotoxic T-lymphocyte 1:50 DK25; Dako,
High Wycombe,UK
CD14
(supernatant)
Monocytes/macrophages Neat 3C10; Cell,
Canton, MA
USA
CD16
(supernatant)
Granulocytes, natural
killer cells
1:50 3G8; Cell
Canton, MA
USA
CD 20 B-Lymphocytes 1:50 4KB128; Dako,
High Wycombe,UK
CD45
(supernatant)
All leucocytes (leucocyte
common antigen)
Neat F10-89-4; Cell
Canton, MA
USA
CD69 ActivatedT-lymphocytes,
B-lymphocytes and
macrophages
1:20 CH/4; Serotec
Oxon, UK
MHC class II
supernatant
antigens
MHC class II, macrophages Neat L243; Cell
Canton, MA
USA
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In wells incubated with CD45, both positive and negative (unstained, identified by blue 
nucleus) cells were counted. This proportion was used to determine the proportion of 
leucocytes relative to other round cells (immature germ cells) in the ejaculate. The percentage 
of CD45 positive cells were determined from the number of CD45 positive cells divided by 
the sum of both the CD45 positive and negative cells. Since all samples were initially diluted 
to lx 106/ml, these results represent the total number of leucocytes per ejaculate. The absolute 
counts of the monoclonal antibodies were used for analysis as some of the monoclonal 
antibodies can cross react with other cells and hence the medians were used for the analysis 
rather than expressing them as a percentage of the total round cell count.
2.5.4 ASA Study
The seminology laboratory at the hospital carried out a number of tests on each sample, 
including details on sperm number, motility and the presence of bound antisperm antibodies, 
as detailed by WHO and discussed by Biljan et al185. The samples were divided into two 
groups (ASA+ve, ASA~ve) on the basis of bound ASA levels above 50% as detected by the 
MAR test (WHO, 1992). After routine semen analysis, the remainder of the sample 
underwent immunocytochemical staining.
2.5.5 Statistical Analysis
Statistical analysis of results was performed using SPSS version 13 software package. Using 
the Shapiro Wilkes test for non normality it was established that the results obtained were not 
normally distributed. This indicated that a non parametric test should be used. The Mann- 
Whitney U test was applied to analyse the difference between cell counts from ASA-ve / 
ASA+ve / control groups of patients and differences between sperm parameters. Spearman’s 
rank correlation coefficient was used to determine the correlation between leucocyte count
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and sperm parameters for both the ASA-ve and ASA+ve groups of patients. Similarly, the 
Mann-Whitney U test was applied to analyse the difference between cell counts from culture 
positive and culture negative groups of patients and differences between sperm pammeters. 
Spearman’s rank correlation coefficient was used to determine the correlation between 
leucocyte count and sperm parameters for culture -ve and culture +ve patients. Statistical 
significance was taken at the 5% confidence level (p<0.05) and 1% confidence level 
(p<0.01). The numbers of patients were relatively small as this was aimed as a pilot study and 
if significant levels of leucocytes were found then an adequately powered study would be 
required to determine the statistical and the clinical significance of these findings. Thus both 
levels of statistical significance were looked at as these numbers were on the low side and 1% 
confidence level would make this study more robust.
2.6 ELISA
2.6.1 Preparation and storage of the semen samples
The supernatant was removed from the previously centrifuged samples and stored at -20°C 
until assayed.
2.6.2 Cytokines assays
Cytokine sandwich ELISAs are sensitive enzyme immunoassays that can specifically detect 
and quantitate the concentration of soluble cytokine and chemokine proteins. The basic 
cytokine sandwich ELISA method makes use of highly-purified anti-cytokine antibodies 
(capture antibodies) which are noncovalently adsorbed (“coated” - primarily as a result of 
hydrophobic interactions) onto plastic microwell plates. After plate washings, the 
immobilised antibodies serve to specifically capture soluble cytokine proteins present in 
samples which are applied to the plate.
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After washing away unbound material, the captured cytokine proteins are detected by biotin- 
conjugated anti-cytokine antibodies (detection antibodies) followed by an enzyme-labeled 
avidin or streptavidin stage. Following the addition of a chromogenic substrate-containing 
solution, the level of a coloured product generated by the bound, enzyme-linked detection 
reagents can be conveniently measured spectrophotometrically using an ELISA plate reader 
at an appropriate optical density (OD). Data storage and reanalysis are greatly simplified 
when the plate reader is connected to a computer. By including serial dilutions of a standard 
cytokine protein solution of known concentration, the sandwich ELISA supports the 
development of standard curves.
Standard curves (aka “calibration curves”) are generally plotted as the standard cytokine 
protein concentration (typically ng or pg of cytokine/ml) versus the corresponding mean OD 
value of replicates. The concentrations of the putative cytokine-containing samples can be 
interpolated from the standard curve.
Cytokine concentrations were measured using specific commercial ELISA kits (TNF-a by 
Genzyme Duoset kit Cambridge, Massachusetts, USA and IL-6, IL-8, IL-10, IL-11, IL-12 
and IFN-y from R&D Systems, Abingdon, U.K). The range of measurement of the cytokines 
was IL-6 (3.125-300 pg/ml), IL-8 (31.2-2000 pg/ml), IL-10 (31.25-2000 pg/ml), IL-11 (15.6- 
1000 pg/ml), IL-12 (7.8-500 pg/ml), IFN-y, TNF-a (15.6-1000 pg/ml). The sensitivity of the 
assays for IL-6, IL-8, IL-10, IL-11, IL-12, IFN-y and TNF-a were less than 0.6pg/ml, 
2.6pg/ml, 6.3pg/ml, 4.4pg/ml, 2pg/ml, 8pg/ml and 1.6pg/ml respectively.
An example of how an assay was performed is described below.
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ELISA for Human IL-8
Required:
1. The following reagents from R&D systems:
Capture ab Mouse anti-human IL-8 (cat no. MAB208).
Second ab Goat anti-human IL-8, biotinylated (cat no. BAF208).
Detection agent Streptavidin horseradish peroxidise (Zymed cat no. 43-4323). 
Standard Recombinant human IL-8 (cat no. 208-IL-010).
2. Substrate: Sigma one-step TMB/peroxide, part # T-8540.
3. BSA: need fatty acid-free, suitable for ELISA, e.g. Sigma pail # A-3803.
4. Microtiter plates, Nunc MaxiSorp paid # 439454.
5. 37°C incubator, plate reader, polypropyplene tubes.
6. Stop solution: 2N H2SO4.
7. Coating solution: PBS.
8. Blocking buffer: PBS + 1% BSA+ 5% sucrose + 0.05% sodium azide.
9. Wash buffer: PBS + 0.05% Tween 20.
10. Antibody diluent (used for biotinylated 2nd ab and streptavidin-HRP reagent): PBS + 
0.05% Tween 20 + 0.1% BSA.
Preparation of reagents and buffers:
Capture antibody: Mouse anti-human IL-8, Stock =500 pg/ml in PBS.
Coat at 4pg/ml i.e. 1:125 dilution in PBS.
For one plate will require 80pl in 10 mis.
IL-8 Standards: Use polypropylene tubes, dilute in culture medium without FBS if testing 
culture supernatants. Stock=10pg/ml, reconstituted in 1.0 ml PBS+0.1% BSA. Aliquots 
frozen at -20°C, 50pl per tube.
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Dilute stock 5|li1 +10mls medium = 5000pg/ml
Then prepare serial doubling dilutions i.e. 300pl + 300pl medium to produce the following 
standai'ds: 2500, 1250, 625, 312.5, 156, 78.
Also require medium control and medium + FBS control.
Secondary antibody: Goat anti-human IL-8 biotinylated, 50pg/ml stock in PBS +0.1% BSA. 
Use at 0.02pg/ml ie 1:2500 in PBS/Tw/BSA.
For one plate will require 4pl/10 mis.
Streptavidin-HRP: Dilute 1:4000 in PBS/Tw/BSA; prepare 1:400 dilution first (can store at 
4°C), then 1:10.
Method: The plates were coated with lOOpl per well of capture antibody. They were 
subsequently incubated at room temperature overnight. The wells were washed the following 
day five times with PBS/Tween. It is very important to fill wells forcefully and decant or blot 
to remove all the liquid. Each well was coated with 300pl blocking buffer and kept for 90 
minutes at room temperature. Meanwhile the standai'ds and the samples were prepared. The 
wells were washed again with PBS/Tween. lOOpl of standards and samples were added to the 
wells. It was covered and incubated for 1 hour. The wells were washed five times again with 
PBS. lOOpl of the 2nd ab was added to each well. It was covered and incubated at 37°C for 1 
hour. The wells were washed five times with PBS. lOOpl of Streptavidin-HRP (1:4000) was 
added to each of the wells. It was covered and incubated for 20 minutes at room temperature. 
Subsequntly, the wells were washed five times again with PBS. lOOpl of substrate 
TMB/H2O2 was added to each well. The plates were then incubated for 20 minutes at room 
temperature in the dark. lOOpl of stop solution was added per well. The plates were read at 
OD 450nm and 550nm within 60 minutes. The 550 readings were substracted from 450. The 
assays for the remaining cytokines are the same except for different capture antibodies.
An example of how a calibration curve looks is depicted in the Figure 2.2.
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Grade 1 Grade 2 Grade 3 Grade4
Figure 2.1: Embryo grading (Grade 1- no fragmentation, Grade 2- <30% 
fragmentation, Grade 3- 30-50% fragmentation, Grade 4- > 50%
fragmentation)190. Reprinted with permission from An Atlas of Human Gametes and 
Conceptuses, 2001; Informa Healthcare.
Standard Curve
i.e-
i.o-
0.4 -
1000
Human IL-8 (pg/ml)
Figure 2.2: Cytokine calibration curve for human IL-8 using ELISA kit and 
calibrated to National Institute of Biological Standards and Control. Reprinted 
with permission from Guidebook to cytokines and their receptors; 1994, Oxford 
University Press.
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2.6.3 Statistical Analysis
Statistical analysis was performed using the statistical package for social sciences (SPSS) 
software version 13. The Shapiro Wilkes test was used to test for normal distribution. The 
individual cytokine levels in the normospermic group were compared to the levels of the 
respective individual cytokine from the other subsets. As the data was not normally 
distributed, statistical analysis was performed using the Mann-Whitney non-parametric two- 
sample test. Statistical analysis was performed using the Mann-Whitney test to compare poor 
fertilisers and good fertilisers. Correlations between cytokine concentrations were tested 
using the non-parametric Spearman’s correlation test. Similarly, using the Spearman’s 
correlation coefficient, correlations between cytokine concentrations and the fertilisation rates 
were measured. The correlation between the semen parameters and fertilisation rates was also 
measured using Spearman’s correlation coefficient.
There was a lack of published data in this field, at the time of recruitment, making it difficult 
to estimate accurate numbers for this study. However, a power calculation was performed 
with the assistance of a statistician. The incidence of leucocytospermia was quoted to be 
approximately 10% in infertile men. Based on this incidence, a sample size of 80 was 
estimated with 10 patients in each group of subfertile men. The numbers of patients were 
relatively small as this was aimed as a pilot study and if significant levels of cytokines were 
found then an adequately powered study would be required to determine the statistical and 
the clinical significance of these findings. Thus both levels of statistical significance were 
looked at as these numbers were on the low side and the 1% confidence level would make 
this study more robust.
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CHAPTER 3: LEUCOCYTE SUBSETS IN DIFFERENT INFERTILE MALE
GROUPS AND IN FERTILE CONTROLS
The relationship between leucocytes and the fertilising potential of an ejaculate remains 
highly controversial. Leucocytopsermia, a frequent finding in infertile patients, is often 
associated with poor semen quality. However, some authors have failed to show a robust 
association between sperm and leucocytospermia and these have been discussed in Chapter 1. 
Most of the previously performed studies investigated the effects of leucocytes on sperm 
motility. However, it is still unclear whether leucocytospermia actually has any effect on 
fertilisation or not.
Hence, the aim was to investigate not alone the role of leucocytospermia in male subfertility 
but also to look at what effect the different leucocyte subpopulations have on various sperm 
parameters such as motility, numbers and fertilisation potential. The leucocyte populations 
studied and characterised were the T lymphocytes, B lymphocytes, monocytes / 
macrophages, activated T and B lymphocytes and macrophages, granulocytes and MHC class 
II macrophages.
This chapter has been subdivided into subsections 3.1- 3.7. Each of the subsection aims to 
answer particular’ questions with regards to leucocyte subsets and their role in male 
subfertility:
3.1- To determine if ASA+ve patients exhibit leucocytospermia and if so, if there is any 
differential attraction of leucocyte subpopulations and compare them to the ASA-ve patients 
and controls.
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3.2- To determine if microbiologically culture positive patients exhibit leucocytospermia and 
if so, if there is any differential attraction of leucocyte subpopulations between patient groups 
or in specific infections.
3.3- To determine if oligospermic patients exhibit leucocytospermia and to analyse the effect 
of seminal leucocyte subpopulations on various sperm parameters (count, motility, 
morphology and migration test) with particular emphasis on the sperm count.
3.4- To determine whether asthenospermic patients exhibit leucocytospermia and if there is a 
relationship between various leucocyte subpopulations and sperm motility.
3.5- To determine if oligoasthenospermic patients exhibit leucocytospermia and to show the 
effect of various leucocyte subpopulations on sperm parameters with particular' emphasis on 
sperm count and motility.
3.6- To determine if azoospermic patients exhibit leucocytospermia and to which and at what 
levels the various leucocyte subpopulations are present in azoospermia.
3.7- To determine if poor fertilisers exhibit leucocytopsermia and the true effect of T and B 
cell subpopulations on the fertilisation rates in an IVF cycle.
3.1 STUDY NUMBER X: Leucocyte subsets in Antisperm Antibody Positive versus 
Antisperm Antibody Negative patients versus the Controls
3.1.1 Introduction
Autoimmunity is a condition in which the immune system is sensitised to self tissues. 
Spermatozoa contain at least three powerful membrane antigens, against which a specific 
immune response may be mounted via the production of antibodies which may be formed as 
a result of local sequestration of leucocytes197. The role of cell mediated immunity (and hence 
the significance of leucocytospermia) in the production of ASA is much debated. A slight but
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not statistically significant correlation between ASA and leucocytospermia has been 
reported , whereas in another study the presence and levels of ASA were completely 
unrelated to the concentration of leucocytes.
Various subgroups of leucocytes play different roles in autoimmunity, which may account for 
their varying incidence amongst ejaculate with antisperm antibodies. Antibodies are produced 
by B lymphocytes. y5 T cells are present in the human semen, they comprise about one third 
to one half of the total number of T lymphocytes in this compartment and their mean 
concentration is increased about ten fold in men whose sperm contains bound auto- 
antibodies . This suggests that a localised autoimmune response to sperm is associated with 
activation and proliferation of y5 T cells in the male reproductive tract28.
The hypothesis was that there would be a difference in the leucocyte populations found in 
ASA positive and ASA negative patients which might reflect the different aetiological roles 
of leucocytes in these two cases. Therefore the aim was to examine the leucocyte 
subpopulations in the semen and to compare these between the antibody positive, antibody 
negative subjects and control subjects.
3.1.2 Materials and Methods
MAR test was used to detect bound ASA levels as outlined in Chapter 2 section 2.5.4.
3.1.3 Statistical Analysis
As outlined in Chapter 2 section 2.5.5.
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3.1.4 Results
64 patients were recruited into this study. 26 fertile men were recruited as the control group. 
These 26 men were attending the IVF clinic due to female factor infertility, were ASA-ve and 
their partners had achieved a pregnancy and thus were considered to be an adequate control 
group. Twenty of the azoospermic men were removed from the analysis as there was no 
sperm to bind to the ASA. Seventeen patients were found to be ASA+ve, Twenty one patients 
were ASA-ve. Eighteen men had equivocal results (level of binding < 50%) and thus not 
considered into further analysis. The sperm parameters (sperm count, motility, morphology 
and sperm migration test) were significantly reduced in the ASA+ve group when compared to 
the normal control group (p<0.01). The morphology and the SMT were significantly reduced 
in the ASA+ve group when compared to the ASA-ve group at p<0.01 and p<0.04 
respectively (Table 3.1).
The subpopulations of leucocytes present amongst ASA+ve, ASA-ve and control groups are 
given in Table 3.2. The total leucocyte number (CD45 +ve cells) was higher among ASA+ve 
(11.1) than ASA-ve (5.35) samples, although it did not reach statistical significance. The T 
lymphocytes (CD 2, 3, 4 and 8), B lymphocytes (CD20) and the large granular lymphocyte 
(CD56) were significantly higher in the ASA+ve (1.3, 0.8, 1.1, 0.8, 0.6 and 0.5) and ASA-ve 
groups (1.15, 1.05, 1.65, 0.85, 0.75 and 0.5) when compared to the control group (0.15, 0.15, 
0.2, 0.1, 0.2, and 0.1) respectively. However, there was no statistically significant difference 
amongst the T lymphocyte counts between the ASA+ve and ASA-ve groups. The similar 
finding was mirrored in the analysis of activated T and B cells (CD69).
95
Table 3.1: Comparison of sperm parameters between ASA negative, positive and 
control subjects. Values are expressed as medians, with the range for each group 
given in brackets. P value relates to a statistical significance between ASA negative 
vs. controls, ASA positive vs. controls and ASA positive vs. negative. ^Significant at 
5% level significant at 1% level.
Sperm
Parameters
ASA Negative 
(0=21) 
Median and 
Ranges
ASA Positive 
(n=17) 
Median and 
Ranges
Controls 
(u=26) 
Median and 
Ranges
P -value 
Negative 
vs.
controls
P -value 
Positive
vs.
controls
P -value 
Positive
vs.
negative
Sperm count 
106/ml 35.5 (8.5-52.5) 26 (11-40) 104 (73-119) 0.002** 0.0001** 0.83
Motility % 25 (15.5-36.25) 20 (17.5-30) 90 (80-99) 0.0001** 0.0001** 0.46
Morphology 
% normal 
forms
30 (19.25- 
34.25) 12 (10-23.25) 41 (31-48) 0.003** 0.0001** 0.01*
SMT
106/ml 4.5 (1.5-10) 1.5 (0.2-4) 24 (15-30) 0.001** 0.0001** 0.04*
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Table 3.2: Comparison of leucocyte subpopulations between each subject group.
Values are expressed as median cell count (per 10 high power fields), with ranges for 
each group given in brackets. P value indicates that results reached statistical 
significance between the following comparisons: ASA Negative vs. controls, ASA 
positive vs. controls, ASA negative vs. ASA positive. ^Significant at 5% level 
significant at 1% level.
Antibody
To
ASA Negative 
(n=21) 
Median and 
Ranges
ASA Positive 
(n= 17) 
Median and 
Ranges
Controls 
(n=26) 
Median and 
Ranges
P -value 
Negative 
vs.
controls
P -value 
Positive
vs.
controls
P -value 
Positive
vs.
negative
CD4S 5.35 (3.15-25.15) 11.1 (4.7-20.1) 2.25 (0.63-4.95) 0.01** 0.0001** 0.47
CD2 1.15 (0.55-1.95) 1,3 (0.7-2.1) 0.15 (0-0.55) 0.01** 0.001** 0.61
CD3 1.05(0.45-1.7) 0.8 (0.4-1.7) 0.15 (0.05-0.65) 0.004** 0.003** 0.93
CD4 1.65 (0.85-2.35) 1.1 (0.8-2.1) 0.2 (0-0.3) 0.001** 0.0001** 0.61
CDS 0.85 (0.45-1.3) 0.8 (0.6-1) 0.1 (0-0.4) 0.01** 0,001** 0.74
CD14 1.85 (0.55-2.9) 1.6 (0.7-2.4) 0.55 (0.1-2.25) 0.07 0.08 0.84
CD16 2.65 (1.5-5.6) 1.7 (0.8-6.8) 0.65 (0.05-1,05) 0.0001** 0.002** 0.49
CD20 0.75 (0.35-1.85) 0,6 (0.4-1.1) 0.2 (0-0.6) 0.01** 0.003** 0.99
CDS6 0.5 (0.3-0.75) 0.5 (0.3-0.7) 0.1 (0-0.35) 0.004** 0.01** 0.82
CD69 1.2 (0.35-1.7) 0.9 (0.4-1.7) 0 (0-0.1) 0.0001** 0.0001** 0.72
CD4/CD8
Ratio 1.9 1.37 2
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The macrophages and monocytes (CD14) were elevated in tire ASA+ve (1.6) and ASA-ve 
(1.85) groups but this elevation was not statistically significant when compared to the control 
group (0.55). However, the granulocytes (CD16) were significantly elevated in both the 
ASA+ve and ASA-ve groups when compared to the control group (Figure 3.1). However, 
there was no statistically significant elevation between the ASA+ve and the ASA-ve groups. 
Figure 3.2 represents the median and ranges of activated T and B cells (CD69) in the 
different groups.
The analyses of the different groups were repeated after excluding the patients who were 
microbiology culture positive. This was done to find out the true effect of ASA on sperm 
parameters. This included 12 patients in the ASA negative group, 11 patients in the ASA 
positive group. The control group (n=26) had negative cultures. Table 3.3 represents the 
median and ranges of the sperm parameters and the CD counts in the different groups after 
exclusion of the infected samples. The results mirrored the previous analysis.
There was a good correlation between leucocytopsermia in the ASA+ve group and poor 
sperm morphology as shown in Figure 3.3. Figures 3.4 - 3.7 illustrate the CD2, CDS, CD45 
and CD69 cells respectively in the ASA+ve sample. Figure 3.8 depicts the various 
correlations identified between the T and B cells in the ASA+ve patients. There was a 
positive correlation (r= 0.74, p<0.01) between the T cells (CD3) and B cells (CD20) which is 
depicted in Figure 3.9.
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Figure 3.1: Box plots showing macrophages, granulocytes and large granular 
lymphocytes.
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Figure 3.2: Box plot representing CD 69 (activated T and B cells) in the ASA 
positive, ASA negative and controls
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Table 3.3: Median and ranges for the sperm parameters and the CD counts 
(expressed as cells/10 hpf) for the ASA positive and negative groups vs. controls 
who are culture negative. ^Significant at 5% level ^significant at 1% level.
ASA negative 
(n=12) 
Median and 
ranges
ASA 
positive 
(n=ll) 
Median and 
ranges
Controls 
(n=26) 
Median and 
ranges
Negative vs. 
controls
Positive vs. 
controls
CD 45 12.4 (4.3-43.8) 5.9 (3.7- 12.1) 2.25 (0.65-4.7) 0.003** 0.01**
CD 2 1.7 (0.2-2.2) 1.8 (0.7-2.2) 0.15 (0-0.55) 0.04* 0.001**
CDS 1.3 (0.4-1.9) 0.8 (0.4-2.2) 0.15 (0.05-0.65) 0.02* 0.01**
CD 4 1.8 (0.6-3.6) 1 (0.8-2.1) 0.2 (0-0.3) 0.003** 0,001**
CDS 0.9 (0.2-2.1) 0.9 (0.6-1) 0.1 (0-0.4) 0.1 0.003**
CD 14 2.8 (0.5-16.2) 2 (0.7-2.8) 0.55 (0.1-2.25) 0.06 0.08
CD 16 3 (1.5-16.2) 1.7 (0.8-7.4) 0.65 (0.05-1.05) 0.006** 0.01**
CD 20 0.9 (0.3-3) 0.5 (0.4-1.7) 0.2 (0-0.6) 0.01** 0.01**
CD 56 0.5 (0.3-0.9) 0.5 (0.3-0.8) 0.1 (0-0.35) 0.01** 0.01**
CD 69 1.7 (0.2-2.2) 0.8 (0.4-1.7) 0 (0-0.1) 0.006** 0.0001**
L 243 3.9 (1.7-15.6) 2.2 (0.9-3.8) 0.7 (0.3-1.8) 0.01** 0.03*
CD4/CD8
Ratio 2 1.11 2
100
% normal forms 
r=0.563 
P value <0.05
9fc normal forms 
r=0.732 
P value <0.01
Cells
median/10 hpf
Cells median/10 
hpf
Figure 3.3: Correlations between leucocytes with sperm morphology in 
ASA+ve group.
Figure 3.4: CD 2 cells highlighted in the ASA+ve sample,
Figure 3.5: CD 8 cell highlighted in the ASA+ve sample.
Figure 3.6: CD 45 cells present in the ASA+ve sample.
• • N
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Figure 3.7: CD 69 cells in the ASA+ve sample.
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Figure 3.8: Correlations between T and B cells in the ASA+ve group (r
correlation coefficient).
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Figure 3.9: Correlation matrix depicting the correlation between T and B cells 
(expressed as median per 10 hpf) with CD 69 (CD3 and CD69 r {correlation 
coefficient} = 0.74, CD3 and CD20 r = 0.74, CD3 and CD4 r = 0.75, p 
valuecO.Ol).
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3.1.5 Discussion
In this study granulocytes were found to be the predominant leucocyte in both the ASA group 
and the control group. In direct contrast to previous studies, this study also showed CD4 as 
the predominant T lymphocyte in both the ASA groups and CD 16 is the predominant cell in 
the control group and there was no significant difference in the levels of the CDS 
lymphocytes between the ASA+ve or ASA-ve groups.
Furthermore, what was interesting to note was that the ratio of the CD4 / CDS (Table 3.2) 
was significantly lower in the ASA+ve group (1.37) when compared to the ASA-ve group 
(1.9) or the control group (2). When culture negative individuals were only analysed the ratio 
of the CD4 / CDS (Table 3.3) was significantly lower in the ASA+ve group (1.1) when 
compared to the ASA-ve group (2) or the control group (2). This might suggest that the CDS 
lymphocytes actually have a more cytotoxic role and hence the reduction in the ratio of 
helper to cytotoxic cells.
This might be proven if the sperm count in the ASA+ve group is also lowered. This has also 
been looked at, which showed the sperm count in the ASA+ve group to be much lower at 26 
(11-40) when compared to the control group at 104 (73-119) x 106/ml, median and range 
respectively. This was highly statistically significant. The sperm count in the ASA-ve group 
was also higher in comparison to the ASA+ve group although it did not reach statistical 
significance.
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An increase in the phagocytic activity of the leucocytes in men with antisperm antibodies 
may be expected as many of the spermatozoa would be opsonized by antibody. However, in 
this study, the median and the range of the CD45 counts in the ASA+ve group was higher at 
11.1 (4.7-20.1) x 106/ml. This was not a statistically significant difference when compared to 
the ASA-ve group at 5.35 (3.15-25.15) x 106/ml.
Unfortunately, in this study there were patients with genital infections in the ASA group. This 
may, to a certain extent, explain the presence of an increased number of leucocytes in the 
ASA group, particularly the ASA+ve group. When patients with genital infections were 
excluded in our study and a subgroup analysis was performed, the CD45 count was lower in 
the ASA+ve group when compared to the ASA-ve group and thus establishes that there was 
no relationship between the presence of ASA and the number of leucocytes in the ejaculate.
These results mirror those of another study and suggest that, despite the fact that both 
abnormalities are manifestations of an immunological response, they are not interrelated48. 
Leucocytopsermia was not significantly related to the presence of local antisperm antibodies 
of the IgG or IgA class. There was also no significant association of antisperm antibodies 
with the concentration of PMN elastase in seminal plasma and the outcome of semen 
cultures198.
In this study, leucocytospermic samples with antisperm antibodies were associated with low 
sperm count, decreased motility, abnormal sperm morphology and poor SMTs. This 
association was highly significant (p=0.0001). It is also interesting to note that even in the 
ASA-ve group, leucocytospermia was associated with low sperm count, decreased motility,
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abnormal sperm morphology and poor SMT. This association also reached statistical 
significance (p=0.002, 0.0001, 0.003 and 0.001 respectively).
This would lead one to believe that leucocytospermia, despite the presence or absence of 
ASA, could act as an individual variable in affecting sperm parameters directly . However, 
leucocytes in ejaculates with negative bacterial cultures was not a representative parameter of 
fertilising ability as a variable number of leucocytes were found in the semen samples, and 
that leucocytes are a normal cellular* component of human semen samples.
Maybe leucocytospermia alters semen quality only when seminal vesicles are also affected as 
the seminal vesicles produce antigens that could protect the sperm from immune response. 
Gonzales et al. also suggested that in conditions whereby function of the seminal vesicles 
becomes altered, the protecting antigen secreted by the seminal vesicles will be reduced; 
therefore, sperm antigens will sensitise leucocytes, resulting in an immune response with the 
production of antisperm antibodies199.
Interferon produced by TH1 cells at high concentrations was noted to adversely affect sperm 
motility200 and men with antisperm antibodies have lower sperm motility201;202, suggesting 
the mechanism of the effect of antisperm antibodies on sperm motility may be via the action 
of IFN. This hypothesis needs to be specifically tested and this has been endeavoured to do so 
in the present study in Chapter 4 when discussing the role of cytokines in male infertility.
Returning to the hypothesis, there were no statistically significant differences observed in the 
leucocyte subpopulations between the ASA+ve and the ASA-ve groups in the current study.
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3.2 STUDY NUMBER 2: Leucocyte subsets in patients with Positive cultures versus 
patients with Negative cultures
3.2.1 Introduction
Microorganisms present in the male genital tract and / or the ejaculate may often be difficult 
to detect in clinical andrology and pathology laboratories. The proteolytic and growth 
inhibitory properties of seminal fluid interfere with microbial growth in vitro and / or 
compromise the viability of cultured mammalian cells necessary for the replication of 
obligate intracellular microorganisms such as Chlamydia trachomatis or viruses. 
Microorganisms present in concentrations below the current limit of detection may, 
nevertheless, negatively influence sperm function. Microorganisms may bind to spermatozoa 
and compromise then- ability to reach the fallopian tubes as well as their capacity for 
fertilisation.
Direct culture of semen is ideally the best practice method to detect male genital tract 
infection as it is 100% specific. However, these are technically demanding, needing cold 
chain particularly for Chlamydia to preserve specimen viability in transport and are not 
readily available. Furthermore, the results can take up to eight days.
Nucleic Acid Amplification Tests (NAAT) are both highly sensitive and specific (95%). The 
results of NAAT are received within a few horns. Thus, NAAT is replacing culture as the 
tests of choice in detecting male genital tract infections. However, to date there are no 
commercial NAAT tests available for testing semen203.
108
The hypothesis was that leucocytospermia was present in the culture positive patients. The 
leucocyte subsets that are likely to be increased were the granulocyte and macrophages in the 
culture positive group. The aim of study 2 was to identify the presence of leucocytospermia 
and also analyse the activity of the different leucocyte subpopulations in the culture positive 
patients.
3.2.2 Materials and Methods
Direct culture of semen was used to identify male genital tract infections as outlined in 
Chapter 2 section 2.2.
3.2.3 Statistical Analysis
As outlined in Chapter 2 section 2.5.5.
3.2.4 Results
Out of the remaining 73 subfertile patients, 20 were found to be positive for Ureaplasma and 
53 were negative. Of the 73 patients studied, 24 tested positive for general infections such as 
Enterococcus and Streptococcus. All the patients tested negative for Mycoplasma, Chlamydia 
trachomatis and Trichomonas vaginalis. There were no differences in the sperm parameters 
(numbers, motility, morphology) between the culture positive group and the culture negative 
groups (Tables 3.4 and 3.5). The levels of CD45 +ve cells and Granulocytes (CD 16) were 
higher in the Ureaplasma positive group; however, these did not reach statistical significance 
(Table 3.6). Figures 3.10 and 3.11 represent the correlations that exist between T and B cells 
and granulocytes.
109
Table 3.4: Sperm parameters as median and ranges in Ureaplasma positive vs. 
Ureaplasma negative groups.
Sperm Parameters
Positive
(n=20)
Median and 
Ranges
Negative (n=53) 
Median and 
Ranges
P -value 
Positive 
vs.
negative
Sperm count l06/ml 9 {0.8-18.5) 7 (0-29) 0.84
Motility % 7.5 (1-25) 10 (0-20) 0.83
Morphology %normal forms 11 (5-22) 10(0-17) 0.56
SMTioVml 0.3 (0-2) 0.1 (0-2.2) 0.86
Table 3.5: Sperm parameters in general culture positive vs. negative (parameters 
were unaffected in the presence of infection).
Sperm Parameters
Positive (n=24) 
Median and 
Ranges
Negative (n=46) 
Median and 
Ranges
P -value 
Positive 
vs.
negative
Sperm count loVml 5 (0-28.5) 9 (0-34) 0.57
Motility % 15.5 (0-25) 10(0-20) 0.46
Morphology %normal 
forms 11 (0-20) 10 (0-18) 0.74
SMT io6/nil 0.05 (0-2.75) 0.1 (0-1.5) 0.83
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Table 3.6: Median and ranges of the cell surface markers (per 10 hpf) in 
Ureaplasma positive vs. Ureaplasma negative groups.
Antibodies
Positive
(n=20)
Median and Ranges
Negative 
(n=53) 
Median and 
Ranges
P - value
Positive vs. negative
CD 45% 82(75-90) 77(63-89) 0.09
CD45 11 (5.8-15.9) 5.9 (3.7-11.8) 0.08
CD2 1.4 (0.6-2.6) 1.2 (0.6-1.9) 0.44
CDS 1.5 (0.8-2.9) 1.2 (0.6-1.9) 0.36
CD4 2 (1.1-3) 1.5 (0.8-2.5) 0.22
CDS 0.9 (0.7-1.1) 0.7 (0.3-1.7) 0.4
CD14 2.1 (0.9-3.1) 1.5 (0.7-3.5) 0.55
CD16 3(1.6-5.5) 2.4 (1-5.4) 0.32
CD20 1 (0.6-2.2) 0.7 (0.3-2.3) 0.17
CD56 0.6 (0.2-1.4) 0.4 (0.3-0.8) 0.21
CD69 1.2 (0.7-2) 0.9 (0.3-1.7) 0.14
L 243 2.9 (2.3-4) 2.1 (1.3-4.9) 0.12
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Figure 3.10: Correlation between macrophages and granulocytes (expressed as 
cells per 10 hpf) and between T and B cells in the Ureaplasma positive group.
112
T & BCells 
median/10 
hpf
CD 56Cells median/10 hpf
O CD20
COM
CO«
CD4 and CD56 
r=0.75
CD20 and CD56 
r=0.78 
P value<0.01
T & B Cells 
median/10 hpf
o cois cois
CD4 and L243 
r=0.85
CD 16 and L243 
r=0.68
CD20 andL243 
r=0.66
P v»hw<fVni
ooo-
L243 Cells median/10 hpf
Figure 3.11: Correlation between T cells, B cells and large granular lymphocytes 
(expressed as cells per 10 hpf) in Ureaplasma positive group.
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Table 3.7: Median and ranges of antibodies (expressed as cells per 10 hpf) in 
general culture positive vs. negative. (Culture positive included Enterococcus, 
Mixed Anaerobes, Streptococcus milleri and Beta haemolytic streptococcus.) *
Significance at 5% level p value < 0.05, CD45, CD14 and CD16 levels were 
significantly higher in the culture negative group.
Antibodies
Positive
(n=24)
Median and Ranges
Negative
(n=46)
Median and 
Ranges
P-value
Positive vs. negative
CD45% 75(63-87) 79(70-92) 0.06
CD45 4.65 (3.15-10.3) 7.2 (4-14.85) 0.05*
CD2 1.25 (0.5-1.6) 1.45 (0.65-2.35) 0.13
CDS 1 (0.5-1.65) 1.55 (0.6-2.85) 0.14
CD4 1.4 (0.95-2.1) 1.75 (0.8-3.1) 0.32
CDS 0.75 (0.5-0.95) 0.9 (0.4-2) 0.36
CD14 1.35 (0.65-2) 2 (0.8-4.9) 0.05*
CD16 1.9 (0.85-3.15) 3(1.65-6.25) 0.03*
CD20 0.7 (0.3-1.25) 1 (0.4-3.3) 0.1
CD56 0.4 (0.2-0.65) 0.5 (0.3-1.3) 0.09
CD69 0.7 (0.3-1.2) 1.4 (0.4-1.85) 0.11
L 243 2.45 (1.45-3.15) 2.35 (1.6-6.3) 0.36
CD4/CD8
Ratio 1.8 1.9
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Figure 3.12: Box plots representing leucocytes (expressed as cells per 10 hpf) in 
general culture positive vs. negative. (Culture positive included Enterococcus, 
Mixed Anaerobes, Streptococcus milled and Beta haemolytic streptococcus.) 
CD45, CD14 and CD16 are statistically significantly different between the two 
groups (p value<0.05).
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general culture positive group.
3.2.5 Discussion
This study failed to detect any statistical significant difference between the Ureaplasma 
positive and the Ureaplasma negative groups with regards to sperm parameters, particularly 
with reference to morphology or motility. It was also demonstrated that there was no 
statistical significant difference with regards to sperm count and SMT between the 
Ureaplasma positive and negative groups as shown in Table 3.4. Similarly, other study 
groups have also been unable to confirm any association between Ureaplasma infections and 
infertility or sperm quality204.
Furthermore, there was no statistically significant leucocytopsermia amongst the Ureaplasma 
positive and Ureaplasma negative groups as shown in Table 3.6. The findings from this study 
would suggest that Ureaplasma is unable to mount a severe inflammatory response and 
Ureaplasma urealyticum, which is so widespread in the normal reproductive tract, can 
increase in numbers simply because the local immune system is attenuated by a primary 
infection and hence, its aetiological significance is weakened.
However, Ureaplasma urealyticum has been considered an aetiological agent in male 
infertility ever since the early observation that these organisms can attach firmly to 
spermatozoa . Indeed, when Ureaplasma urealyticum has been implicated as a causative 
factor, it has often been associated with reduced sperm motility and poor sperm 
morphology206. Mycoplasma infections also appear to be associated with an increase in the 
percentage of coiled sperm tails207 and infected speim exhibit reduced oocyte penetration208. 
Mycoplasma genitalium and Ureaplasma urealyticum have strong adhesive properties and 
can bind to the sperm head and midpiece and negatively influence motility209.
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The antibody- and complement-coated spermatozoa would also be susceptible to 
phagocytosis by neutrophils and macrophages which possess complement or immunoglobulin 
Fc receptors. In many cases in which tetracycline therapy was initiated, varying grades of 
improvement in sperm quality have been recorded. The incidence of Ureaplasma infection 
has been reported to be higher amongst couples with idiopathic infertility.
Unfortunately, it is impossible to comment on the role of Chlamydia and sperm parameters 
and leucocyte count in the seminal plasma as none of the patients in this study tested positive 
for Chlamydia. It could be argued that one of the potential weaknesses of this study was the 
non utilisation of molecular laboratory techniques to identify Chlamydial infection. 
However, to overcome similar issues, a study recruiting men from a primary care setting 
found semen of men who tested positive for Chlamydial DNA were found to have 
significantly increased ejaculate volumes, leucocyte numbers and did not contain increased 
numbers of dead sperm 210. This finding was supported by another study which found that 
sperm quality was unaffected by past or current Chlamydial infection211. However, this study 
went on to show that conception was negatively affected by previos Chlamydial infections. 
This was thought to be due to the affliction of the seminal vesicles by these organisms and 
thus decrease the antioxidant production which could leave the sperm more susceptible for 
free radical damage particularly during assisted reproduction techniques. Chlamydial 
infection is thought to affect sperm DNA fragmentation particularly when coinfected with
212Mycoplasma .
The role of Chlamydia trachomatis has been documented to be one of the other main 
aetiological agents in urethritis and acute epididymitis. The route of spread of the organism is 
intracanalicular, possibly secondary to urinary reflux into the vasa caused by the structural
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changes in the ejaculatory ducts. It also implies that non-symptomatic Chlamydia prostatitis 
may precede acute epididymal infection213. Negative cultures of Chlamydia trachomatis from 
prostatic fluid or semen should not be taken as definitive proof that the bacteria is not present, 
because of its intracellular nature and the fact that male reproductive fluids can exert an 
inhibitory influence on the culture cells used to demonstrate the organism . Up to 50% of 
men infected with Chlamydia remain asymptomatic215.
A number of studies show that no relationship could be established between sperm quality 
and a Chlamydial infection, previous or present using culture or serology. Several factors 
could be considered in this respect; Chlamydia trachomatis constitutes a weak antigenic 
stimulus to the immune system, resulting in only modest antibody responses. An 
immunological response cannot be detected in approximately 20% of infected males. Seminal 
IgA could reduce the false positive tests that could result from cross reaction with non genital 
species when serum IgG is measured216. Chlamydia is associated with deep seated infection 
and a urethral discharge may not be appropriate in the majority of cases.
Chlamydia trachomatis may influence infertility by inducing sperm antibodies28. In men with 
Mycoplasmal or Chlamydial infections there was a highly significant increase (14 vs. 1.2%) 
in the number with sperm antibodies in their seminal plasma compared to non-infected 
controls217. Infection may also impair more subtle aspects of sperm quality not registered by 
conventional techniques. It may be significant in this respect that a special form of jerking 
movement has been registered by automatic motility analysis of sperm from men infected 
with Chlamydia trachomatis which is normalised after treatment with tetracycline .
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Co-incubation with Chalmydial serovar was found to cause a statistically significant decline 
in the percentage of motile sperm and a dose dependant caspases mediated increase in the 
proportion of dead spermatozoa219. This was attributed to Chlamydia’s potential to release 
lipopolysaccharide (LPS) which can be a 550 fold more potent spermicide when compared to 
Gram-ve LPS220. Chlamydia can also cause increased tyrosine phosphorylation of sperm 
proteins which is receptor mediated and thus affect sperm function as sperm capacitation is 
mediated through the phosphorylation process .
Furthermore, increased incidence of Chlamydia trachomatis has been found in men with 
obstructive azoospermia221. The mechanism responsible for this induction of antibodies is 
still unknown. Inflammation may lead to the migration of immune cells into the genital tract 
which then reacts to spermatozoa, which may be trapped in excurrent ducts. Alternatively, 
antibodies may be formed to common antigens between the bacteria and spermatozoa.
Due to the lack of positive patients in this study, it is difficult to either support or refute the 
role played by Chlamydia trachomatis infection in male subfertility. However, the issues 
have been discussed with regards to Chlamydia and male subfertility. Some of the seminal 
cultures tested positive for Enterococcus, mixed anaerobes, Streptococcus milleri and beta 
haemolytic Streptococcus. The sperm parameters were unaffected due to the presence of 
these infections as shown in Table 3.6.
No correlation was found between sperm characteristics and positive bacterial cultures and in 
semen in this study. The findings of this study mirror the findings of another study101. This 
would suggest that subclinical genital tract infection in asymptomatic patients has no major 
role in male infertility. There was no significant difference in the CD4 / CDS ration between
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the general culture positive and the culture negative group. Surprisingly, the CD45, CD 14 
and CD 16 levels were significantly higher in the culture negative group as shown in Table 
3.7. Thus it could be inferred that an increase in the macrophages in the culture negative 
group may be due to the need for phagocytosis of post capacitated human spermatozoa222. 
The correlations between the T and B cells have been shown again in Figure 3.15. This shows 
that activation of T cells leads to an activation of B cells thus providing the link in cell 
mediated immunity.
Although leucocytospermia is commonly found in genital tract infections, high 
concentrations of seminal WBC also occur in infertility patients in whom microbiological 
investigations, including Chlamydia and Mycoplasma, have revealed no bacterial agents. 
Such patients may be asymptomatic or may have clinical symptoms and / or ultrasonographic 
signs of an inflammation e.g. prostatovesiculitis223. Patients with clinical symptoms of an 
inflammatory process, despite negative bacterial cultures, might have an encapsulated 
infection or an infection caused by a virus.
A genital tract infection might cause release of toxic products from the microorganisms or 
changes in the biochemistry of seminal plasma. E.g. concentration of fructose, in itself 
affecting sperm function199. Genital tract infections have been associated with the formation 
of autoantibodies to the sperm in man90. It has been proposed that activation of T 
lymphocytes by a Chlamydia trachomatis infection initiates the development of an 
autoimmune response to spermatozoa in the male genital tract224. There have also been a 
large number of studies on the effects of antibiotic therapy on sperm quality and pregnancy 
rates, many of which have been contradictory.
121
There may be several reasons for difficulties in showing an antibiotic effect on male 
infertility: 1) the therapy may not have been appropriate for the organism responsible or it 
may not have been of adequate dose or duration; or 2) the pathological changes in the 
reproductive tract responsible for the poor sperm quality may be permanent.
In conclusion, analysing the leucocyte responses to bacterial infections, it was found that 
there was no statistically significant increase in the leucocyte count in the Ureaplasma 
positive group. This would suggest that this organism is incapable of mounting a severe 
inflammatory response. Also, other subclinical bacterial infections are unable to mount a 
sufficient inflammatory response. However, contrary to the hypothesis, in the general culture 
negative group the CD45, CD 14 and CD 16 numbers were increased. This would suggest that 
the increase in these cells is for removal of post capacitated spermatozoa.
3.3 STUDY NUMBER 3: Leucocyte subsets in Oligospermic versus the Normospermic 
group of patients
3.3.1 Introduction
Increased PMN concentrations are related to decreased percentages of noimal forms of 
spermatozoa and a significant increase in the percentage of midpiece abnormalities225. At two 
different cut off points of seminal leucocytic concentration (0.5xl06 and IxlO6 leucocytes per 
ml), the patient group with lower mean leucocyte concentration had a significantly higher 
proportion of sperm with normal morphology compared with patients who had a higher mean 
leucocyte concentmtion. There was also a significant positive correlation between leucocyte 
concentration and midpiece defects. No other correlation was detected225.
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A rise in the WBC concentration in semen was found due to an increased occurrence of 
morphologically abnormal sperm226. Another study has suggested a reduction of 
morphologically abnormal sperm by phagocytic activity in men with higher concentrations of 
WBC202. It is surprising that ejaculates from normal fertile men often continuously contain 
considerable numbers of morphologically abnormal sperm but only a few WBC. The 
peroxidase test determined WBC count had no statistically significant effect on sperm 
morphology227.
The aim of the third study was to analyse the effect of seminal leucocyte subpopulations on 
various sperm parameters (count, motility, morphology and migration test) with particular 
emphasis on the sperm count. The hypothesis was that elevated numbers CD 14 and CD 16 
positive cells macrophages and granulocytes would be associated with the oligospermic 
group. Presence of these cells being associated with abnormal sperm structure.
3.3.2 Materials and Methods
Immunohistological staining using monoclonal antibodies was carried out as outlined in 
Chapter 2 sections 2.5.1, 2.5.2 and 2.5.3.
3.3.3 Statistical Analysis
The analysis was performed as described in Chapter 2 section 2.5.5.
3.3.4 Results
13 (Mild-6) (Severe-?) oligospermic men were identified and compared to 14 normospermic 
men. The age of men ranged from 22-49 years (median 34.5 years). The duration of infertility 
was between 2-13 years (median 5 years).
123
Thirty eight of the men consumed alcohol on an average of 10-12 units/week. Twenty of the 
men also smoked on average 10-20 cigarettes per day.
Mild oligospermia was defined a sperm count of between 10-20xl06 and a motility of >40% 
and severe oligospermia was defined as a sperm count of <10xl06 and motlity of >40%. As 
expected, the sperm count in the mild (14.5 x 106/ml) and severe (5 x 106/ml) oligospermic 
group was significantly reduced when compared to the normospermic group (43 x 106/ml). 
The SMT and sperm morphology was significantly reduced in the severe oligospermic group 
as outlined in Table 3.8. The CD45 count was increased in the mild and severe oligospermic 
group compared to the normospermic group but did not reach statistical significance as seen 
in Table 3,9, The T lymphocytes (CD2, CD3, CD4 and CDS) were found predominantly in 
the mild and severe oligospermic group compared to the normospermic group. Only CD3 was 
significant. Granulocytes also formed a major percentage (29%) of the leucocytes in the 
oligospermic group. The MHC class 2 cells (L243) were found in all three groups.
The sperm parameters and cell surface receptor expression of the oligospermic group were 
compared to the control group and the results are outlined in Table 3.10. All the values were 
statistically significant. Figure 3.14 also shows the difference in the distribution of T and B 
cells in the three groups. CD3 was significantly elevated in the oligospermic group when 
compared to the normospermic group which could suggest an increased T cell helper activity 
in the oligospermic group. However, when compared to the control group all the cell surface 
receptor levels were significantly elevated in both the oligospermic and the normospermic 
group.
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Table 3.8: Median and ranges of the sperm parameters in the oligospermic 
group vs. the normospermic group. ** Significance at the 1% level ^significance at 
5% level.
Sperm
Parameters
Mild
Oligospermic
group
(n=6)
Severe
Oligospermic
group
(n=7)
Normospermic
group
(n=14)
Mild
Oligospermic 
group vs. 
Normospermic 
group
P value
Severe 
Oligospermic 
group vs. 
Normospermic 
group
P value
Sperm count 
106/inl 14,5 (10-19) 5 (5-9) 43 (28-75) 0.0001** 0.0001**
Motility % 28.75 (27.5-30) 27.5 (25-30) 25 (20-40) 0.84 0.64
Morphology 
% normal 
forms
22 (17-26) 18 (10-21) 28 (18-32) 0.15 0.01**
SMT lOVml 2 (1-4) 0.5 (0.1-0.5) 8 (2.5-12) 0.03* 0.001**
Table 3.9: Median and ranges of the leucocytes (expressed as cells per 10 hpf) in 
the mild and severe oligospermic group vs. the normospermic group.
^Significance at 5% level, ^^significance at the 1% level
Mild
Oligospermic
(n=6)
Median and 
ranges
Severe
Oligospermic
(n=7)
Median and 
ranges
Normospermic 
(n=14) 
Median and 
ranges
P value 
Normo 
spermi
CVS.
Mild
Oligosp
ermic
P value
Normospermic 
vs. Severe 
Oligospermic
P value
Normospermic vs. 
Oligospermic
CD 45% 79(67-96) 75(27-89) 63(55.5-76) 0.14 0.41 0.43
CD 45 7.65 (4-26.1) 10.3 (4.5-13.5) 5.9 (3.9-16.7) 0.82 0.7 0.69
CD 2 1,45 (0,6-2.2) 1.6 (1,3-2.4) 0.7 (0.3-1.9) 0.48 0.2 0.21
CDS 1.25 (0.6-2.2) 1.8 (1.6-2.9) 0.5 (0.3-1.3) 0.11 0.002** 0.003**
CD 4 1.5 (0.8-3.9) 1.8 (1.1-2) 1 (0.6-2.2) 0.46 0.44 0.34
CDS 0.75 (0,7-1.9) 0.7 (0.3-0.9) 0.6 (0.2-1.1) 0.24 0.8 0.39
CD 14 0.65 (0.4-2.3) 1.6 (0.9-1.9) 1.2 (0.5-2.8) 0.56 0.44 0.87
CD 16 1.6 (0.5-2.7) 3 (2.3-5.7) 2.5 (1.5-5.7) 0.27 0.67 0.71
CD 20 0.65(0.3-1.1) 0.9 (0.2-1.1) 0.4 (0.2-1) 0.58 0.55 0.47
CD 56 0.5 (0.2-0.9) 0.6 (0.2-0.9) 0.4 (0.3-0.5) 0.75 0.48 0.52
CD 69 0.5 (0.4-2) 1.3 (1.2-1.8) 0.5 (0.2-1.2) 0.7 0.09 0.18
L243 2.4(1.1-3.3) 2.5 (1.7-2.9) 2.4 (1.7-5.5) 0.79 0.89 0.80
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Table 3:10: Medians and ranges of the sperm parameters, CD counts (expressed as cells 
per 10 hpf) in the oligospermic group vs. the control group. ** Significance at the 1% 
level ^significance at the 5% level.
Mild
Oligospermic
group
(n=6)
Severe
Oligospermic
group
(n=7)
Controls
(n=26)
Median and ranges
Mild
Oligospermic 
group vs.
Controls
P value
Severe
Oligospermic 
group vs.
Controls
P value
Sperm
Count
106/ml
14.5 (10-19) 5 (5-9) 104 (73-119) 0.0001** 0.0001**
Motility % 28.75 (27.5- 30) 27.5 (25-30) 90 (80-99) 0.0001** 0.0001**
Morphology 
% normal 
forms
22 (17-26) 18 (10-21) 41 (31-48) 0.001** 0.0001**
SMT 106/ml 2(1-4) 0.5 (0.1-0.5) 24 (15-30) 0.0001** o o o o 7T *
CD 45% 79(67-96) 75(27-89) 76(69-90) 0.83 0.48
CD 45 7.65 (4-26.1) 10.3 (4.5- 13.5) 2.25 (0.65-4.7) 0.0001** 0.0001**
CD 2 1.45 (0.6-2.2) 1.6(1.3-2.4) 0.15 (0-0.55) 0.0001** 0.0001**
CD 3 1.25 (0.6-2.2) 1.8 (1.6-2.9) 0.15 (0.05-0.65) 0.0001** 0.0001**
CD 4 1.5 (0.8-3.9) 1.8 (1.1-2) 0.2 (0-0.3) 0.0001** 0.0001**
CDS 0.75 (0.7-1.9) 0.7 (0.3-0.9) 0.1 (0-0.4) 0.0001** 0.0001**
CD14 0.65 (0.4-2.3) 1.6 (0.9-1.9) 0.55 (0.1-2.25) 0.002** 0.0001**
CD16 1.6 (0.5-2.7) 3 (2.3-5.7) 0.65 (0.05-1.05) 0.0001** 0.0001**
CD20 0.65 (0.3-1.1) 0.9 (0.2-1.1) 0.2 (0-0.6) 0.0001** 0.0001**
CD56 0.5 (0.2-0.9) 0.6 (0.2-0.9) 0.1 (0-0.35) 0.011** 0.0001**
CD69 0.5 (0.4-2) 1.3 (1.2-1.8) 0 (0-0.1) 0.003** 0.0001**
L 243 2.4 (1.1-3.3) 2.5 (1.7-2,9) 0.7 (0.3-1.8) 0.0001** 0.0001**
CD4/CD8
Ratio 2 2.5 2
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Figure 3.14: Box plots representing the leucocytes expressed as (cells per 10 hpf) 
in the oligospermic group, normospermic group and controls.
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3.3.5 Discussion
Leucocyte spermia was shown to impair sperm function through reduced antioxidant activity 
and enhanced T helper 1 modulation228. This study showed for the first time that significant 
levels of CD3 helper T lymphocytes were present in the oligospermic group compared to the 
normospermic group. Lymphocytes subpopulations have been demonstrated in the rete testis, 
epididymis, vas deferens, prostate and seminal vesicles229.
The ratio of T helper cells to T cytotoxic cells is altered in the different subgroups of male 
infertile patients. This ratio was not altered between the mild oligospermic group and the 
control group which was 2 when compared to the severe oligospermic group which was 2.5. 
This would suggest an increase in the helper T cell activity in this group. There is no 
explanation for this finding.
There was no increase in the CD 14 and CD 16 cells in the oligospermic group when 
compared to the normospermic group contrary to the hypothesis. This would suggest that 
these leucocyte subpopulations are not a major factor in influencing sperm concentration.
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3.4 STUDY NUMBER 4: Leucocyte subsets in Asthenospermic versus the 
Normospermic group of patients
3.4.1 Introduction
A potential mechanism through which leucocytospermia may induce alteration in sperm 
function is excessive ROS production by activated granulocytes. It has been argued that 
oxidative stress may induce alterations in the regulation of spermatogenesis, resulting in 
structural defects of the sperm ’ .
On the subcellular level, it has been shown that leucocytospermia and excessive ROS levels 
are associated with an increase in chromatin alterations and DNA damage in sperm, as 
defined by the sperm chromatin structure assay232.
On a different level, it has been shown that a high incidence of sperm tail defects is 
associated with sperm chromosomal abnormalities233. It is thus conceivable that peroxidative 
genetic damage may have led to a significant increase in the proportion of sperm with tail 
defects observed in the leucocytospermic study population.
The aim of the fourth study was to determine if there was a relationship between various 
seminal leucocyte subpopulations and sperm motility.
3.4.2 Materials and Methods
Immunohistological staining using monoclonal antibodies was carried out as outlined in 
Chapter 2 sections 2.5.1, 2.5.2 and 2.5.3.
3.4.3 Statistical Analysis
As outlined in Chapter 2 section 2.5.5.
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3.4.4 Results
10 asthenospermic men were identified and compared to 14 normospermic men, 
Asthenospermia was defined as a sperm count >20x106 and a motility of <40%. On 
comparison with the normospermic group, the sperm motility, SMT and the sperm 
morphology were significantly reduced in the asthenospermic group as shown in Table 3.11.
The predominant leucocyte subgroup was the granulocytes in the normospermic and the 
asthenospermic group. The CD3 and the CD20 levels were significantly increased in the 
asthenospermic group (2.35 and 1.85 x 106/ml) when compared to the normospermic group 
(0.5 and 0.4 x 106/ml) respectively as shown in Table 3.12.
A further comparison between the asthenospermic group and the control group was 
performed. The results are outlined in Table 3.13. All the pammeters were significantly 
increased in the asthenospermic group. Figures 3.15 and 3.16 depict the CD3 and CD20 cells 
stained pink which were significantly elevated in the asthenospermic group.
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Table 3.11: Median and ranges of the sperm parameters in the asthenospermic 
group vs. the normospermic group. ** Significance at the 1% level.
Sperm Parameters Normospermic group 
(n=14)
Median and ranges
Asthenospermic group 
(n=10)
Median and Ranges
Asthenospermic group 
vs. Normospermic 
group (p value)
Sperm count 106/ml 43 (28-75) 46.5 (34-83) 0.8
Motility % 25 (20-40) 13.75 (2.5-17.5) 0.0001**
Progression 30 (25-60) 33.75 (8-37.5) 0.85
SMT lOVml 8(2.5-12) 0.3 (0-1.5) 0.001**
Morphology % normal 
forms
28 (18-32) 10(9-12) 0.003**
Table 3.12: Median and ranges of the leucocytes (expressed as cells per 10 hpf) in 
the asthenospermic group vs. the normospermic group. **Significance at the 1% 
level *significance at the 5% level.
Antibodies
Normospermic group 
(n=14)
Median and ranges
Asthenospermic group 
(n=10)
Median and ranges
Asthenospermic vs. 
Normospermic 
group 
p value
CD 45% 63 (55.5-76) 77 (69-79) 0.14
CD 45 5.9 (3.9-16.7) 12.3 (9.6-18.4) 0.39
CD 2 0.7 (0.3-1.9) 1.6 (1-4) 0.15
CD 3 0.5 (0.3-1.3) 2.35 (0.9-5) 0.01**
CD 4 1 (0.6-2.2) 2.15(1-3) 0.19
CDS 0.6 (0.2-1.1) 0.95 (0.9-3.2) 0.06
CD 14 1.2 (0.5-2.8) 3.25(1.8-4.5) 0.08
CD 16 2.5(1.5-5.7) 3.85 (1.6-5.5) 0.82
CD 20 0.4 (0.2-1) 1.85(1-5.4) 0.02*
CD 56 0.4 (0.3-0.5) 0.4 (0.1-0.8) 0.8
CD 69 0.5 (0.2-1.2) 1.75 (0.7-3.1) 0.07
L243 2.4(1.7-5.5) 2.8(1.7-6.4) 0.93
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Table 3.13: Medians and ranges of the sperm parameters and CD counts 
(expressed as cells per 10 hpf) in the asthenospermic group vs. the control group.
** Significance at the 1% level *significance at the 5% level.
Asthenospermic group 
(n=10)
Controls
(n=26)
Median and ranges
Asthenospermic 
group vs. 
Controls
P value
Sperm Count 
106/ml
46.5 (34-83) 104(73-119) 0.01**
Motility % 13.75 (2.5-17.5) 90 (80-99) 0.0001**
Morphology % 
normal forms
10(9-12) 41(31-48) 0.0001**
SMT lOVml 0.3 (0-1.5) 24(15-30) 0.0001**
CD 45% 77(69-79) 76 (69-90) 0.53
CD 45 12.3 (9.6-18.4) 2.25 (0.65-4.7) 0.0001**
CD 2 1.6 (1-4) 0.15(0-0.55) 0.0001**
CD 3 2.35 (0.9-5) 0.15(0.05-0.65) 0.0001**
CD 4 2.15 (1-3) 0.2 (0-0.3) 0.0001**
CDS 0.95 (0.9-3.2) 0.1 (0-0.4) 0.0001**
CD14 3.25(1.8-4.5) 0.55 (0.1-2.25) 0.0001**
CD16 3.85 (1.6-5.5) 0.65 (0.05-1.05) 0.0001**
CD20 1.85(1-5.4) 0.2 (0-0.6) 0.0001**
CD56 0.4 (0.1-0.8) 0.1 (0-0.35) 0.0001**
CD69 1.75 (0.7-3.1) 0 (0-0.1) 0.0001**
L 243 2.8(1.7-6.4) 0.7 (0.3-1.8) 0.0001**
CD4/CD8
Ratio
2.2 2
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Figure 3.15: CD3 cells (stained pink in colour) in the asthenospermic sample.
Figure 3.16: CD20 cells (stained pink) in the asthenospermic sample.
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3.4.5 Discussion
This study showed for the first time that significant levels of CDS helper T lymphocytes were 
present in the asthenospermic group when compared to the normospermic group. This would 
suggest an increase in the helper T cell activity in this group.
Significant levels of CD20 were also identified in the asthenospermic group when compared 
to the normospermic group. This would suggest that an increase in this cell group could affect 
sperm motility through an increased ASA production. This ASA could bind to the sperm and 
decrease its motility. The activation of a resting helper T cell causes it to release cytokines in 
particular IFN which is known to affect sperm motility. Similarly, activation of resting T 
helper cells could stimulate the activity of B cells (CD20), the latter producing antibodies and 
thus further decreasing sperm motility.
The correlation between leucocytespermia and male infertility is controversial: some studies 
have failed to find any association ’ . However, there is evidence of sperm damage due to
leucocytes: (i) seminal leucocytes numbers have been reported to be higher in infertile than in 
fertile male patients; (ii) leucocytospermia has been associated with decreased sperm 
concentration and motility; (iii) leucocytes damage sperm function and are an important 
prognostic factor for IVF-ET failure102.
Other studies have demonstrated teratoasthenozoospermia and necrozoospermia in 
leucocytospermic men * * . A significant correlation between leucocytospermia and
sperm defects at acrosome and tail level was highlighted by another study235. Leucocytes are 
activated by different stimuli which generate an inflammatory response: the presence in the 
seminal fluid of inflammatory mediators might induce oxidative stress, alteration in sperm
134
motility, acrosome reaction and DNA integrity1115114’232. Different studies suggest a negative 
effect of leucocytes and reactive-oxygen species, primarily produced by leucocytes, on semen 
quality 236;237.
This is the first study which reports raised T helper cells (CD3) and B cells (CD20) in 
the asthenospermic group.
3.5 STUDY NUMBER 5: Leucocyte subsets in Oligoasthenospermic versus the 
Normospermic group of patients
3.5.1 Introduction
Different hypotheses have been explored recently to explain the relationship between 
leucocytospermia and sperm structural damage. The hypotheses that sperm structural damage 
occurs during spermatogenesis is consistent with the findings of a study which showed that 
infertile men with and without leucocytospermia had similar sperm concentrations in 
semen . Low sperm concentrations would have been expected if the leucocyte induced 
damage occurred during spermatocytogenesis (proliferative phase).
The mechanism through which leucocytospermia may induce the alteration in sperm structure 
is not clear'. However, one potential explanation is that leucocytospermia could be a marker 
for an inflammatory process in the testis and in most cases would be related to a subclinical 
inflammatory process and not due to an overt epididymoorchitis. The presence of 
proinflammatory mediators such as cytokines in the testis could lead to alterations in the 
regulation of spermiogenesis by interfering with Sertoli cell function leading to abnormal 
spermrogenesrs .
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In addition, significantly higher proportions of sperm with cytoplasmic droplet in the 
leucocytospermic patient group could be due to defective Sertoli cell function and 
disorganised speimiation235. Alternatively, it could be due to alterations in the maturation 
process that the sperm undergo while transient in the epididymis.
Alterations in epididymal sperm maturation would also explain why leucocytospermic men 
have significantly lower sperm motility. Thus, leucocytospermia induced sperm damage may 
commence during spermiogenesis and continue through speimiation and epididymal 
migration.
Thus, leucocytospermia could induce sperm damage by a number of mechanisms such as: 1) 
DNA damage; 2) release ROS; 3) affect spermatogenesis; 4) lead to cytokine induced speim 
damage; and 5) alteration in the sperm epididymal maturation which could lead to decreased 
sperm motility. The aim of the fifth study was to show the affect of various leucocyte 
subpopulations on sperm parameters with particular emphasis on sperm count and motility.
3.5.2 Materials and Methods
Immunohistological staining using monoclonal antibodies was carried out as outlined in 
Chapter 2 sections 2.5.1, 2.5.2 and 2.5.3.
3.5.3 Statistical Analysis
The analysis was performed as described in Chapter 2 section 2.5.5.
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3.5.4 Results
19 (Mild-5, Severe- 14) oligoasthenospermic men were identified and compared to 14 
normospermic men. Mild oligoasthenospermia was defined as a sperm count of between 10- 
20xl06 and amotility of <40%. Severe oligoasthenospermia was defined as a sperm count of 
<10 xlO6 and motility of <30%.
All the sperm parameters were significantly reduced particularly the sperm count and motility 
in the mild (18 x 106/ml, 10%) and severe (3.6 x 106/ml, 5%) oligoasthenospermic group 
when compared to the normospermic group (43 x 106/ml, 25%) respectively (Table 3.14).
The T cells (CD 3 {1.3 x 106/ml} and CDS {0.95 x 106/ml}), B cells (CD20 {1.15 x 106/ml}) 
and large granular lymphocytes (CD56 {0.7 x 106/ml}) were significantly raised in the severe 
oligoasthenospermic group compared to the normospermic group {0.5, 0.6, 0.4 and 0.4 x 
106/ml} respectively (Table 3.15).
There seems to be a finely balanced interaction between the T cells and the B cells in the 
oligoasthenospermic group, increased T cell activity is more likely to be of a helper in nature, 
whereas the increased B cells activity might be the cause of decreased motility due to 
antibody production and the increased CD56 activity could be removing the non functioning 
sperm. The likely severity of the condition will probably depend of die predominance of the 
cell group.
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Table 3.14: Median and ranges of the sperm parameters in the
oligosthenospermic group vs. the normospermic group. ** Significance at the 1% 
level.
Sperm
Parameters
Normosper 
mic group 
(n=14) 
Median 
and ranges
Mild
Oligoasthe 
nospermic 
group 
(n=5) 
Median 
and ranges
Severe
Oligoasthenosp 
ermic group 
(n=14) 
Median and 
ranges
Mild
Oligoasthenosp 
ermic vs. 
normospermic
P value
Severe
Oligoasthenosp 
ermic vs, 
normospermic
P value
Oligoasthenos 
permic vs. 
normospermi 
c
P value
Sperm count 
lOVml 43 (28-75) 18(15-18) 3.6 (1.6-7) 0.001** 0.0001** 0.0001**
Motility % 25 (20-40) 10 (2.5-10) 5 (5-15) 0.002* * 0.0001** 0.0001**
SMT lO'Vml 8 (2.5-12) 0.4 (0.1-1) 0 (0-0.4) 0.004** 0.0001** 0.0001**
Morphology % 
normal forms 28 (18-32) 9 (9-12) 15 (8-16) 0.003** 0.0001** 0.0001**
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Table 3.15: Median and ranges of leucocytes (expressed as cells per 10 hpf) in 
mild and severe oligoasthenospermic group vs. the normospermic group.
^Significance at 5% level ^^significance at the 1% level.
Antibodies
Normosp
ermic
group
(n=14)
Median
and
ranges
Mild
Oligoasthenosp 
ermic group 
(n=5)
Median and 
ranges
Severe
Oligoasthenos 
perniic group 
(n=14) 
Median and 
ranges
Mild
Oligoasthenos 
perniic vs. 
normospernii 
c
P value
Severe
Oligoasthenosp 
ermic vs. 
normosperniie
P value
Oligoasthen 
ospermic vs. 
normosperm 
ic
P value
CD 45% 63(55.5-76) 77(72-77.3) 81.7(66-90) 0.38 0.07
0.09
CD 45 5.9 (3.9- 16.7) 7.5 (4-8.2) 7.75 (4.1-12.4) 0.83 0.98
0.945
CD 2 0.7 (0.3- 1.9)
1.9 (1.6-2) 1.85 (0.6-2.9) 0.11 0.19 0.09
CD 3 0.5 (0.3- 1.3) 1.9(1.7-2.4) 1.3 (0.5-6.7) 0.003** 0.04*
0.004**
CD 4 1 (0.6- 2.2) 2.4 (2-2.5) 1.7 (0.8-3.2) 0.18 0.35
0,2
CDS 0.6 (0.2- 1.1) 1.1 (0.9-1.7) 0.95 (0.7-2.6) 0.1
0.04* 0.02*
CD 14 1.2 (0.5- 2.8) 2.8 (2-3.1) 1.9 (0.8-4.7) 0.29
0.31 0.22
CD 16 2.5 (1.5- 5.7) 2.8 (2.5-8) 2.05 (1.2-4.7) 0.46 0.65 0.94
CD 20 0.4 (0.2- 
1)
0.5 (0.4-3) 1.15(0.6-2.2) 0.16 0.03* 0.02*
CD 56 0.4 (0.3- 0.5) 0.3 (0.3-1.1) 0.7 (0.5-1.9) 0.79
0.02* 0.05*
CD 69 0.5 (0.2- 1.2) 1.7 (0.9-2.5) 1.05(0.5-1.5) 0.17 0.16
0.1
L243 2.4 (1.7- 5.5) 2.2 (1.7-4.9) 2.5 (1.6-4.1) 0.76 0.62 0.6
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Table 3.16: Medians and ranges of the sperm parameters and leucocytes 
(expressed as cells per 10 hpf) in the oligosthenospermic group vs. the control 
group.
Mild
Oligoasthenospermi 
c group 
(n=5)
Median and ranges
Severe
Oligoasthenospermic 
group (n=14) 
Median and ranges
Controls 
(n=26) 
Median and 
ranges
Mild
oligoasthenos 
permic group 
vs. Controls
P value
Severe 
Oligoastheno 
spermic vs. 
controls
P value
Sperm Count 
lOVml
18 (15-18) 3.6 (1.6-7) 104(73-119) 0.001** 0.0001**
Motility % 10(2.5-10) 5 (5-15) 90 (80-99) 0.0001** 0.0001**
Morphology 
% normal 
forms
9 (9-12) 15 (8-16) 41 (31-48) 0.001** 0.0001**
SMT 107ml 0.4 (0.1-1) 0 (0-0.4) 24 (15-30) 0.001** 0.0001**
CD 45% 77(72-77.3) 81.7(66-90) 76(69-90) 0.66 0.89
CD 45 7.5 (4-8.2) 7.75 (4.1-12.4) 2.25 (0.65-4.7) 0.0001** 0.0001**
CD 2 1.9 (1.6-2) 1.85 (0.6-2.9) 0.15 (0-0.55) 0.0001** 0.0001**
CD3 1.9 (1.7-2.4) 1.3 (0.5-6.7) 0.15 (0.05-0.65) 0.0001** 0.0001**
CD4 2.4 (2-2.5) 1.7 (0.8-3.2) 0.2 (0-0.3) 0.0001** 0.0001**
CDS 1.1 (0.9-1.7) 0.95 (0.7-2.6) 0.1 (0-0.4) 0.0001** 0.0001**
CD14 2.8 (2-3.1) 1.9 (0.8-4.7) 0.55 (0.1-2.25) 0.0001** 0.0001**
CD16 2.8 (2.5-8) 2.05 (1.2-4.7) 0.65 (0.05-1.05) 0.0001** 0.0001**
CD20 0.5 (0.4-3) 1.15 (0.6-2.2) 0.2 (0-0.6) 0.0001** 0.0001**
CDS6 0.3 (0.3-1.1) 0.7 (0.5-1.9) 0.1 (0-0.35) 0.0001** 0.0001**
CD69 1.7 (0.9-2.5) 1.05 (0.5-1.5) 0 (0-0.1) 0.0001** 0.0001**
L 243 2.2 (1.7-4.9) 2.5 (1.6-4.1) 0.7 (0.3-1.8) 0.0001** 0.0001**
CD4/CD8
Ratio
2.18 1.78 2
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Figure 3.17: Box plots representing the median and ranges of the antibodies 
(expressed as cells per 10 hpf) in the oligoasthenospermic group vs. the 
normospermic group and the controls.
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A comparison was performed between the oligoasthenospermic group and the control group. 
The results are outlined in Table 3.16. A representation of the T cells and B cells is shown in 
Figure 3.17. It can be observed from Table 3.16 that the T and B cells are significantly 
increased in the oligoasthenospermic group.
The correlations between the sperm parameters and the cell surface markers demonstrate a 
negative con-elation between T cells (CD2 and CD3) with sperm count. Interestingly, there is 
a negative correlation between CD45 and SMT and morphology as shown in Figure 3.18. It 
has been noted that increased CD56 levels were associated with decreased sperm count 
whereas increased CD45 count associated with poor morphology.
There exists a conelation between the T and B cells. There are correlations between the L243 
cells and the T and B cells. These conelations are shown in Figures 3.18, 3.19 and 3.20. CD2 
con-elated with CD20 especially in the severely oligospermic group (r=0.97, p<0.001). When 
the mild and the severe oligospermic groups were combined as one group to look for* 
correlations between T and B cells it was found that again CD2, CD3 and CD4 and CD20 
conelated well {(r=0.47, p<0.04), (r=0.48, p<0.04), (r=0.57, p<0.01)} respectively. However, 
it was also identified that there were no correlations between CDS and CD20. Figures 3.21, 
3.22 and 3.23 show the L243, CD3 and CD16 cells in the oligoasthenospermic group.
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Figure 3.18: Correlation between leucocytes and sperm parameters in the 
oligoasthenospermic group.
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the mild oligoasthenospermic group.
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Figure 3.21: L243 cells (stained pink) in the severe oligoasthenospermic sample.
Figure 3.23: CD 16 cells (stained pink) in the severe oligoasthenospermic sample.
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3.5.5 Discussion
The results from this section of the study concur with the results of another study where 
powerful associations were observed between the incidence of leucocytospermia and 
abnormalities in sperm number and motility82. In the severe oligoasthenospermic group, the 
CDS and the CD20 levels were significantly elevated. This finding was no surprise and it 
concurs with the findings of the earlier two studies (studies 3 and 4) where CD3 was elevated 
in the oligospermic group and CDS and CD20 were elevated in the asthenospermic group. 
However, it was also possible to identify an increase in the CDS and the CD56 cells in the 
severe oligoasthenospermic group. The CD4 / CDS ratio was 1.78 in the oligoasthenospermic 
group when compared to the control group which was 2. This may have some diagnostic 
utility. It has also been shown that a correlation exists between CD56 (NK cells) and sperm 
count. The increase in the CD56 count was associated with a decrease in the sperm count. 
This study identified an increase in the CD45 was associated with poor sperm morphology. In 
contrast to this study, other studies have failed to identify a significant difference in leucocyte 
counts between groups of patients exhibiting either a normal semen profile or 
oligozoospermia239’240, and even found oligozoospermia to be associated with a significant 
decline in leucocyte numbers241. It has been reported that the presence of abnormal 
spermatozoa and leucocytospermia can increase ROS production in semen, but their 
damaging effects on sperm properties are still controversial107;202;242:243. According to some 
authors, ROS generated by leucocytes can be harmful for sperm cells only in the absence of 
seminal plasma scavenger systems, as in acute testicular or epididymal infections102. 
However, it has been shown here that there exists a balance between T and B lymphocytes on 
sperm parameters. A disturbance or trigger factor could explain the recruitment of the 
lymphocytes to enhance sperm damage.
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3.6 STUDY NUMBER 6: Leucocyte subsets in the Obstructive Azoospermic and Germ 
cell damaged Azoospermic group versus the Normospermic group.
3.6.1 Introduction
In the samples with asthenozoospermia, granulocytes were predominant, whereas in those 
with azoospermia a reduction in the number of macrophages and lymphocytes was observed, 
suggesting an obstructive process in the azoospermic group, at the level of epididymis and / 
or vas deferens where these leucocytes are mostly produced. The influence of leucocytes on 
seminal fluid is controversial, despite its high incidence among infertile men, ranging from 
15% to 28%, whereas in fertile men it is 10%244.
A few studies have failed to detect a negative effect of leucocytes on sperm quality: it has 
even been suggested that leucocytes have a role in the removal of abnormal spermatozoa from 
the ejaculate, increasing the percentage of sperm with normal morphology241, and others have 
not observed sperm damage during leucocytospermia245.
On the contrary, many other authors have found evidence that WBCs are a significant 
cofactor of male infertility, influencing sperm number, motility and functions in a negative
82* 100*225-235way ’ ’ ’ , as also demonstrated by the hamster ovum penetration test, an important
prognostic factor for IVF102.
Due to the absence of clinical symptoms, the origin of the leucocytes is unclear. Normally, 
most leucocytes appear to originate from the epididymis because vasectomised men show 
very few leucocytes in semen. Sperm damage by WBCs can also be mediated by reactive- 
oxygen species, proteases and cytokines.
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Moreover, it has been suggested that leucocytes induce DNA damage in a cascade-like 
manner, particularly in sperm with poor morphology and motility236. DNA fragmentation also 
affects the outcome of assisted reproductive technologies. There have been no studies 
evaluating the presence of leucocytospermia in azoospermic patients.
The aim of the sixth study was to determine which and at what levels the various leucocyte 
subpopulations are present in azoospermia.
3.6.2 Materials and Methods
Immunohistological staining using monoclonal antibodies was canied out as outlined in 
Chapter 2 sections 2.5.1, 2.5.2 and 2.5.3.
3.6.3 Statistical Analysis
The analysis was performed as described in Chapter 2 section 2.5.5.
3.6.4 Results
Azoospermia was defined as the complete absence of sperm. Azoospermia was further 
divided into two groups depending on the aetiology for the azoospermia into either germ cell 
failure (non obstructive) group or obstructive. The obstructive azoospermic group had all 
undergone vasectomy.
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Although testicular biopsy is the definitive test to rule out the non obstructive from the 
obstructive groups, the presence or absence of active spermatogenesis can be accurately 
predicted by measuring the testis volume and serum FSH. Hence the differentiation between 
germ cell failure azoospermia and obstructive azoospermia was made by the serum follicle 
stimulating hormone (FSH) levels, karyotyping and testicular volume. The testicular volume 
in the non obstructive group was reduced (< 7 ml).
20 (Germ cell- 10, Obstructive -10) azoospermic men were identified and compared to 14 
normospermic men. In obstructive azoospermia, there was an increase in the number of T 
cells (CDS; p=0.01), B cells (CD 20; p=0.02), large granular* lymphocytes (CD56; p=0.03) 
and activated T and B cells (CD69; p~0.03) when compared to the normospermic group. 
These increased numbers were statistically significant (Table 3.17 and Figure 3.24).
All the leucocytes were significantly elevated in the azoospermic group in comparsion to the 
control group as shown in Figure 3.24. In germ cell damage azoospermia, there was an 
increase in the number of T cells (CD3; p=0.05). Positive correlation was identified between 
the leucocytes in the germ cell damage azoospermic group (Figure 3.25). Figure 3.26 shows 
CD3 cells in a germ cell failure azoospermic sample.
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Table 3.17: Median and ranges of the leucocytes in obstructive and germ cell 
damage azoospermia vs. normospermia. ^significance at 5% level111 * significance at 
the 1 % level.
Antibodies
Normospermic 
group 
(n=14) 
Median and 
ranges
Obstructive 
Azoospermia 
(n=10) 
Median and 
ranges
Azoospermia 
(Germ cell 
damage)
(n=10)
Median and ranges
Obstructive
Azoospermia
vs.
normospermic
P value
Azoospermia 
(Germ cell 
damage)
Vs
normospermic
P value
Azoospermia
vs.
Normosper
mic
P value
CD 45% 63(55.5-76) 93(83-97) 80(64-96) 0.001** 0.1 0.2
CD 45 5.9 (3.9-16.7) 6.65 (3.6-8,4) 5.35(2.6-11.1) 0.82 0.47 0.57
CD 2 0.7 (0.3-1.9) 1.3 (0.7-2.5) 0.9 (0.5-1.5) 0.45 0.72 0.5
CD 3 0.5 (0.3-1.3) 1.35 (1-2.8) 0.85 (0.6-2.5) 0.01* 0.05* 0.01*
CD 4 1 (0.6-2.2) 2.05 (1.2-3) 1.65 (1.5-3.9) 0.22 0.17 0.12
CDS 0.6 (0.2-1.1) 1 (0.5-1.7) 0.35 (0.3-2.1) 0.1 0.82 0.26
CD 14 1.2 (0.5-2.8) 2.15 (1.5-3.5) 1.05 (0.7-2.5) 0.11 0.72 0.24
CD 16 2.5 (1.5-5.7) 2.8 (2,2-3.3) 1.7 (1.4-3) 0.96 0.44 0.66
CD 20 0.4 (0.2-1) 1.45 (0.7-3.3) 0.6 (0.3-1.1) 0.02* 0.33 0.05*
CD 56 0.4 (0.3-0.5) 0.8 (0.5-1.4) 0.5 (0.1-3.3) 0.03* 0.47 0.09
CD 69 0.5 (0.2-1.2) 1.6 (1-2.4) 0.65 (0.4-1.6) 0.03* 0.45 0.08
L243 2.4 (1.7-5.5) 2.5 (1.7-5) 2 (1.3-6.1) 0.96 0.68 0.78
CD4
/CDS
Ratio
1.67 2.05 4.71
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Figure 3.24: Box plots representing the median and ranges of the leucocytes 
(expressed as cells per 10 hpf) in the azoospermic group, normospermic group 
and the controls.
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Figure 3.25: Correlation matrix showing the positive correlations (CD4 and L243 
r=0.90, CD14 and CD4 r=0.86, CD14 and L243 r=0.97, p values <0.01) between 
the leucocytes in the azoospermic germ cell failure group.
Figure 3.26: CD3 cells (stained pink) in the germ cell failure azoospermic sample.
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3.6.5 Discussion
This study has found helper T cells (CD4) as the predominant cell in the control group. The 
results of this study concur with the findings of a study in rats, where the main T cell 
population in the epididymis of the rats were the helper T cells246. Furthermore, the rat study 
also showed that in the rat epididymis following vasectomy, there was a decrease in the T4 
helper cells number and an increase in the T8 cytotoxic cells number246. In direct contrast, a 
study of the lymphocyte subpopulations in the male genital tract showed that the majority of 
the T cell population were cytotoxic (CDS) T cells in the scrotal portion of the vas deferens229. 
This ratio changed in patients who had had a vasectomy, where marked increases of helper 
(CD4) T cells were noted. This study also concurs that there was a significant increase in the 
cytotoxic cells (CDS) in the obstructive azoospermic group when compared to fertile controls. 
However, there was also a substantial increase in the helper T cells as well. The CD4 / CDS 
ratio in the obstructive group was 2.05 when compared to the germ cell failure group which 
was significantly raised at 4.71. This ratio might be potentially useful in differentiating 
between the two azoospermic groups. The seminal population of leucocytes was studied here 
rather than at the level of the epididymis in the respective groups. In the current study, there 
was no significant difference in the total leucocyte count or the CD 14 (monocyte) count and 
the two azoospermic groups when compared with normospermic groups as shown in Table 
3.18. In addition, the CD3 T lymphocyte and CD56 (large granular lymphocyte) were 
significantly elevated in the obstructive group. However, all the leucocytes were significantly 
elevated in the azoospermic group in comparison to the fertile control group.
Lymphocytes, mostly T cells, tend to be concentrated in large numbers in the epididymis, vas 
deferens and the prostate gland. There were few in number in the rete testis, the ampulla of the 
vas and the seminal vescicles. B lymphocytes were demonstrated only in the stroma of the
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prostate in the same study. Cytotoxic T cells were predominantly present in the lamina propria 
of the epididymis, vas deferens and seminal vesicles. In contrast, the helper T cells were more 
abundant in the interstitial connective tissues. It is mostly likely that the cytotoxic T cells in 
the epithelial lining of the male genital tract function as a major immunological barrier which 
normally prevents the development of autohumoral or cellular immune responses to sperm
229antigens .
The presence of two predominant T cell subsets in the semen could be as a result of antigen 
sequestration. The variation in the T cell subset numbers may represent a part of a much wider 
change that occurs to counteract the increased antigen within the genital tract caused by 
obstruction of the efferent duct. This could lead to two theories of antigen sequestration by 
the T cells either by immune sequestration or by immune tolerance. T cytotoxic cells are 
present in increased numbers as they try to suppress the development of an immune response 
to the happed sperm as a result of an obstruction. Similarly, the CD20 and the CD69 counts 
were significantly elevated in the obstructive group. This increase in the B cell population in 
the azoospermic group may result in increased levels of antisperm antibody being secreted. 
This might suggest either the site of seminal leucocyte production is not necessarily confined 
to the vas or the epididymis as once thought.
The leucocyte subpopulations identified to be significantly increased in this study were CDS 
in the germ cell damage azoospermic group and increased CDS, CD20, CD56 and CD69 in 
the obstructive azoospermic group.
“Detection of subpopulations of leucocytes in different subgroups of semen sample qualities”- 
This paper has been accepted for publication in Andrologia Journal.
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3.7 STUDY NUMBER 7: Leucocyte subsets in the IVF group (Fertilisers versus the 
Non-Fertilisers)
3.7.1 Introduction
One of the interesting findings of a previous study was the correlation between an increased 
proportion of sperm with tail defects and the significant increase in sperm ROS production235. 
In standard IVF treatment, men who failed to fertilise had a significantly higher mean 
proportion of spermatozoa with tail defects in semen than those who were successful 
fertilisers247. In another report, the percentage of sperm with tail defects correlated negatively 
with fertilisation rates in vitro both before and after sperm preparation techniques248. 
Leucocytospermia has been linked with poor fertilisation rates and embryo development rates 
in the leucocytospermic group compared with control groups although there were no 
statistical differences for embryo quality, embryo cleavage and pregnancy rates. These results 
indicate that the outcome of ICS I was negatively affected by the presence of 
leucocytospermia. In contrast, another study found the overall fertilisation rate and the 
corresponding pregnancy rates were not affected by the presence of leucocytospermia in 
patients undergoing IVF / ICSI.
The hypothesis was that leucocytospermia leads to increased ROS production which could 
induce tail defects in the spermatozoa and thereby affect fertilisation rates. Hence the aim 
was to determine the true effect of T and B cell subpopulations on the fertilisation rates in an 
IVF cycle.
3.7.2 Materials and Methods
As outlined in Chapter 2 sections 2.5.1, 2.5.2 and 2.5.3. Semen was obtained from the 
partners of women attending for IVF cycle, by masturbation after three-five days of sexual
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abstinence. The samples were collected and analysed similar to group 1 as described in 
section 2.2. Couples undergoing traditional IVF only were chosen so as to study the effect of 
the various leucocyte subpopulations on IVF outcome rather than sperm parameters. The 
inclusion criteria for the men were that they neither had illnesses nor did they take any 
medication that could have affected cytokine metabolism. These men did not smoke or drink 
on a regular basis. These men formed the control group.
3.7.3 Statistical analysis
The analysis was performed as described in Chapter 2 section 2.5.5.
3.7.4 Results
36 men were recruited into the study. The age of the men ranged from 25-45 years (median 
34 year's). The duration of infertility was a median of 3 year's and ranged from 2-6 year's. The 
underlying diagnosis of infertility was due to female factors. All men had a normal sperm 
count, but their sperm motility ranged from 20-100%. Seven were identified as poor 
fertilisers (fertilisation rates <35%) and 14 (fertilisation rates >60%) were good fertilisers.
The total leucocyte counts (CD45), between the poor and good fertilisers were not 
statistically significant. The macrophages and the monocytes (CD 14) were significantly 
elevated in the good fertilisers group (0.7) in comparison to the poor fertilisers (0.3). The 
correlation of various leucocytes with the fertilising potential is depicted in Figure 3.27. 
Figure 3.28 depicts the CD45 cells stained pink in the seminal plasma from an IVF sample.
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Table 3.18: Median and ranges of the CD counts in men with fertilisation rates < 
35% and >60%.
Fertilisation rate <35%
(n=7)
Median and Ranges
Fertilisation rate >60% 
(n=14)
Median and Ranges
P value
CD45 1.8 (0.5-3.9) 2.5 (1.3-5.2)
0.30
CD2 0 (0-0.6) 0.4 (0-0.6)
0.36
CD3 0.1 (0-0.7) 0.25 (0,1-0.6)
0.42
CD4 0 (0-0.3) 0.2 (0-0.4)
0,25
CDS 0 (0-0.2) 0.2 (0.1-0.3)
0.15
CD14 0.3 (0.1-0.5) 0.7 (0.3-1.3)
0.05:i;
CD16 0.3 (0-1) 0.4(0.1-0.7)
0.88
CD20 0.1 (0-0.2) 0.15 (0-0.7)
0.28
CD22 0 (0-0.1) 0 (0-0.1)
0.47
CD56 0.1 (0-0.3) 0.15 (0-0.3)
0.51
CD69 0 0.1 (0-0.3)
0.06
L243 1.2 (0.4-1.8) 0.65 (0.4-1.5)
0.59
158
20.00-
CD 2,4, 8 & CD 14 
Cells median/lOhpf
15 00-
10 00-
5 00-
ooo-
20.00 40.00 60.00 80.00 100.00
Fertilization rate in %
O
O
o
o
CD2
Fertilization rate 
CD4
FertHtatton rate 
CDS
Fertiization rate 
CD14
Fertiization rate 
CD2
Fertiization rate 
CD4
Fertiization rate 
CDS
Fertiization rate 
CD14
Fertiization rate
Figure 3.27: Correlation between leucocytes and fertilisation rate showing that 
the T cells (CD2, CD4, CD 8) and CD14 (macrophages) correlate significantly 
(r=0.47, p value < 0.01) with the fertilisation rate.
Figure 3.28: CD45 cells (stained pink) in the IVF sample.
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3.7.5 Discussion
In this study, the median levels of CD45 were higher in the good fertilisers (2.5) in 
comparison to the poor fertilisers (1.8). However, this did not reach statistical significance. 
However, the macrophages and the monocytes (CD 14) were significantly elevated in the 
good fertilisers group in comparison to the poor fertilisers. This could be due to the fact that 
in these individuals there is increased phagocytic activity which would therefore remove the 
sperm with abnormal morphology and hence increase the fertilising potential. Another study 
concurred with this study stating that leucocytospermia may not necessarily have a negative 
effect on outcome after either in vitro fertilisation or xntracytoplasmic sperm injection184. 
Similarly, evaluation of the elastase-inhibitor complex in seminal plasma, a marker of male 
genital tract inflammation, in men undergoing in vitro fertilisation (IVF) found no correlation 
between the seminal elastase-inhibitor levels and fertilisation rates. However, it was shown 
that leucocytospermia could affect the blastocyst development and lead to embryo arrest249. 
There did not seem to be any role for the T cells in the IVF group.
However, other studies have observed that the concentration of WBC in semen was a strong 
predictive factor for IVF-embryo transfer success86;87 and, more recently, it was shown that 
the number of leucocytes expressing CD45 was negatively correlated with the fertilisation 
rate of metaphase II oocytes250. Similarly, fertilisation rates were found to be significantly 
reduced in the leucocytospermic group when compared to the control group183.
These conflicting reports are probably due to different detection methods, different 
populations studied and to the fact that leucocyte subtypes in semen may have different 
functions. Most of these studies lacked an accurate, reliable methodology for detecting WBC, 
making it impossible to draw any firm conclusions from such results. Although
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immunocytochemistry is considered the gold standard for the detection of WBC in semen, it 
is however a manual, subjective method. Data show that correlation between flow cytometry 
combined with monoclonal antibodies and other methods is limited when used to quantify 
semen parameters and leucocyte concentrations.
There are a few limitations to this study. The numbers of patients in each group are small. 
Hence statistical significance may not correlate with clinical significance. Although it has 
been endeavoured to classify the patient groups as good and poor fertilisers using an arbitrary 
point of 60% and 35% respectively, some conventional authors may not agree with the 
quoted reference ranges of semen parameters. It would have also been useful to look at the 
number of biochemical / clinical pregnancies resulting from the embryos created by the good 
and poor fertilisers. This would have then led to further discussion about the correlation / 
relationship between pregnancy outcome and the seminal plasma cytokine content.
Hence the presence of leucocytes does not adversely affect the fertilisation rates and the 
outcome of an IVF cycle.
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CHAPTER 4
CYTOKINES IN THE DIFFERENT SUBGROUPS OF MALE FACTOR 
INFERTILITY
As discussed in Chapter 1 (section 1.7) cytokines are important mediators of immune and 
inflammatory reactions. Human semen contains a repertoire of these molecules whose effects 
on semen quality and sperm function remain the subject of much debate.
This chapter has been divided into subsections. Each of the subsections aims to answer 
particular questions with regards to cytokines and their role in male subfertility. The 
objectives were:
4.1- To determine if there is an elevation of cytokines in the ASA+ve patients and whether 
cytokine mediated sperm damage could explain the subfertility in this group of patients.
4.2- To determine if microbilogically culture positive patients exhibit elevated levels of 
cytokines and if so whether this could explain their subfertility due to cytokine mediated 
sperm damage.
4.3- To determime the presence of a repertoire of seminal cytokines IL-6, IL-8, IL-10, IL-11, 
IL-12, TNF-ot, and IFN-y and to evaluate their role in male subfertility and identify any 
possible networks that may exist.
4.4- To determine the presence of a network of cytokines within the seminal plasma and 
whether this network may influence fertilisation rates either directly or indirectly.
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4.1 STUDY NUMBER 1: Cytokines in Antisperm Antibody Positive versus Antisperm 
Antibody Negative patients versus the Controls
4.1.1 Introduction
Immune responses, both humoral (ASA) and cell mediated (CMI), against sperm may be 
implicated in some cases of infertility of undefined aetiology and in male factor infertility. A 
study has suggested that a high IL-8 and IL-6 concentration occurred more frequently in 
ejaculates with IgG class ASA, but this did not reach statistical significance251.
There was no relationship of TNF-a and IL-ip levels in seminal plasma with semen quality 
or parameters of sperm functional capacity, and there was no association with local ASA of 
the IgG or IgA class in another study252. However, IL-12 was detected at significantly lower 
levels in both male factor infertile and immunoinfertile men253.
Some studies have shown an increase in IFN-y and IL-6 levels in seminal plasma of infertile / 
immunoinfertile men compared to those of fertile men254;255. The main aim of this study was 
to show if elevation of cytokines in the ASA+ve patients could explain their subfertility as a 
result of cytokine mediated sperm damage.
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4.1.2 Materials and Methods
The cytokine assays were performed using the cytokine sandwich ELISA method as outlined 
in Chapter 2 section 2.6.2.
4.1.3 Statistical Analysis
The analysis was performed as described in Chapter 2 section 2.6.3.
4.1.4 Results
64 patients were recruited into this study out of which 26 fertile men foimed the control 
group. These 26 men were attending the IVF clinic due to female factor infertility, were 
ASA-ve, culture negative and their partners had achieved a pregnancy and thus were 
considered to be an adequate control group. IL-10 was significantly raised in the ASA+ve 
group when compared to the control group (Table 4.1).
However, there was no significant difference between the ASA+ve and the ASA-ve group. 
The cytokines to reach statistical significance in the ASA+ve and ASA-ve group when 
compared to the control group were IFN-y and TNF-a as shown in Table 4.1. In addition, 
IFN-y was also found to have a negative correlation with sperm motility as shown in Figure 
4.1.
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Figure 4.1: Effect of cytokines (pg/ml) on motility and SMT- A negative correlation 
(IFN gamma and SMT r=-0.525, IL-10 and motility r=-0.310, p value< 0.01).
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Table 4.1: Comparison of the cytokine levels between each subject group. Values 
are expressed as picograms/ml, with ranges for each group given in brackets. P value 
indicates that results reached statistical significance between the following 
comparisons: ASA negative vs. controls, ASA positive vs. controls, ASA negative vs. 
ASA positive. ^Significant at 5% level ^'^significant at 1% level.
Cytokines
pg/nil
ASA Negative 
(n=21)
Median and 
Ranges
ASA Positive 
(n=17)
Median and 
Ranges
Controls
(n=26)
Median and 
Ranges
P -value 
Negative 
vs.
controls
P -value 
Positive
vs.
controls
P -value 
Positive
vs.
negative
IL-6 21.5 (13-60.5) 40(21-84.5) 35 (24-56) 0.31 0.58 0.19
IL-8 1400 (950-1700) 1800(1350-2100) 945 (320-1800) 0.54 0.06 0.25
IL-11 6370 (2550-9460) 5365 (2500-9600) 3175 (2317-5475) 0.16 0.09 0.96
IL-10 83.5 (63.5-145) 109 (76.5-190.5) 61.67 (35.83-100) 0.27 0.02* 0.28
IL-12 11.5(3-31.75) 6(0-15) 12 (7-15) 0.49 0.23 0.14
TNF-
Alpha 0 0 8(0-18) 0.11 0.01** 0.63
IFN-
Ganima 605 (390.5-955) 587.5 (396-958.5) 83 (42-329) 0.0001** 0.0001** 0.85
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4.1.5 Discussion
Mechanisms that result in ASA production and autoimmunity are enhanced by the secretion 
of proinflammatory cytokines such as IL-1, IFN-y, TNF-a, and reduced by the secretion of 
antiinflammatory cytokines such as IL-10 ’ .
In this study, statistically significant raised levels of IL-10 (p<0.02) were found in the 
ASA+ve group when compared to the control group which may support the view that IL-10 
is an antiinflammatory cytokine with immunoregulatory functions and inhibits the production 
of several proinflammatory cytokines including TNF-a and IFN-y by altering the accessory 
cell function of macrophages. Hence the increased levels in the ASA+ve group compared to 
the ASA-ve group. In agreement with previous studies252, no relationship between TNF-a and 
antisperm antibodies was found.
Significant levels of IFN-y were present in the subfertile group irrespective of their ASA 
status when compared to the control group. IFN-y was also found to have a negative 
correlation with the SMT as shown in Figure 4.1. IFN-y, at high concentrations, has been 
noted to adversely affect sperm motility200 and men with antisperm antibodies have lower 
sperm motility such that the mechanism of the effect of antisperm antibodies on sperm 
motility may be via the action of IFN-y.
These findings support the hypothesis that there are significant differences in the levels of 
certain cytokines in the ASA+ve patients. Some have a protective role (IL-10 the 
antiinflammatory cytokine was significantly raised in the ASA+ve group), whereas others 
can cause subfertility through cytokine mediated damage which seems to particularly affect
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sperm motility (raised IFN-y in the subfertile group irrespective of the ASA status). This 
could explain that previous theories of how ASA could affect sperm motility in a mechanical 
way by antibody binding to the sperm tail may not be wholly true and the cytokine IFN- 
y may have had a role to play.
4.2 STUDY NUMBER 2: Cytokines in patients with Positive cultures versus patients 
with Negative cultures
4.2.1 Introduction
Inflammatory cytokines are produced by white blood cells (WBC), mainly by macrophages, 
in response to foreign antigens, pathogens (infection challenge) and also in chronic 
inflammation (immunological activation). Acute and chronic infections may play a 
contributory role in male infertility. The clinical relevance of silent infection in asymptomatic 
patients is, however, not clear. Cytokines play an important role in the immuno-inflammatory 
mechanisms which underlie the host response to infection, the most appropriate subdivisions 
being those that modulate leucocytes to produce proinflammatory responses, and those that 
have the capacity to down regulate inflammatory cells172.
The appearance of different cytokines in relation to infection might depend upon the infecting 
organism and the genetic make up of the individual258. It was hypothesised that even 
subclinical or asymptomatic infection could mount an immune response thereby causing an 
elevation of cytokines in the seminal plasma. Therefore, the aim of the study was to identify 
if elevated levels of cytokines in the culture positive patients could explain their subfertility 
due to cytokine mediated sperm damage.
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4.2.2 Materials and Methods
The cytokine assays were performed using the cytokine sandwich ELISA method as outlined 
in Chapter 2 section 2.6.2.
4.2.3 Statistical Analysis
The analysis was performed as outlined in Chapter 2 section 2.6.3.
4.2.4 Results
The total number of men recruited was 76 for the cytokine study. Three samples were lost 
during transport for cytokine analysis and hence the final study number was 73. In this study 
there were no significant differences in the levels of cytokines (IL-6, IL-8, IL-10, EL-11, IL- 
12, TNF-ot, and IFN-y) between the culture positive and the culture negative groups. This 
was true not only for the Ureaplasma group as shown in Table 4.2, but also for the general 
culture positive group which had organisms such as Enterococcus, mixed anaerobes, 
Streptococcus milleri and beta haemolytic Streptococcus as shown in Table 4.3.
In the Ureaplasma culture positive group there was a highly significant negative correlation 
(p< 0.01) between IL-11 and speim parameters (morphology, motility and SMT) as shown in 
Figure 4.2. There was also a significant negative correlation (p<0,05) between IL-10 and 
SMT as shown in Figure 4.2. In the general culture positive group there was a highly 
significant negative correlation between IL-11 and sperm morphology (p<0.01) and an 
equally significant negative correlation between IFN-y and sperm morphology and sperm 
count as shown in Figure 4.3. Similarly, IL-10 had a significant negative correlation to speim 
count, morphology and SMT in the general culture positive group as shown in Figure 4.4.
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Table 4.2: Median and ranges of cytokines (pg/ml) in Ureaplasma positive vs. 
XJreaplasma negative groups.
Cytokines
pg/ml
Positive
(n=20)
Median and Ranges
Negative 
(n=53) 
Median and 
Ranges
P -value 
Positive vs. 
negative
IL-6 36.5 (22-84.5) 30 (18-69) 0.5
IL-8 1950 (1400-2600) 1750 (1375- 2500) 0.84
IL-10 104.5 (65-172.5) 117(80-202) 0.53
IL-11 5500 (4083-9250) 6579 (3700- 11670) 0.72
IL-12 4.5 (0-20.5) 13.5 (0-40) 0.18
TNF alpha 0 0 (0-6.5) 0.49
1FN gamma 461 (313.5-1069) 741 (456-1200) 0.09
Table 4.3: Median and ranges of cytokines (pg/ml) in general culture positive vs. 
negative. (Culture positives included Enterococcus, Mixed Anaerobes, Streptococcus 
milleri and Beta haemolytic streptococcus).
Cytokines
pg/ml
Positive (n=24) 
Median and Ranges
Negative 
(n=46) 
Median and 
Ranges
P -value 
Positive vs. 
negative
IL-6 24 (17-50) 38 (19-96) 0.08
IL-8 1720 (1000-2100) 1950 (1450- 2600) 0.11
IL-10 117 (73-175) 112(70-210) 0.89
IL-11 6579(4150-11500) 6130 (3167- 9983) 0.62
IL-12 13 (0-72) 9 (0-25) 0.33
TNF-alpha 0 (0-20) 0 0.1
IFN-
Gamma 744 (328-1429) 656 (347-1109) 0.53
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Figure 4.2: Negative correlation between cytokines and sperm parameters 
in the Ureaplasma positive group (IL-11 and motility and SMT r=-0.27, IL-10 
and SMT r=-0.252, IL-11 and morphology r=-0.296, p value< 0.01).
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Figure 4.3: Negative correlation between IL-11 and IFN- gamma with sperm 
parameters in the general culture positive group (IL-11 and morphology r=- 
0.296, IFN- gamma and morphology r= -0.476, p value< 0.01).
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Figure 4.4: Correlation matrix depicting the relationship between IL-10 and 
sperm parameters in the general culture positive group (IL-10 (pg/ml) with SMT 
(106/ml), sperm count (106/ml) and morphology (% normal forms) r=0.386, 0.362 
and 0.343 respectively, p value < 0.01).
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4.2.5 Discussion
There was no significant difference in the IL-6 levels between the two groups in this study. 
This finding is in agreement with another study by Kocak et al. which showed no significant 
difference in IL-6 levels between normal men and those with male accessory gland infections 
(MAGI)259. This may be due to the wide range of values for proinflammatory cytokines in the 
MAGI group.
IL-8 is a chemokine and has been thought to play a key role in T cell mediated immune 
responses. There was no significant difference detected between the levels of IL-8 in the 
culture positive or culture negative group in this study. The origin of IL-8 in the male 
reproductive tract and its role in spermatogenesis and steroidogenesis has not been elucidated 
but a study had shown that there were significant differences in levels between normal men 
and infertile men with leucospermia / male accessory gland infection260. An increased IL-8 
secretion was shown in the infertile group with infection of the accessory genital glands261. 
The findings of the above two studies are in direct contrast to this study. This could be due to 
the fact that the patients in the before mentioned studies had overt infection compared to this 
patient group who had only subclinical infection.
There was no significant difference between the IL-10 and IL-11 levels amongst the two 
groups, but IL-11 had a significantly negative correlation with sperm parameters in the 
culture positive group. Although increased levels of IL-11 were found in men with male 
accessory gland infection when compared to normal men, IL-11 levels did not show any 
significant difference between normal men and those with abnormal speimiograms262. 
However, it is likely that rather than acting independently, IL-11 acts in combination with IL- 
6 and IL-8 in affecting sperm parameters particularly in patients with urogenital infections.
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Thus the presence of IL-11 in seminal plasma may still be considered as a potential marker of 
infertility.
Unfortunately, it is not possible to form any conclusions on the role of Chlamydial infection 
and sperm parameters and cytokine levels in the seminal plasma as none of the patients 
studied tested positive for Chlamydia. It could be argued that one of the potential weaknesses 
of this study was the non utilisation of molecular laboratory techniques to identify 
Chlamydial infection. Similarly, this patient group did not test positive for Mycoplasma 
species or Trichomonas vaginalis. Direct culture of semen is ideally the best practice method 
to detect male genital tract infection as it is 100% specific. However, these are technically 
demanding, needing a cold chain particularly for Chlamydia to preserve specimen viability in 
transport and are not readily available. Furthermore, the results can take up to eight days. 
Nucleic Acid Amplification Tests (NAAT) are both highly sensitive and specific (95%). The 
results of NAAT are received within a few hours. Thus, NAAT is replacing culture as the 
tests of choice in detecting male genital tract infections. However, to date there are no 
commercial NAAT semen tests available263. Furthermore, men attending an infertility clinic 
are likely to have reduced sperm quality which could have had an impact on the findings 
here.
There were no significantly elevated cytokine levels in the culture positive group and hence it 
is difficult to solely implicate cytokines as the cause of apparent subfertility in this group. 
This would go to suggest that the presence of asymptomatic infection might not produce the 
desired inflammatory response including the production of cytokines or that the distal 
urogenital tract is not sterile. Not many cytokines had significant negative correlations with
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sperm parameters which could suggest that the cytokines may not be originating in the testis 
and thus may not be influencing speimatogenesis.
Due to the lack of positive patients in this study, it is impossible to either support or refute the 
role played by Chlamydia trachomatis, Mycoplasma species and Trichomonas vaginalis 
infections in male subfertility.
4.3 STUDY NUMBER 3: Cytokines in different subfertile groups
4.3.1 Introduction
During the last decade there has been much evidence to suggest the involvement of paracrine 
control mechanisms such as the cytokines, in the control of reproductive function, 
particularly with regal’d to speimatogenesis. Cytokines may have a multitude of actions 
including both as growth and differentiation factors within the seminiferous tubule. It was 
hypothesised that there exists an intricate network of cytokines within the seminal plasma 
which may influence sperm function directly or indirectly. Thus the main aim of the study 
was to evaluate the role of a repertoire of seminal cytokines IL-6, IL-8, IL-10, IL-11, IL-12, 
TNF-a, and IFN-y in male subfertility and identify any possible networks that may exist.
4.3.2 Materials and Methods
The cytokine assays were performed using the cytokine sandwich ELISA method as outlined 
in Chapter 2 section 2.6.2.
4.3.3 Statistical Analysis
The analysis was performed as outlined in Chapter 2 section 2.6.3.
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4.3.4 Results
The total number of men recruited was 76 for the cytokine study. Three samples were lost 
during transport for cytokine analysis and hence the final study number was 73. The 
normospermic group was compared with each of the other patient groups. The number 
recruited for the study is shown in Table 4.4.
The groups were defined as:
1. Nonnospermia.
2. Asthenospermia- sperm count >20xl06 and a motility of <40%.
3. Mild oligospermia - 10-20xl06 and >40%.
4. Severe oligospermia - <10xl06 and >40%.
5. Mild oligoasthenospermia - 10-20xl06 and <40%.
6. S evere oligoasthenospermia - < 10 x 106 and <30%.
7. Azoospermia - complete absence of sperm in the semen.
Table 4.4: The groups of men recruited into the study
Patient Groups Cytokine Study
Normospermia 14
Oligospermia 13
Asthenospermia 8
Oligoasthenospermia 19
Azoospermia (Obstruction) 10
Azoospermia (GCF) 9
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Azoospermia was further divided into two groups depending on the aetiology for the 
azoospermia into either germ cell failure (non obstructive) group or obstructive. The 
obstructive azoospermic group had all undergone vasectomy. Although testicular biopsy is 
the definitive test to rule out the non obstructive from the obstructive groups, the presence or 
absence of active spermatogenesis can be accurately predicted by measuring the testis volume 
and serum FSH. Hence the differentiation between germ cell failure azoospermia and 
obstructive azoospermia was made by the serum follicle stimulating hormone (FSH) levels, 
karyotyping and testicular volume. The testicular volume in the non obstructive group was 
reduced (< 7 ml).
The median values and the ranges for all the cytokines are given in Table 4.5. Significantly 
higher concentrations of IL-6 (p<0.05) were present in the asthenospermic, mild 
oligospermic, severe oligospemiic, severe oligoasthenospermic, azoospermic obstructive and 
germ cell damage groups when compared to the normospermic group. Significantly higher 
concentrations of IL-8 (p<0.05), were present in the asthenospermic group when compared to 
the normospermic group. Significantly higher concentrations of IL-10 (p<0.05), were present 
in the asthenospermic, severe oligoasthenospermic and azoospermic obstructive group when 
compared to the normospermic group as shown in Figure 4.5.
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Table 4.5: The median and ranges of cytokine levels (pg/ml) in the normospermic 
group are compared to the different subsets of subfertile men (*= p<0.05).
Cytokine levels
Pg/ml IL-6 IL-8 IL-10 IL-11 IL-12 TNF-ot IFN-y
Normospermic
(n=14)
18
(4-73)
1300
(220-2600)
76.5
(0-357)
6472
(13-11760)
21.5
(0-100)
0
(0-44) 454
(97-2135)
Asthenospermic
(n=8)
69.5
(4-
568)*
2850
(450-
49500)*
158
(35-832)*
4602.5
(750-27417)
11
(0-26)
0
(0-0)
563
(192-1665)
Mild oligospermic 
(n=6)
46
(16-
166)*
1400
(25-2500)
85
(39-153)
9820
(6130-
14083)
6.5
(0-25)
0
(0-41)
561.5
(2-1232)
Severe oligospermic 
(n=7)
26
(8-
140)*
1650
(1400-
1750)
78
(43-175)
5083
(2550-
12210)
15
(0-72)
0
(0-20)
636
(314-1551)
Mild oligo astheno 
spermic (n=5)
19
(8-355)
2100
(320-2600)
58
(25-245)
5850
(667-9250)
0
(0-55)
6
(0-30)
723
(224-1109)
Severe oligoastheno 
spermic (n=14)
33.5
(7-
211)*
1675
(160-
32750)
137.5
(0-272)*
4104
(333-16980)
0
(0-110)
0
(0-51)
619
(59-1566)
Azoospermic 
obstructive (n=10)
42
(14-
101)*
2050
(1250-
5000)
186
(80490)*
9529
(3750-
21804)
25
(6-140)
23
(0-73)*
1049.5
(202-1704)*
Azoospermic non
obstructive (n=9)
37
(11-
1006)*
2100
(700-3250)
93
(2-253)
4991.5
(0-33441)
18
(0-80)
0
(0-14)
901
(0-1575)
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Figure 4.5: IL-10 levels (pg/ml) in the different subsets of subfertile men.
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Figure 4.6: Correlation between IL-10 with IL-11 in the obstructive azoospermic 
group (r=0.75, p<0.01).
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Figure 4.7: Correlation between IL-10 with IL-11 and IFN-y pg/ml in the severe 
oligoasthenospermic group (IL-11 and IL-10 r=0.75, IFN-gamma and IL-10 
r=0.84, p<0.01).
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Furthermore, IL-6, EL-'10, TNF-a and IFN-y were significantly increased in the obsti'uctive 
azoospermic group when compared to the normospermic group. A significant correlation was 
found between IL-10 and IL-11 in the oligospermic (p<0.05) and obsti'uctive azoospermic 
(p<0.01) (Figure 4.6) groups. A significant correlation (p<0.01) was found between IL-10 
and IL-11 and between IL-10 and IFN-y in the severe oligoasthenospermic group as shown in 
Figure 4.7.
A significant correlation (p<0.05) was found between IL-10 and IL-6 in the severe 
oligoasthenospermic group. A significant correlation (p<0.01) was found between IL-10 and 
IFN-y in the oligospermic and asthenospermic groups.
4.3.5 Discussion
IL-6 is produced by the Sertoli cells and has a number of effects including stimulation of 
transferrin production by Sertoli cells128 and inhibition of meiotic DNA synthesis in pre- 
leptotene spermatocytes129. In this study, statistically significant raised levels of IL-6 were 
found in the mild oligospermic, severe oligospermic, asthenospermic and the severe 
oligoasthenospermic group. These results correlate with two previous studies where increased 
levels of IL-6 were found in the infertile groups2641265. Similarly, elevated levels of IL-6 have 
correlated significantly with sperm numbers in the ejaculate, sperm penetration rates in the 
sperm penetration assay, and some sperm motion parameters254. Increased levels of EL-6 were 
found in men with accessory gland infection when compared to normal men, but in contrast 
to this study, IL-6 levels did not show any significant differences between normal men and 
those with abnormal spermiograms.
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In this study, there were significantly high levels of IL-6 in the obstructive azoospermic 
patients which would suggest that the testis may not contribute to the high IL-6 levels in the 
seminal plasma and may be coming from the seminal vesicles and / or prostate. Similarly, 
significant correlations of IL-6 and fructose levels indicated that the seminal vesicles also
Ofifttake part in the production of seminal IL-6 .
Increased amounts of IL-8 (p<0.05) were identified in the asthenospermic and obstructive 
azoospermic groups when compared to the normospermic group in this study. As IL-8 levels 
were increased in the obstructive azoospermic group this may suggest that the testis is 
probably not the site of production for this cytokine. The site of production for this cytokine 
could be inferred to be at the level of the epididymis by the fact that asthenospermic patients 
may have epididymal disease and the obstructed patients could have epididymal obstruction. 
The origin of IL-8 and its role in spermatogenesis and steroidogenesis has not yet been 
elucidated.
Statistically significant raised levels of IL-10 (p<0.05) were found in this study in the 
asthenospermic, severe oligoasthenospermic and obstructive azoospermic group when 
compared to the normospermic group. The latter suggest that the testis is probably not the site 
of its production. In contrast, high levels of IL-10 have been observed in the seminal plasma 
of fertile men when compared to infertile men with or without leucocytospermia267. The 
reason for this could be that in this work there was only a classification of infertile groups 
with or without leucocytospermia rather than individual analysis of cytokines in the different 
subgroups of infertile men.
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This study found significant correlations between XL-10 and other proinflammatory cytokines 
in the oligospermic, asthenospermic, severe oligoasthenospermic and azoospermic groups. 
Raised levels of XL-10 were found along with raised levels of IL-6, IL-8 and TNF-ain the 
obstructive azoospermic group and raised levels of XL-10 were found along with raised levels 
of IL-6 and IL-8 in the asthenospermic group. IL-10 is an antiinflammatory cytokine with 
immunoregulatory functions and inhibits the production of several proinflammatory 
cytokines including IL-8 by altering the accessory cell function of macrophages268. Hence it 
is possible that the raised levels of IL-10 seen in this study were in direct response to 
suppress the proinflammatory cytokines such as IL6, IL-8 and IFN-y. In contrast, IL-10 levels 
have been shown to be significantly decreased in the seminal plasma of oligo-teratospermia 
and asthenoteratospermic patients with genital infection when compared to fertile, 
azoospermic or oligo-terato-asthenospermic patients without infection269.
Previously, increased levels of IL-11 were found in men with male accessory gland infection 
when compared to normal men, but IL-11 levels did not show any significant differences 
between normal men and those with abnormal spermiograms262. This study did not find any 
statistically significant difference in the levels of IL-11 amongst the various subgroups of 
subfertile men in comparison to normospermic group. This would suggest that this cytokine 
may not be influencing spermatogenesis.
This project demonstrated no significant difference in the IL-12 levels between the 
normospermic and subfertile subgroups. This is in agreement with other studies269;27°.
In this study, the TNF-ot and IFN-y levels were significantly increased (p<0.05) in the 
azoospermic obstructive group only. This would suggest that the testis is unlikely to be the
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site of production of these cytokines. This study would support the finding of the study 
carried out by Eggert Kruse whereby TNF-adid not affect sperm numbers or motility. 
Furthermore, another study reported no differences in the TNF-a levels between fertile and 
infertile groups (bilateral testicular atrophy, male accessory gland infection, varicocele and 
post varicocelectomy: groups classified according to history, physical examination and sperm 
parameters) of men who attended a urology clinic259. In support of this study findings, there 
was no relationship between TNF-alpha levels in seminal plasma and semen quality or 
parameters of sperm functional capacity252. However, in this study the azoospermic men were 
excluded. Prominent cytokines associated with T cell function, such as IL-10, IL-12 and IFN- 
y, were detected at a low concentration (< 100 pg/ml) in only a few samples of normal men. 
This is similar' to the normospermic group values. This suggests that cellular immune activity 
is low in the genital tract of normal men271.
However, in contrast to these findings, elevated levels of TNF-a and IFN-y have been 
identified in the oligozoospermic as well as the azoospermic groups272. A study by Nabil et 
al. 2008 also showed significantly increased levels of TNF-a in the oligoasthenozoospermic 
and the azoospermic group when compared to the normospermic group. However, the 
azoospermic group was not subdivided into obstructive and non obstructive. TNF-a levels in 
seminal plasma have been shown to be negatively correlated with the number of 
progressively motile sperm in the ejaculate, but there was no correlation with total sperm 
counts, viability, morphology etc177. However, in a repertoire study of cytokines in seminal 
plasma, out of the cytokines tested (IL-1, IL-2, IL-4, IL-6, IL-8, TNF-a, IFN-y, G-CSF, M- 
CSF andgranulocyte elastase) only IL-1, IL-8, TNF-a and G-CSF were significantly higher- 
in the leucocytospermic group when compared to normospermic, azoospermic, oligospermic 
and asthenospermic groups273.
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IFN-y exerts its inhibitory effects on testosterone production at the level of cholesterol 
transport into mitochondria . IFN-y is thought to stimulate the production of TNF-cc and it 
is reported that there is a significant overproduction of IFN-y levels in the seminal plasma of 
infertile men and a significant negative correlation with sperm count and motility275. 
However, in this study IFN-y was elevated only in the obstructive azoospermic group.
As increased levels of cytokines in this study were found in the obstructive azoospermic 
group, the measured levels must be coming from either the seminal vesicles or the prostate. 
Although unlikely, there may even be a small contribution from the epididymis. The only 
definitive way to prove that the cytokines are not originating from the testis is to measure the 
cytokine levels from testicular' sperm extraction samples.
This study confirms the effect of individual cytokines on sperm numbers and motility. It also 
confirms the hypothesis that there is an intricate cytokine network that exists in the seminal 
plasma as shown by the numerous correlations present in the various subfertile subgroups and 
their effect on sperm function. This cell mediated immunity could be up regulated by genital 
tract infection and lead to an increase in the levels of these cytokines276.
"'This study is published in the American Journal of Reproductive Immunology (Appendix 5).
* Citation- Seshadri et al. The Role of Cytokine Expression in Different Subgroups of Subfertile 
Men. AJRI2009; 62 (5): 275-282.
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4.4 STUDY NUMBER 4: Cytokine expression in IYF patients (Good fertilisers versus 
the Poor fertilisers)
4.4.1 Introduction
Cytokines are involved in gonadal and sperm function. Some in vitro studies have shown that 
cytokines such as IFN-y and TNF-cc decrease the motility of the spermatozoa175’200. Certain 
cytokines increase the generation of reactive oxygen species by human spermatozoa which 
increases the oxidative stress in the male genital tract277. Leucocytes and oxidative stress 
negatively affect the integrity of the speim chromatin inducing DNA fragmentation278 which 
increases morphological abnormalities of the spermatozoa232. Sperm DNA integrity 
impairment negatively affects embryo development235.
It was hypothesised that there exists an intricate network of cytokines within the seminal 
plasma which may influence fertilisation rates either directly or indirectly. The aim of this 
study was to determine the function of the seminal cytokine network in relation to the 
fertilising capacity of sperm with regards to fertilisation rates and pregnancy outcomes in a 
subsequent IVF cycle. In most studies, only a few cytokines (up to four) in seminal plasma 
have been measured, and the pathophysiological effect of these cytokines on fertilisation 
rates and pregnancy outcomes has remained largely unexplored.
In this study the cytokines were measured in the ejaculate at the time of IVF so it represented 
the true physiological situation since those sperm were used to inseminate and thereafter 
fertilise the oocytes. To our knowledge this is the first study testing seven cytokines in the 
seminal plasma of men attending IVF and comparing cytokine levels with fertilisation rates 
and pregnancy outcomes in an IVF cycle. These cytokines were selected as they have been
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studied previously either individually or as pairs with conflicting results. The hypothesis was 
also tested by finding out if there was any correlation amongst the cytokines to thus 
determine whether cytokines act individually or more as a network, which could be one 
reason for the conflicting results of previous studies.
4.4.2 Materials and Methods 
Study Design
As outlined in Chapter 2 section 2.6.2. Semen was obtained from the partners of women 
attending for IVF cycle, by masturbation after three-five days of sexual abstinence. The 
samples were collected and analysed similar to group 1 as described in section 2.2. Couples 
undergoing traditional IVF only were chosen so as to study the effect of the various cytokines 
on IVF outcome rather than sperm parameters. The inclusion criteria for the men were that 
they neither had illnesses nor did they take any medication that could have affected cytokine 
metabolism. These men did not smoke or drink on a regular basis. These men formed the 
control group.
Different grading schemes are in use to grade embryos when they reach the blastocyst stage 
(around day three of their development). An in house grading system of Grades 1-4 as 
outlined in Chapter 2 section 2.3 (Figure 2.1) was used. Although grading systems vary 
slightly from one unit to another, they all produce similar results.
4.4.3 Statistical Analysis
The analysis was performed as outlined in Chapter 2 section 2.6.3,
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4.4.4 Results
36 men were recruited into this study. The results of the seminal analysis from all patients are 
shown in Table 4.6. Sperm motility ranged from 20% - 100%. There was no correlation 
between sperm morphology and count when compared with the fertilisation rates. The 
embryos were graded from 1 to 4. There were 28 Grade 1, three Grade 2 and one Grade 3 
embryos. The age range of the female partners was 23-42 years with a median of 34 year's. 
The causes of their primary infertility included tubal factor (n=18), ovulatory (n=l) and 
unexplained (n=10).
Cytokine levels in the seminal plasma
IL-6, IL-8, IL-10, IL-11, were detected in all samples and IL-12, TNF-a and IFN-y were 
detected in most samples. It was not possible to assay all cytokines in all 36 samples as some 
of the volumes of the ejaculate were limited. Due to insufficient specimen samples it was not 
possible to test some cytokines such IL-8, IL-11 and TNF-a in all the samples. There was no 
conscious decision made to test some cytokines more than the others. However, this is one of 
the limitations of this study as the correlation between ejaculate volume and cytokine levels 
could have been overlooked. Table 4.7 shows the median and ranges for all cytokines. IL-8 
and IL-11 were present at higher levels than other cytokines.
The men were classified according to the fertilisation rates achieved by IVF. Four samples 
were excluded from the analysis as there was no data on the fertilisation rates. However, 
there was no correlation between cytokine concentration and fertilisation rates for any 
cytokine. Further analysis was performed by dividing men into good fertilisers (men who had 
a fertilisation rate above 60%) and poor fertilisers (fertilisation rate below 35%).
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Table 4.6: Clinical data and sperm parameters of the men attending IVF.
Parameters Median (Range)
Age (in years) 34 (25-45)
Sperm motility (%) 90 (20-100)
Normal morphology (%) 38% (9-67%)
Sperm count (x 106/ml) 90 (38-186)
Round cells (per HPF) 
HPF- High Power Field 2 (0-5)
Fertilisation rate (%) 60 (0-100)
Cleavage rate (%) 60 (0-100)
Biochemical pregnancies 12/32
Clinical pregnancies 10/32
Table 4.7: Median and the inter-quartile ranges of the different cytokines in 
pg/ml.
Cytokines
pg/ml N Median (pg/ml) Inter quartile range (pg/ml)
IL-6 36 36 24.5-71.5
IL-8 31 1150 380- 1800
IL-10 36 70.25 34.17- 100.42
IL-11 34 3575 2675 - 5475
IL-12 36 11 5 - 15
TNF- a 30 9 0-18
iFN-y 36 79 46-318
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The arbitrary values of 60% and 35% were set as a result of a decision made by the IVF unit 
as 60% is the average fertilisation rate for the unit. It was thought that if a significant 
difference were to be found between the poor fertiliser and good fertiliser group, then further 
analysis would be carried out by looking at the men with fertilisation rates between 35%- 
60%. Furthermore, this would also give an insight into the role of cytokines in the extremes 
of fertilisation rates. The remaining men who had fertilisation rates between 35% and 60% 
(n=6) were excluded from analysis. The cytokine levels of the poor and good fertilisers 
groups are shown in Table 4.8. Levels of IL-11 were significantly higher in the good 
fertilisers group (Mann-Whitney U=39.5; p=0.05) (Figure 4.8).
Correlation between cytokines
Spearman’s non-parametric test was used to measure the correlations between cytokines. A 
positive correlation was found between IL-8 and IL-6 (oo 0.40, p<0.03) (Figure 4.9). A 
positive correlation also exists between IFN-y with IL-10 and IL-11 (oo 0.36, p<0.04 and oo 
0.69, p<0.0001) respectively (Figure 4.10). There was also a positive correlation between IL- 
10 and IL-ll(oo 0.53, p<0.001).
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Figure 4.8: Significant levels of IL-ll(pg/ml) in »roup.
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Table 4.8: Cytokine levels (pg/ml) in men with fertilisation rates <35% & > 
60%.
Cytokines
pg/ml Fertilisation rate <35% Fertilisation rate >= 60%
N Median(pg/ml)
Inter quartile range 
(pg/ml) N Median(pg/ml)
Inter quartile range 
(pg/ml)
IL-6 9 26 23 - 65 17 35 29-49
IL-S 7 900 450 - 1400 14 1425 450- 1800
IL-10 9 40.83 25 -100.83 17 68.00 30.83-99.17
IL-11 9 2675 2317-3100 17 3750 3133-5475
IL-12 9 11 7-14 17 11 0-15
TNF- a 6 7.5 0-17 14 10 0-19
IFN-Y 9 57 47-72 17 68 35-212
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Figure 4.9: Positive correlation between IL-6 and IL-8 levels (pg/ml).
12,000 IL-10&IL-11 pg/ml
10,000
6,000 -
Level of Interferon gamma (pg/ml)
Fig 4.10: Correlation of IFN-gamma with IL-10 & IL-11 (pg/ml).
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4.4.5 Discussion
The IL-6 level found in this study was slightly higher by about 4 (pg/ml) than in previous 
published studies177;279&280. The effect of IL-6 on sperm is unclear281. Some studies have 
failed to demonstrate any effects of IL-6 on the semen although others have171’259’266. One 
study demonstrated an inverse correlation between sperm number and motility parameters 
and seminal IL-6 levels . IL-6 has been found to enhance the fertilising capacity of human 
sperm cells in vitro in some studies179 but not others283’284. In this study there was no 
correlation between IL-6 levels and fertilisation rates. This is in agreement with other studies 
showing IL-6 levels are not associated with the outcome of the sperm cervical mucus 
penetration test251;285.
In this study, although the levels of IL-8 were higher in the good fertilisers group, they did 
not reach statistical significance. There was no correlation between IL-8 levels and 
fertilisation rates in this study. This is in agreement with another study, in which there was 
no reported correlation between IL-8 and sperm parameters286. Conversely, IL-8 has been 
reported to exert a negative effect on the fertilising potential of spermatozoa277.
IL-10 was detected in the seminal plasma of normal men in this study and was found to have 
no effect on the fertilising capacity. These data are similar to other studies267;269. IL-10 is an 
antiinflammatory cytokine and is produced mainly by macrophages and T cells and 
suppresses the production of various proinflammatory cytokines287. High levels of IL-10 have 
been observed in the seminal plasma of fertile men267. Significantly decreased levels of IL-10 
have been found in the seminal plasma of infertile men269.
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There have been only a few studies analysing the levels of IL-11 in seminal plasma. In this 
study, IL-11 levels detected were considerably higher than other studies262. Significantly 
higher levels of IL-11 were found in the good fertilisers group. In one previous study no 
correlation was found between IL-11 levels and variables of the spermiogram262. Another 
study showed that significantly higher levels of IL-11 were present in the seminal plasma of 
infertile men with genital infection and oligo-terato-asthenospermia140. The role of IL-11 in 
seminal plasma and its relationship to the fertilising capacity of sperm has not been fully 
evaluated. Further studies need to determine the role of IL-11 in seminal plasma and in 
preimplantation embryo development.
This study detected IL-12 in the seminal plasma; however, there was no correlation between 
the levels of IL-12 and the fertilisation rates. The levels of IL-12 detected in normal men 
have differed between various studies ’ * . IL-12 is an immunoregulatory polypeptide
growth factor and is produced by a wide variety of cells including macrophages, neutrophils 
and is known to promote both the growth of natural killer cells and cytotoxic T cell activity. 
It also induces the secretion of interferon-y and promotes the growth of activated T and NK 
cells288"290. Leucocyte free infertile men have been seen to have significantly lower levels of 
IL-12 compared to fertile men, indicating a direct or indirect role for leucocytes in male 
fertility253. The exact pathophysiological pathway involved in the modulation of IL-12 levels 
as related to the reproductive function of the sperm requires further investigation.
The levels of TNF-a detected in this study mirror the levels in other studies177’259. This study 
showed no relation between the levels of TNF-a and fertilisation rates. TNF-a has adverse 
effects on sperm motility291,259. Results of a different study showed the levels of TNF-a and 
IFN-y are elevated in human semen during inflammation related infertility292.
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The results of another study showed that when spermatozoa are exposed to TNF-a and IFN-y 
in combination, the viability and integrity of the spermatozoa are compromised thereby 
indirectly contributing to the fertilising potential of the sperm293. It is possible that only at 
high concentrations TNF-a affects the fertilising capacity of the sperm. However, further 
studies are needed to confirm this hypothesis.
This study was able to detect IFN-y in all the seminal plasma samples collected. This is in 
agreement with the data presented by others275. This study showed no relation between IFN-y 
and fertilisation rates. IFN-y, a secretory product of activated T cells and natural killer cells 
has been hypothesised to have a toxic effect on sperm function. IFN-y has been demonstrated 
in vitro to adversely affect sperm motion parameters200 and the fertilising ability of human 
sperm to penetrate zona-free hamster eggs163. In vivo data on IFN-y concentrations in a 
relatively small number of seminal plasma samples have been published, showing no 
significant difference in IFN-y levels between fertile and infertile subjects. However, in 
another study, increased IFN-y concentrations in the seminal plasma of infertile subjects was 
found . Further studies are required to assess the role of IFN-y and TNF-a in seminal 
plasma.
There are a few limitations to this study. The numbers of patients in each group are small as 
this was meant to be a pilot study. Hence statistical significance may not correlate with 
clinical significance. A revised definition on sperm quality has been published by WHO in 
2010. However, it is unlildey that the 2010 definition would have changed much of these 
results or interpretations. Although it has been endeavoured to classify the patient groups as 
good and poor fertilisers using an arbitrary point of 60% and 35% respectively, some 
conventional authors may not agree with the quoted reference ranges of semen parameters. 
They could have preferred to have even compared the upper quartile to the lower quartile.
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The relevance of this study could have been increased by the measurement of the same 
cytokines in the oocyte / embryo culture medium. It would have also been useful to look at 
the number of biochemical / clinical pregnancies resulting from the embryos created by the 
good and poor fertilisers. This would have then led to further discussion about the correlation 
/ relationship between pregnancy outcome and the seminal plasma cytokine content.
This study has shown that six cytokines do not affect sperm-oocyte interaction and 
fertilisation rates in IVF. However, it appears that IL-11 could have a role in the fertilising 
capacity of the sperm. Significant correlations between cytokines have also been identified. 
The modulation of this cytokine network could explain the wide variability of the success 
rates seen in IVF when male factor is ruled out by normal semen analysis. The sperm is 
washed and prepared prior to IVF. The aim of washing and preparation of the sperm are to 
separate sperm from the seminal plasma which contains the cytokines. The process of sperm 
preparation during IVF thus removes any potential adverse effect of cytokines on sperm 
capacitation and sperm-oocyte interactions.
“Cytokine expression in the seminal plasma and its effects on fertilisation rates in an 
IVF cycle”. ::This study has been accepted for publication in the Andrologia Journal.
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CHAPTER 5: LEUCOCYTES AND CYTOKINES IN SUBFERTILE MEN
5.1.1 Introduction
Little is known about the physiological significance of the inflammatory cells and cytokines 
in seminal plasma in terms of their effects on uterine receptivity to embryo implantation and 
pregnancy. There is gathering evidence that human seminal plasma lymphocytes and 
cytokines influence implantation. Hence, there is a necessity to understand the role of 
lymphocytes and cytokines in seminal plasma.
Evidence is accumulating to support the hypothesis that insemination is causally linked to the 
activation and expansion of populations of lymphocytes mediating forms of active immune 
tolerance in the implantation site294. Several cytokines activated by semen are attributed with 
regulating proliferation, viability and differentiation of blastomeres in the embryos295’296. 
Cytokines targeting the developing blastocyst include IL-6 and leucocyte inhibitory factor 
that are induced after exposure to semen297;298.
There is some evidence from the previous two Chapters (3 and 4) to show that neither 
leucocytes nor cytokines on their own affect male fertility significantly. However, in 
combination they could lead to male subfertility. The hypothesis was to confirm the presence 
of cell mediated response in the seminal plasma and the main aim of this study was to 
identify any correlations between the different leucocyte subpopulations and the individual 
cytokines and their combined effect on sperm parameters.
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5.1.2 Materials and Methods
Immunohistological techniques as outlined in Chapter 2 sections 2.5.1, 2.5.2, 2.5.3 for 
leucocytes and cytokine ELISA sandwich method as outlined 2.6.2 for cytokines was used.
5.1.3 Statistical Analysis
The analysis was performed as outlined in Chapter 2 sections 2.5.5 for leucocytes and 2.6.3 
for cytokines.
5.1.4 Results
The results were drawn from the same group of patients in whom the leucocytes and 
cytokines were studied independently in Chapters 3 and 4 respectively. Further analysis was 
performed to find out if any significant correlation existed between the leucocytes and 
cytokines in various groups of sub-fertile men as described in the previous chapters. 
Significant positive correlations were identified between the T cells and B cells and the 
various cytokines in the different subfertile groups. IL-6 a proinflammatory cytokine 
positively correlated with the T cell (CD3), B cell (CD20) and MHC class II (L243) in the 
ASA group as shown in the correlation matrix in Figure 5.1 (IL-6, L243, CD20 with CDS 
r=0.67, IL-6 and L243 r=0.69 p-value<0.01). Similarly IL-6 also correlated positively with 
activated T and B cells (CD69) and IL-8 positively correlated with macrophages and 
monocytes (CD 14) in the culture positive group as shown in Figure 5.2 (IL-6 and CD69 
r=0.56, IL8 and CD14 r=0.67, P<0.01). This finding correlates with previous studies which 
have noted increased levels of both IL-6 and IL-8 in men with accessory gland 
infections ’ . EL-6 can cause sperm damage through the activation of activated T and B
cells (CD69) and IL-6 was significantly elevated in the oligospermic, asthenospermic and 
azoospermic groups whereas IL-8 was elevated in the asthenospermic and azoospermic 
group.
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CDS CD20 L243 IL6
Figure 5.1: Correlation matrix depicting the correlation between T and B cells 
(expressed as cells per 10 hpf) with IL-6 (pg/ml) (IL-6, L243, CD20 with CD3 
r=0.67, IL-6 and L243 r=0.69 p value < 0.01) in the ASA group.
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A positive correlation was detected between IL-11, IFN-7 and monocytes and macrophages 
(CD 14) in the general culture positive group as shown in Figure 5.3. Although IL-11 has 
been found in men with male accessory gland infection, it hasn’t been found to affect 
spermatogenesis in this study. Although specific association of IFN-y and CD 14 has never 
been studied before, it could lead to spenn membrane lipid peroxidation which could be 
important in the sperm fecundation process.
IL-6 positively correlated with L243 in the mild oligospermic group as shown in Figure 5.4 
(r=0.83, p-value<0.01) and IFN-y negatively correlated with CD20 in the severe oligospermic 
group as shown in Figure 5.5 (r=-0.74, p<0.05).
IL-10 positively correlated with CD69 in the asthenospermic group as shown in Figure 5.6 
and IFN-y positively correlated with CD69 and L243 in the same group as shown in Figure 
5.7. IFN-y correlation between the various leucocyte subpopulations in different subferile 
men could suggest that IFN-y could lead to increased sperm membrane lipid peroxidation.
202
Cells per lOhpf
IL-6 and 
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IL8 and 
CD14 r=0.67 
P<0.01
Figure 5.2: Correlation between IL-6 and IL-8 (pg/ml) and CD69 (activated T 
and B cells) and CD14 (expressed as cells per 10 hpf) respectively in the culture 
positive group.
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Figure 5.3: Correlations between the leucocytes (expressed as cells per 10 hpf) 
and cytokines (pg/ml) in the general culture positive group.
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Figure 5.4: Correlation between leucocytes and cytokines in the mild 
oligospermic group (r=0.83, p value< 0.01).
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Figure 5.5: A negative correlation between CD20 and IFN-gamma in the severe 
oligospermic group (r=-0.74, p<0.05).
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Figure 5.6: Correlation between leucocytes and cytokines in the asthenospermic 
group (r=0.88, pcO.Ol).
CD 69 L 243 IFN gamma
Figure 5.7: Correlation matrix between cytokines (pg/ml) and leucocytes 
(expressed as cells per 10 hpf) in the asthenospermic group (r=0.86, p value < 
0.01).
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5.1.5 Discussion
In this study, in the ASA positive group, IL-6 positively correlated with the presence of T and 
B cells. It is possible that CDS positive T cells could induce CD20 positive B cells to release 
both IL- 6 and antibodies. IL-6 expression correlated positively with activated number of T 
and B cells and IL-8 positively correlated with macrophages and monocytes (CD 14) in the 
culture positive group as shown.
CD 14 mediates the induction of IL-8 and this leads to inflammation. Although there is only 
limited evidence for this in the seminal plasma, this is thought to be the process involved in 
other inflammatory pathology including periodontal pathogens299 and in Helicobacter pylori 
(H. pylori) infection300. IL-8 increased the levels of sperm membrane lipid peroxidation at 
physiological concentrations and also showed a higher effect when assayed in the presence of 
leucocytes, at infection-inflammation concentrations. Thus, IL-8, either alone or in the 
presence of leucocytes, could drive the lipid peroxidation of the spermatozoa plasma 
membrane to levels that can affect the sperm fertility capacity301.
No significant correlations were detected between the various leucocyte subpopulations and 
the cytokines IL-10, IL-11 and IL-12 in the various subfertile group studied. This would 
strongly suggest that these cytokines do not influence spermatogenesis. However, IL-11 may 
have a role in male reproductive capacity as this was elevated in the good fertiliser group. IL- 
11 is expressed in the developing spermatogonia in the testis and is developmentally 
regulated. It is also been shown to play a role in the recovery of spermatogenesis following 
cytotoxic therapy . It has been shown that lack of IL-11 receptors leads to defective 
decidual response to implantation303.
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No correlations were evident between TNF-a expression and the leucocyte subpopulations 
studied. However, another study found TNF-a level in the leucocytospermic group to be 
significantly higher than those in the normal and asthenospermic groups. The reason for the 
difference observed between this study and the above study could be due to the fact that the 
patients in the current study probably had sub-clinical infection and thus were not mounting a 
significant immune response. Furthermore, none of the patients in this study tested positive 
for Chlamydial infection.
Similarly to the case with IL-8, it has been shown that physiological levels of TNF-a can 
increase the levels of sperm membrane lipid peroxidation and also showed a higher effect 
when assayed in the presence of leucocytes. Thus, TNF-a, in the presence of leucocytes, 
could drive the lipid peroxidation of the spermatozoa plasma membrane to levels that can 
affect the sperm fertility capacity304.
The biological role and the clinical significance of increased numbers of leucocytes in semen 
remains a subject of controversy. The determination of leucocyte counts in semen is 
important but not critical for the detection of infection or inflammation in the male 
reproductive tract304. Moreover, rather than the leucocyte numbers in semen, their activity 
levels decide the final effects of oxidative stress on spermatozoa170. In addition, the presence 
of activated leucocytes in semen after elimination of an infectious agent may delay 
recovery of the normal oxidative balance in semen170. Cytokines participate in signal 
transmission between cells and perform regulatory roles in different biological processes, 
such as cell activation, proliferation, growth, differentiation, and mobility. They also show 
modulatory effects on inflammatory reactions.
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The course of the inflammatory reaction depends on the levels of cytokines produced, as well 
as the presence of cytokine inhibitors and their specific receptors and / or antagonists. When 
they occur together, they can act synergistically, additively or antagonistically on 
the function of the target cell.
Many authors have observed correlations between the levels of proinflammatory cytokines 
and the number of leucocytes in semen305;306. However, there have also been reports 
demonstrating the elevated levels of proinflammatory cytokines in semen, regardless of the 
presence or absence of leucocytes307. Leucocytes mediate the induction of ROS generation by 
proinflammatory cytokines. Furthermore, oxidative stress that appeal's in leucocytospennia is 
possibly exerted by the increased levels of the cytokines themselves. ROS 
(generated by leucocytes) acts synergistically with proinflammatory cytokines to exacerbate 
the destructive environment for the spermatozoa.
Several proinflammatory cytokines at physiological concentrations increase the level of lipid 
peroxidation of sperm membranes, which could be important for the sperm fecundation 
process. However, as mentioned above, increased concentrations of some cytokines such as 
IL-8 and TNF-oc either alone or in the presence of leucocytes, could drive the lipid 
peroxidation of the spermatozoa plasma membrane to levels that can affect the sperm fertility
• 104capacity .
A causal relationship between either leucocytospermia individually or cytokines on their own 
and subnormal sperm parameters (numbers, morphology, motility) could not be conclusively 
established in this study. However, what this study has shown is that there is a fine balance in 
the seminal plasma with multiple correlations amongst the various T cells, B cells, cytokines
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and antioxidants which help in maintaining male fertility. When this fine balance is tipped 
(i.e. infections, ASA, obstruction etc.) new correlations appear amongst the different 
populations of leucocytes and cytokines which are detrimental to sperm and may result in 
infertility.
Correlations between the cytokines and leucocytes observed on the various subfertile men in 
this study confirm that synergistically they damage the spermatozoa, most likely by 
intensifying the sperm cells membrane peroxidation, affecting their redox profile as well as 
their close environment. Thus, the harmful effect of cytokines on spermatozoa is closely 
connected to the accompanying leucocytospermia. Although the evaluation of leucocyte 
concentration in semen still remains important, it is on its own insufficient in the diagnosis 
and treatment of male genital tract infection / inflammation. The assessment of sperm DNA 
integrity could provide further useful information in explaining the pathologic role of 
leucocytes and cytokines in male subfertility.
Conclusion
The results of this study indicate that there is a marked relationship between some 
proinflammatory cytokines and leucocytes which affects semen quality.
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CHAPTER 6: CONCLUSIONS
6.1.1 Introduction
The predominance of T lymphocytes in the seminal plasma detected in this work would 
explain the significant amounts of various cytokines detected in the different subfertile 
groups in our study. Despite new techniques in the detection of the various seminal cytokines, 
the pathophysiological significance of the cytokines in sperm function is still unclear1 and 
controversial.
Cytokines rarely act in isolation, but rather act to induce or inhibit other cytokines, creating a 
population or network of cytokines to which cells respond308. Elevated levels of IL-6, IL-8 
and IL-11 have been found in the seminal plasma of infertile men with infection and oligo- 
terato-asthenozoospermia140. Hence, we wanted to see if there was a significant correlation 
between the different cytokines in subfertile men. It was thought that this cytokine network 
would render individuals more or less resistant to particular' infections258.
To the best of our knowledge, no previous studies have concurrently analysed the 
simultaneous expression of both leucocytes and seven cytokines in the seminal plasma of 
men belonging to different groups of male subfertility. The role of cytokines in the fertilising 
capacity of sperm has not been fully evaluated either.
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6.1.2 Results summary 
Leucocytes
A low CD4/CD8 ratio might be of diagnostic value in detecting ASA, as the ratio of T helper 
cells to cytotoxic T cells in the ASA + group is 1,37 in comparison to the control group 
which was 2 (Section 3.1).
There was no statistical significant difference between the culture (ureaplasma and other- 
general culture organisms) positive and negative groups with regard to sperm parameters or 
leucocytopsermia. This would suggest that either ureaplasma infection does not induce a 
severe inflammatory response or the organism is a commensal. Subclinical genital tract 
infections in asymptomatic patients are unable to mount sufficient inflammatory response and 
thus do not play a major role in male infertility (Section 3.2). In the general infection group, 
the CD4/CD8 ratio was 1.8 in the infection positive group, in comparison to 1.9 in the 
infection negative group.
There was no increase in the CD14 and CD16 cells in the oligospermic group when 
compared to the normospermic group. This would suggest that these leucocyte 
subpopulations are not a major factor in influencing sperm structure (Section 3.3). In the 
oligospermic group, the CD4/CD8 ratio was 2 in the mild and in the control group, in 
comparison to 2.5 in the severe oligospermic group.
This is the first study to demonstrate raised pan T cells (CDS) and B cells (CD20) in the 
asthenospermic group. The activation of a resting helper T cell causes it to release cytokines, 
in particular IFN which is known to affect sperm motility. Similarly, activation of resting T 
helper cells could stimulate the activity of B cells (CD20), the latter producing antibodies and
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thus further decreasing sperm motility (Section 3.4). In the asthenospermic group, the 
CD4/CD8 ratio was 2.2 in comparison to 2 in the control group.
The T cells (CDS and CDS), B cells (CD20) and large granular lymphocytes (CD56) were 
significantly raised in the Oligoasthenospermic group, which shows that there exists a 
balance between T&B lymphocytes on sperm parameters. A disturbance or trigger factor 
could explain the recruitment of the lymphocytes to enhance sperm damage (Section 3.5). In 
the oligoasthenospermic group, the CD4/CD8 ratio was in 2.18 in the mild and 1.78 in the 
severe in comparison to 2 in the control group.
CDS cells were significantly elevated in the germ cell damage azoospermic group. In 
Obstructive azoospermia, the T cells (CDS), B cells (CD20), large granular- lymphocytes 
(CD56) and activated T and B cells (CD 69) were significantly raised. This might suggest 
that either the site of seminal leucocyte production is not necessarily confined to the vas or 
the epididymis as once thought or there is an increase in the T cell quantity being secreted as 
a result of an immune response to obstruction. Leucocytes may, in this situation, be secreted 
by the prostate and/or seminal vesicles (Section 3.6). In the azoospermic group, the ratio was 
2.05 in obstructive and 4.71 in the germ cell failure, in comparison to 2 in the control group 
and a high CD4/CD8 ratio might be helpful in differentiating azoospermia secondary to germ 
cell failure.
The presence of leucocytes does not adversely affect the fertilisation rates and the outcome of 
an IVF cycle. However, the macrophages and the monocytes (CD14) were significantly 
elevated in the good fertilisers group in comparison to the poor fertilisers. This could be due 
to the fact that in these individuals there is increased phagocytic activity, which would
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therefore remove the sperms with abnormal morphology and thus increase the fertilising 
potential (Section 3.7).
The CD4 / CDS ratio was much lower in the ASA + ve group. The sperm numbers were also 
found to be low in this group. This might suggest that the CDS lymphocytes actually have a 
more cytotoxic role: this would also correlate with the values from the germ cell failure 
group, as the ratio here was 4.71, which is at least double the value of all the groups. This 
would suggest low cytotoxic cell numbers, as there are no sperm to phagocytose.
Cytokines
IL-10, the anti-inflammatory cytokine, was significantly raised in the ASA +ve group. Raised 
IFN-y was noted in the subfertile group, irrespective of the ASA status. This would imply 
that previous theories of how ASA could affect sperm motility in a mechanical way by 
antibody binding to the sperm tail may not be wholly true and that the cytokine IFN-y could 
have had a role to play (Section 4.1).
There were no significantly elevated cytokine levels in the culture +ve group. This would 
tend to suggest either that the presence of asymptomatic infection might not produce the 
desired inflammatory response including the production of cytokines, or that the distal 
urogenital tract is not sterile (Section 4.2). Due to the lack of positive patients in my study, I 
am unable to either support or refute the role played by Chlamydia trachomatis, Mycoplasma 
Species and Trichomonas Vaginalis infections in male subfertility (Section 4.2).
Significantly elevated levels of IL-6 correlates with decreased sperm count and motility by its 
possible effect on sertoli cell transferrin production and meiotic DNA synthesis in the 
spermatocytes (Section 4.3). Although significantly raised levels of IL-8 correlated with
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decreased sperm motility, its role in spermatogenesis and steroidogenesis has not yet been 
fully elucidated (Section 4.3). IL-10 was also significantly raised in the subfertile groups; 
this would suggest that it plays an anti-inflammatory role and tries to suppress the effects of 
other proinflammatory cytokines. This was confiimed by noticing significant correlations 
between IL-10 and other proinflammatory cytokines such as IL-6, IL-8 and TNF- a in the 
obstructive azoospermic group, and raised levels of IL-10 were found, along with raised 
levels of IL-6 & IL-8, in the asthenospermic group (Section 4.3).
IL-11 and IL-12 do not influence spermatogenesis (Section 4.3). TNF-a and IFN-y levels 
were significantly increased (p<0.05) in the azoospermic obstructive group only. This would 
suggest that the testis is unlikely to be the site of production of these cytokines (Section 4.3). 
Not many cytokines had significant negative correlations with sperm parameters, which could 
suggest that the cytokines may not be originating in the testis and thus may not be influencing 
spermatogenesis. There was a significant correlation between the levels of IL-8 and IL-6. IL- 
6 is a multifunctional cytokine and it is possible that there exists a balance between IL-6 and 
IL-8 levels in the seminal plasma and that any alteration in this balance may result in male 
subfertility (Section 4.3).
Six out of the seven cytokines studied did not affect sperm-oocyte interaction and fertilisation 
rates in IVF. However, it appeal's that IL-11 could have a role in the fertilising capacity of the 
sperm and in preimplantation embryo development (Section 4.4). The washing of sperm as a 
part of the process of sperm preparation during IVF removes the seminal plasma from the 
sperm, and thus any potential adverse effect of cytokines on sperm capacitation and sperm- 
oocyte interactions.
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Leucocytes & Cytokines (Chapter 5)
IL-6 con-elated positively with activated T & B cells in the ASA positive group: it is likely 
that CD3 induces CD20 to release both IL- 6 and antibodies. IL-8 positively con-elated with 
macrophages and monocytes (CD 14) in the culture positive group, as shown. CD 14 is likely 
to mediate the induction of IL-8, which leads to inflammation. Thus, IL-8, either alone or in 
the presence of leucocytes, could drive the lipid peroxidation of the spermatozoa plasma 
membrane to levels that can affect the sperm fertility capacity.
I was unable to detect any correlation between the TNF- a and the leucocyte subpopulations 
studied. The results of my study indicate that there is a marked relationship between some 
pro-inflammatory cytokines and leucocytes, which affects semen quality. The significant 
association with seminal leucocytes and other potential inflammation markers suggests that 
IL-8 might be used as a sensitive marker for silent male genital tract infection.
6.1.3 Discussion
The significantly higher frequency of sperm morphological defects in infertile men may 
suggest that leucocytospermia as an independent variable has a detrimental effect on sperm 
morphology. A causal relationship between leucocytospermia and sperm morphology could 
be confirmed, if there is an improvement in sperm morphology after successful treatment of 
leucocytospermia. However, it may be difficult to conduct such a study given that treatment 
of leucocytospermia still remains controversial, as the presence of leucocytospermia is not 
always associated with bacterial infection or vice versa. This study would validate the above 
statement. Moreover, functional and anatomical damage acquired as a result of infection is 
often permanent and not reversible by (antibiotic) treatment. Hence, current evidence would 
suggest that the use of antibiotic therapy should only occur in men with symptomatic
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leucocytospermia with microbiological evidence of bacterial infection. Maybe, instead of 
antibiotic treatment, the use of anti-inflammatory medications (particularly those with mast 
cell stabilising effects) may have a role to play in men with leucocytospermia and infertility, 
as some uncontrolled studies have shown a significant decrease in the leucocyte count and an 
improvement of sperm morphology and motility.
This study attempts to clarify not only the possible association between leucoyte 
concentration and sperm morphology / motility, but also the possible fertility-reducing effect 
of leucocytes. From this it is possible to speculate that sperm structural damage could be due 
to both defective Sertoli cell function and disorganized spermiation, or due to alteration in the 
maturation process that the sperm undergo while transient in the epididymis. Thus, 
leucocytospermia-induced sperm damage may commence during spermiogenesis and 
continue through spermiation and epididymal migration. This sperm damage could be 
mediated either through cytokines which have an influence on the sertoli cell function or by 
the peroxidative damage of ROS released by the activated granulocytes. To clarify the above 
issues, new methods for separation of leucocytes from other cells are needed. Future studies 
are needed, with large patient series and adequate follow-ups, concentrating on the role of 
reactive oxygen species in male subfertility and the relation between leucocytospermia at 
different leucocyte concentrations and fertility.
This study not only confirms the effect of the individual cytokines on sperm numbers and 
motility, but also shows that there is an intricate network of cytokines that exists in seminal 
plasma, which may influence sperm function directly or indirectly. It is possible that they 
affect the reproductive system differently through their soluble receptors309 and could be 
upregulated in the presence of infections. This study’s findings suggest that various cytokines
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may work in an interactive manner that involves cross-talk through a network, to regulate 
fertility positively or negatively. The modulation of this cytokine network could explain the 
wide variability of the success rates seen in IVF when the male factor is ruled out by normal 
semen analysis.
IL-11 belongs to a family of cytokines whose receptors use gpl30 as the signalling molecule 
(Chapter 1, Section 1.6.5). IL-11 has the ability to stimulate the multiplication of a variety of 
cell lines310. IL-11 is expressed in the round spermatids at stage VI-IX seminiferous tubules 
as shown in Fig 6.1. IL-11 not only accelerates spermatogenesis but also has been shown 
to help in the recovery of spermatogenesis post cyotoxic therapy311. IL-11 reaches the uterus 
via the seminal plasma and mediates its actions via its receptor IL-11 R. Within the uterus, 
IL-11 has been shown to increase adhesion of primary human endometrial epithelial cells to 
fibronectin and collagen IV (Chapter 1, Section 1.6.5). It has been shown in murine models 
that defects in IL-11 signalling or lack of its receptor IL-11 R results in foetal loss due to 
defective decidualisation312. Furthermore, in vitro studies have shown that IL-11 may help 
with the implantation by reducing the quantity of endometrial TNF- a in early pregnancy313. 
Thus, IL-11 is not only an important regulator in testicular’ function by accelerating 
spermatogenesis and sperm recovery, but also helps with the endometrial decidualisation via 
its receptor, and helps in the implantation of the foetus as shown in Fig 6.1.
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Fig- 6.1: Schematic diagram depicting the expression of IL-11 in the 
spermatogonia within the testis. The figure depicts the importance of the signal 
transduction by the seminal IL-11 via the endometrial receptor to help with the 
decidualisation and implanataion of the foetus.
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However, further studies are required to assess the role of this cytokine network and 
immunomodulation in sperm function and transport, and particularly to answer such 
questions as: “If ICS I is used to get good fertilisation rates, could subsequent implantation be 
affected if cytokine concentrations are not right?” The measurement of each cytokine 
separately in the seminal plasma of subfertile men, despite significant differences, does not 
have a diagnostic value in male infertility. However, an assay of selective Interleukins in the 
seminal plasma of men may prove of clinical value for the diagnosis of male accessory gland 
infection.
It would be fair to conclude that neither leucocytospennia on its own nor individual cytokines 
have any significant role to play in male subfertiltiy. But the combination of 
leucocytospermia in the presence of a cytokine network may adversely affect sperm 
parameters and lead to male subfertility,
6.1.4 Limitations of the study-
There are a few limitations to our study. The numbers of patients in each group are small. 
Hence, statistical significance may not correlate with clinical significance. In our study we 
did not exclude patients who smoked and consumed alcohol, as none of them were heavy 
smokers (>20 cigarettes / day) {may increase the seminal leucocyte count and thus increase 
the seminal oxidative stress or decrease in semen concentration314} nor chronic alcoholics, 
{heavy alcohol use has been associated with an increase in the seminal leucocytes and 
chronic alcohol consumption (6 units / day for more than 5 days a week) has been shown to 
affect male reproductive hormones and semen quality}.315
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Although we have endeavored to classify our patient sub-groups in reference to the 1999 
WHO manual, some conventional authors may not agree with the quoted reference ranges of 
semen parameters. A revised definition was published by WHO in 2010. However, it is 
unlikely that the 2010 definition would have changed much of our results or interpretation. 
Progressive mean analysis could have been used to ensure whether 10HPF is good or not and 
to test statistical stability316.
Some authors may not agree with our selection of markers used to detect leucocyte 
subpopulations. Although no significant different levels were detected in our study, some 
authors would have wanted us to test for the expression of CD 14 by the human germ cells. 
Correlations between CD 14 and L243 may be considered trivial, as monocytes/macrophages 
express MHC II (clone L243). CD 16 is not restricted to granulocytes and some pro- 
inflammatory monocytes express CD14 and CD16.
The total leucocyte concentration was represented by CD45 count. However, I did not look at 
the total leucocyte count obtained during semen analysis, IL-1 was not studied in depth as it 
has been studied extensively in the past, and, furthermore, has three members in the family, 
two of which are proinflammatory and the third has an anti-inflammtory effect. It would have 
been useful to look at the number of biochemical/clinical pregnancies resulting from the 
embryos created by the good and poor fertilisers. This would have then led to further 
discussion about the correlation / relationship between pregnancy outcome and the seminal 
plasma cytokine content.
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6.1.5 Future research projects-
- Performing testicular biopsies on patients with impaired sperm parameters for the presence 
of inflammatory infiltrates, which would further strengthen my study findings.
- A study into the role of cytokines in the oocyte / embryonic culture medium, as this would 
increase the relevance of my study.
- The role of IL-11 in implantation would be useful to look at, as it was elevated in the good 
fertiliser group. Furthermore, it has been shown in murine model that decidual and 
feotoplacental development is dependent on IL-11.
- The role of Ketotifen in Leucocytospermia- RCT, as some cohort studies have shown that 
anti-inflammatory medication such as ketotifen reduces leucoyte count and improves semen 
quality.
- The role of thymus extract in male subfertility and the role of leucocytes and cytokines in 
recurrent miscaniages may be other useful future research topics.
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APPENDICES
Appendix 1 (Discussed in Section 2.1)
THE UNIVERSITY
of Liverpool
Patient Information Sheet
Leucocytes and cytokines content of human semen including males attending an 
In Vitro Fertilisation (IVF) programme
What is the purpose of this study?
White cells (called leucocytes) and chemical substances (called cytokines) are normally 
present in all semen samples but at a very low concentration. Previous reports have revealed 
that the presence of these in high concentrations in semen could affect the sperm and their 
ability to fertilise eggs.
The aim of our study is to evaluate whether or not increased numbers of leucocytes and 
increasing quantitiy of various cytokines in semen influence sperm parameters and their 
fertilising potential. Once we know how leucocytes and cytokines affect fertility, we may be 
able to provide a treatment to help patients who have an excess of leucocytes in their semen. 
We hope that the results of our study will give us a better understanding of this subject and 
enable us to help people who are infertile due to this condition.
What will happen to me if I take part?
If you give permission after routine semen analysis, we will use any remaining sample for 
research purposes and those who are in an IVF programme it does not affect your success 
rate.
Who is organising the study?
The study is organised by Dr. Srividya Seshadri, Research Fellow in Obstetrics and 
Gynaecology, Liverpool Women’s Hospital. It is a combined work between the Departments 
of Obstetrics and Gynaecology and Immunology of the Liverpool University.
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Confidentiality
All information collected about you during the course of study will be strictly confidential. 
Any information about you that leaves the hospital will be anaonymised so that you cannot be 
recognised from it. Your identity will therefore not be revealed even if the results of the study 
are published. We would usually expect to inform your GP that you are participating in the 
study. Please let us know if you prefer us not to do this.
Voluntary Participation:
Participation in this study is voluntary. If you would like to join the study please complete the 
attached Consent Form. If, at any time you wish to withdraw from the study there is no need 
to justify your decision and your future medical treatment will not be affected.
Contact:
If you have any questions or wish further information at any point in study, contact: 
Dr S. Seshadri
Liveipool Women’s Hospital 
Crown Street 
Liverpool 
L18 7SS
Tel: 0151 708 9988 Ext 4215
Thank you for reading this information and agreeing to take part in this study
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Appendix 2 (Discussed in Section 2.1)
CONSENT FORM
Title of the project: Leucocytes and cytokines content of human semen including
males attending an In Vitro Fertilisation (IVF) programme
Name of the Researcher: Dr Srividya Seshadri
[Name and number of independent person]
Please initial box
1. I confirm that I have read and understood the information sheet for the above study, 
including the use of surplus sample that remains after semen analysis.
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time without medical care or legal rights being affected.
3. I understand that sections of any of my medical notes may be looked at by 
responsible individuals from (company name) or from regulatory authorities where 
it is relevant to my taking part in research. I give permission for these individuals 
to have access to my records.
4. I agree to take part in the above study
Name of patient Date Signature
Researcher Date Signature
1 copy for patient, 1 copy for researcher, 1 copy to be kept with hospital notes
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Appendix 3
Semen Analysis Report
Female name..... .........
Male name................................ . .......
Date of analysis....................... D.O.B.
. Hospital no. 
.Hospital no... 
..Lab code no.
GOPD IVF-NHS IVF-PR1 ADD-NHS ADD-PRI OTHER Referring clinician
Time of sample production
oH
Volume................. ........... .;;;...... 1........mis
Concentration..... ........................x lOVml
Morphology......... ........Vo normal forms
Ejaculation - analysis interval............... mins
Liquefaction: ('Complete' Incomplete
Antisperm antibodies (ASAb) _
IgG..................w-crTT.. % binding
IgA .7.......................... % binding
Motility at..........^...7......°C
Grade A.... r... % (mvlUntprvgnssionl
Grade B ..... : .. % (sluggish progression)
Grade C ...... % (no»-progrvssiw)
Grade D .......... % (non-moaie)
Agglutination 0 /+) ++ +++ Viability..........% viable
Comments
i Analysis performed by
SPERM MIGRATION TEST RESULT
Motility at............. ...........°C
Grade A ....r % (excellentpragrtssion)
Grade B ... % (sluggish progression)
Grade C ........... % (non-progressivei
Grade D.......... % (non-mottle)
REFERENCE VALUES
(WHO laboratory manual /or the examination of human semen and sperm-cervical mucus interaction. ** edition, 1999)
Volume: > 2 Oml» . Morphology: > ISH •
P» >7.2 Viability. > 75S4
Concentration. > 20 xlO*/ml ASAb: <50% .„<_______ . ,
Motility" > 50% grattes A + B or Hound cc.U: < 5 xtoVml ZZZZl'a.eZ
> 25% grade A within 60 mins ^ ■ * fertilisation rate m
of ejaculation vitro decreases
Appendix 4 
Preparation of slides
Materials required:
-Bovine serum albumin (BSA; Sigma, Poole, U.K.)
-Trypan blue
-Teflon coated multiwell slides (C.A.Hendley Ltd, ESSEX) 
-Acetone
-Phosphate buffered saline (PBS);
CaCl .H2 O 0.132 g
KC1 0.2g
KH PO 0.2g
MgCl 6H O O.lg
NaCl 8.0g
Na HPO 1.15g
Make up to 1 litre with distilled water.
Preparation of solutions
Tris buffer saline (TBS)
1) TRIS (molecular weight: 121. lx molarity 50 mM= 6g/l) weigh 30 g/5L
2) NaCL (molecular weight:58.44 x molarity 150 mM= 8.7g/l) weigh 43.59 g/5L
3) Dissolve in 1.5 L distilled water, and stir
4) Adjust pH 7.6 using Hydrochloric acid (11.6 M)
Add distilled water upto 5 L and mix.
0.1M Phosphate buffer saline (PBS) (Sigma D-5773)
Magnesium Chloride (anhydrous) 0.046g/l
Potassium Chloride 0.2 g/1
Potassium Phosphate Monobasic (anhydrous) 0.2 g/1
Sodium Chloride 8.0 g/1
Sodium Phosphate Dibasic 1.15 g/1
Adjust Ph 7.6 using Hydrochloric acid (11.6 M)
Alkaline phosphatase substrate
1) 0.1 M Tris buffer pH 8.2 50 mis
2) Naphthol AX-MX phosphate (Sigma N-4875) lOmg
3) Dimethyl formamide (sigma D-4254) 1.0 ml
4) Levamisole (sigma L-97560) 1M solution 50 pi
Mix in glass bottle, store at 4°C.
0.1 M Tris buffer pH 8.2
Weigh 6.055gm and add 500ml distilled water adjust to pH 8.2 using hydrochloric acid 
(11.6M)
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10% BSA (bovine serum albumin) (Sigma A- 2153)
Dissolve Igm BSA in 10 ml TBS buffer solution, aliquot in microfuge tubes, and store in 
freezer at -20oC.
Preparation of antibody
Initial solution of lOmls TBS added to 0.5ml (0.5%) BSA
Appropriate amount of antibody added to 1ml of solution depending on dilution used 
APAAP
Dilute APAAP complex 1:50 in TBS 
Fast Red
lOmg of fast red diluted in 10ml of alkaline phosphatase passed through filter paper.
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Appendix 5- 
Publications
1) ^Citation- Seshadri et al. The Role of Cytokine Expression in Different Subgroups of 
Subfertile Men. AJRI2009; 62 (5): 275-282.
2) “Cytokine expression in the seminal plasma and its effects on fertilisation rates 
in an IVF cycle”. *This study has been accepted for publication in the 
Andrologia Journal.
3) “Detection of subpopulations of leucocytes in different subgroups of semen 
sample qualities”- This study has been accepted for publication in Andrologia 
Journal
Presentations
Poster:
1. “The role of leucocyte subpopulations in male subfertility” June 2010 ESHRE, 
Rome. Hum. Reprod. (2010) 25(Suppl): il 18-152
2. “Does Ureaplasma play a role in leucocytospermia or male infertility?” 8th RCOG 
International Scientific Meeting, December 2009, Abu Dhabi
3. “The role of cytokine expression in different subsets of subfertile men”. ASRM, 
New Orleans. Fertil Steril, (2006) 86 (Supp2): S492-S493
4. “Cytokines as positive predictors of fertilisation rates in an IVF cycle” - 
December 2003, British Fertility society, Liverpool. Runner up for the best poster 
presentation.
5. “The effect of cytokine expression in the seminal plasma on the fertilisation rates 
in an IVF cycle”. October 2003, ASRM Conference, San Antonio, Texas. Fertil 
Steril (2003) 80 (Supp 3): S210.
Oral;
1. “Leucocytospermia and IVF outcome” - (BFS/ACE/SRF/ICE/IFS) Joint Fertility, 
January 2011, Dublin.
2. “Cell Mediated Immunity in Male subfertility”- Annual BFS Meeting
January 2010, Bristol.
3. “The role of cytokine expression in azoospermia” -4th Joint BAS/BFS/SRF
Meeting April 2005, Warwick.
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Problem
Ttw aim of this study was to evaluate the levels of seminal plasma cyto­
kine* interleukin 6 <IL-0|, Interleukin It Interleukin 10 (ll-IOi,
inierltnikin II ill-11). Interleukin 12 <IL-I2l, tumour necrosis fanor 
alpha <TNF-a| and interferon gamma <IFN-^| In male subfenillty.
Method of study
A total of 73 male partnen of an inlertiie «>uple attending a regional 
amirology unit were recruited Into this prospective study and subdivided 
Into the various groups based on semen analysis. Concentrations of 
cytokines such as lL-6. IL-*. IL-10. IL-M. IL-12, TNF-a and IFN-y in the 
seminal plasma were determined using enzyme linked immunosorbent 
assay (EUSA).
Results
Significant higher concentrations (P < O.OSi of 11.-6 in the mild and 
severe ollgospennic group. 11-8 and II.-10 in the asthenospennic group 
and 11-6, IL-10, TNF-j and IFN-y In the obstructed azoospcrmic group 
were determined. IL-10 concentrations correlated significantly with 
other cytokines in the obstructed azoospcrmic group and the astheno- 
spcmvic group.
Conclusion
Our study confirms that cytokines rarely act in isolation, but rather in a 
network of other cytokines and may affect sperm function directly or 
indirectly. The presence of increased levels of cytokines in the 
obstructed azoospermic group suggests that the cytokines may not origi­
nate from the testis.
Introduction
Male factor infertility is considered to be responsible 
as the primary' cause or a contributory factor in up 
to AS’ti. of infertile couples.1 Cell-mediated immunity 
through cytokines may play a key role in male factor 
infertility.^ Most cytokines act locally to initiate and
Vwfujr. kwnil ol ImnxoKWp* M (XW J7S-3K.1
« XC9 John WEev A Soot AS
modulate immune responses, principally by binding 
to specific, high affinity receptors on responsive 
cells.* Some exert their effects distally in an endo­
crine manner.
Spermatogenesis is an autonomous process largely 
under the control of paracrine factors. Cytokines 
that potentially affect cell populations Involved in
27S
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spcrmatogcncws arc produced within the scminilcr- 
ous epithelium and influence the pest-oKfctttc stages 
ot spemtatogenesis. The rxde of these paracrine regu­
latory proteins remains to be ducktaied. Cytokines 
have aho been implkaiexl In the regulation o( 
growth and differentiation of cells in the endocrine 
and tubular compartment of the testis. Paracrine reg­
ulation ol cellular interactions in the testis is an inte­
grated system between hormones and the local 
environment4. Cytokines are important factors in 
the integration of the ncuroendocrine-immunc net­
work ilwt controls testicular function. The predomi­
nant consensus is that tumour necrosis (actor alpha 
fTNF-ar). interleukin I (II-1 i. Interferon gamma 
lIFN-;) and interleukin 2 (IL-2t inhibit gonarkutro- 
phin or cyclic adenosine mono phosphate (cAMPi 
stimulated steroidogenesis in Leydig cells.' Intlam- 
matory disease has been established as detrimental 
to male reproductive (unction and leitility. Infections 
of the male accessory glands appear to alfect repro­
ductive (unction as indicated by decreased density 
and motility ol spermatozoa and alterations In semi­
nal plasma constituents. Human spermatozoa incu­
bated with IFN-y and TNF-a have demonstrated 
significantly reduced motility. In addition, both cyto­
kines compromised the fertilizing ability of the sper­
matozoa as determined by the zona free hamster egg 
penetration test.* Elevated levels oi cytokines in the 
seminal plasma ol men with fertility problems have 
been clearly documented.*-* Recently, sperm con­
centration. motility and the percentage of normal 
sperm forms were found to he decreased with 
increasing interleukin 6 (JL-6) levels in seminal 
plasma.'' Previously, elevated levels of interferon 
alpha (IFN-zl and IFN-y have been lound in patients 
suilcring Irom oligospermia and azoospermia.10
The objective of this study was to determine the 
relationship ol a repertoire of cytokine's in the semi­
nal plasma of different subgroups of sublertlle men 
attending a regional andrology clinic. To the he's! of 
our knowledge, there have been no studies testing 
these seven cytokines (IL-6. IL-8, IL-IO. IL-11, IL-12. 
TNF-a and IFN-y) in the dillercnt subsets ol male 
subfertility.
Material and methods
Study Design
A prospective comparative study was designed in 
which semen was collected from men attending the
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Reproductive Medicine Unit ol the Liverpool 
Women's Hospital lor infertility investigation. The 
median age of men was M.5 (range 22-4*71 years. 
The medium duration ol infertility was 5 (range 2- 
1years Thirty -eight ol the men consumed alcohol 
on an average rtf 10-12 unttvweek; 20 of the men 
also smoked tut an average ttl 10-20 rigarettes/day. 
Men were divided into the different subgroups 
(normospermic. asthenospermic. mild «*ligospermic. 
severe ollgaspcrmic. mild oligoasthenospermic. 
severe oligoasthcnospcnnic. obstructive azttospcrmic 
and non-obstructive azoospermia) according to the 
results of the seminal analysis on two consecutive 
semen samples. Hie setnlnoktgy laboratory at the 
hospital carried out standard sperm function tests on 
each sample, including details on sperm number, 
motility and the presence of bound anti-sperm anti­
bodies etc., as detailed by WHO, These men had no 
other illnesses nor did they take any medication that 
could have affected their cytokine metabolism 
Ethical approval was granted by the Liver)tool 
Research Ethics Committee. Written. Informed con­
sent was obtained from 7f men attending the Repro­
ductive Medicine Unit. Liverpool Women's Hospital. 
Clinical details of both panners were obtained from 
the case notes.
Semen Collection
Semen was obtained by masturbation after V-5 days 
of sexual abstinence. The samples were collected in 
a sterile, wide mouthed, non-toxic container and 
processed in the laboratory within 1 hr of ejacula­
tion. Samples did not get exposed to extremes of 
temperature. They did not come in contact with 
cither lubricants or latex products. All the samples 
underwent semen analysis in the laboratory in 
accordance with the 199*7 WHO laboratory manual 
for the examination of human semen and the study 
was performed using these reference values,11 Men 
were divided into the different sub groups according 
to the results of two consecutive semen analysis 
6 weeks apart. Given the wide variability between 
ejaculates, two samples were taken to confidently 
define an individual's phenotype. Asthemospermia 
was delined as a sperm motility of <40%. Oligos)H*r- 
mla was defined as a sperm count <10-20 x lo\ oil- 
goasthenosperntla was defined as a sperm count of 
10-20x10*' and motility of <40%. Azoospermia 
was defined as complete absence of sperm in the 
semen either as a result of germ cell failure such as
Amjrtin «uma ol Anwwluctf.* WHiu'WkJiJY 6} tXXW
t> XX# torn war? 1 Sant Ai$
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maturation arrest, hypospemutogencsis or srrtoli cell 
only syndrome tnon-o6»tnictrve gnxipk or as a result 
of obstruction in the sperm delivery system. The 
obstructive aroospermic group had all undergone 
vasectomy. Although testicular biopsy Is the defini­
tive test to ntle out the non-obstructive front the 
obstructive groups, tlte presence or absence td active 
spemvatogencsis can he accurately predicted by mea­
suring the testis volume and serum fctUide stimulat­
ing hormone Heme the dUfcrentiation
between germ cell lailure ansuspemtia and obstnic- 
tise a/oospermia was made by the serum FSH levels, 
karyotyping aitd testicular volume. The testkular vol­
ume In our non-obstructive group was reduced 
(<? mL>. After semen analysK the remaining sample 
was processed for the measurement of cytokines.
Preparation of Seminal Plasma
Samples were centrifuged at 200 xjf lor 10 min and 
tlte supernatant removed and immediately stored at 
-20*C until assayed to prevent the effect of prote­
ases on the individual cytokines. The samples were 
assayed in the same run to reduce inter assay vari­
ability. Cytokine concentrations were measured 
using specific commercial ELISA kits <TNF-a by Gcn- 
ryme Duoset Kit. Cambridge. MA. USA and IL-6. IL- 
8. IL-10, IL-ll. IL-12 and IFN-v front R&D Systems. 
Abingdon. UK| Tlie range of measurement of the 
cytokines was IL-b (V12S-T00 pg^inli. IL-8 tJI.2- 
2000 pg/ntl). IL-10 <»l.2V-2000 pg-Tnl.l. IL-ll
(IS.b-lOOO pg'^Li. IL-12 (7.8-S00 pg/mL), IFN-y. 
TNF-j (IS.n-1000 pg.''ntU. The sensitivity of the 
assays for IL-6. 1L-8. IL-10. IL-ll. IL-12. IFN-y and 
TNF-i was less than 0.6, 2.6. 6.}. 4.4. 2. 8 and 
1.6 pg'mL respectively. Tlte inter and the intra-assay 
variability was 12.2% and 0.55% lor IL-6, was 1.4% 
and 2.94% for IL-8, was 15.5% and 1.52% for IL- 
10. was 49.0% and 1.46% for IL-ll. was 24.2% and 
0.64% for IL-12. was 7% and 1.65% lor TNF-tt and 
14.4% and 1.69% for IFN-y.
Statistical Analysis
Statistical analysis was perionned using the statistical 
package (or smial sciences (SPSS, Chicago. IL. USAi 
software. Tlte Shapiro-wilkes test was used to test 
for normal distribution. The Individual cytokine lev­
els in the normospcrmic group were compared with 
the levels of the respective individual cytokine from 
the other subsets. As our data were not normally
Anwitcon KSfiWi Of Immwwiog. *3 rJMOf J?S-3(U
0 J0C« John wf«v * Scm AS
distributed, statistical analysts was performed using 
the Mann-Whitney non-parametric two-sample test. 
Correlations between cytokine concentrations were 
tested using the non-parametric Spearman's correla­
tion test. The number of patients is relatively small 
as this was aimed to he a pilot study and if signifi­
cant levels of cytokines were found in the various 
subgroups then an adequately powered study will be 
required to determine both the statistical and the 
diniral significance ol these findings.
Results
The normospcrmic group was compared with each 
of the other patient subsets. The median values and 
the ranges for all the cytokines arc shown in the 
Table I. Significantly higher concentrations ol IL-6 
(P < 0.05) were present in the oligospcrmic. 
avthenospermic. oligoasthenospermic. a/oosperm k 
<'hortative and germ cell damage groups when com­
pared with the ttonnospertnic group. Signilkantly 
htgher concentrations of IL-8 (T < 0.05) were pres­
ent in the asthenospermio group when compared 
with the normmpcnnic group. Significant amount i>l 
IL-10 (P < 0.05) was present in the asthcnospcrmic. 
oligoavthenospermic and a/tx>spermic obstructive 
groups when compared with the normospermic 
group. Furthermore, IL-6. IL-10, TNF-a and IFN-;,* 
were significantly increased in the obstructive azoo- 
spermic group when compared with the rtormosper- 
mlc group. A significant correlation was found 
between IL-10 and IL-ll in the oligospcrmic 
(P<0.05) and obstruaivc a/txKpcmnc (P<0.0li 
groups. A significant correlation (P<0.0l) was 
Immd between IL-10 and IL-ll and between IL-10 
and IFN-y In the oliRoasthenospemtic group (Fig. I) 
This is shown to allude to the lact that cy tokines can 
affect both the sperm numbers and motility, A sig­
nificant correlation (P < 0.05) was found between 
IL-10 and IL-6 in the oligoasthenospermic group. A 
significant correlation |P< 0.01) was found between 
IL-10 and IFN-y in the oligospermic and astheno- 
spcrmic groups.
Discussion
During the last decade, there has been much evi­
dence to suggest the involvement of paracrine con­
trol mechanisms such as the cytokines, in tlte 
control of reproductive function particularly with 
regard to spermatogenesis." Cytokines may have a
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multitude o( jettons induding both as growth and 
differentiation factors within the semlnifermis 
tttbitle. IL-6 is produc'd by the Sertoli cells and has 
a number of effects including stimulation of transfer­
rin production by senoli cells14 and inhibition of 
meiotic DNA synthesis in prc-lcptotene spermato­
cytes.1'
In this study, statistically significant raised levels 
id IL-6 were found in the oiigospermic, asthenosjter- 
mic and the oltgoasthenospemtic groups. These 
results correlate with two previous studies where 
Increased levels of 1I.-6 were found In the infertile 
groups.9 1 ^ Similarly elevated levels of tL-6 have cor­
related signiflcantly with sperm number in the ejac­
ulate. penetration rates in the sperm penetration 
assay, and some sperm motion parameters,'' 
Increased levels of IL-6 were found in men with 
accessory gland Infection when compared with nor­
mal men. but In contrast to our study. IL-6 levels 
did not show any significant difference between nor­
mal men and those with abnormal spermtograms as. 
the testis may not contribute to the high IL-6 levels 
in the seminal plasma1' but may be coming from
AifMrrjn «iumd of A»pn}<)tKIN« f-mn-wtogv U 00W1 VS-M) 
» XXK KMi < Sent Ai$
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the seminal vesicles and or prosute. Similarly siemt- 
icant cnrrcUtH'ns ol IL-6 and Inictose levels indi­
cated that the seminal vesicles aho take part in the 
production id seminal IL-6,“ In «>ur study, there 
were significamls high levels id tl-6 in the ohsmic- 
tive aroospermic path'ntv
In this study. IL-S {P < 0.0S> was signifkantly 
increased in the asthemsspermic grmip when com­
pared with the normospennic group. This may be 
due to the lact that asthenospennic* may have epi- 
didymal disease secondary to a male accessory gland 
inlection. The origin id IL-8 and its role in the sper­
matogenesis and steroidogenesis has mn heen eluci- 
dated bin investigations have revealed ih.it there are 
signiricant differences In levels between normal and 
inlenile men with loucospermia/raalc accessory 
gland Infection.1''
IL-IO was increased |P < 0.05| in the asthenosper- 
mic. oligoasthenospcnnic and aroospermic obstrui- 
tive groups when compared with the normospennic 
group whkh may suggest that the testis is twohahly 
not the sire of Its production. A recent study also 
concurs ssirh our study that I1.-I0 lewis were signifi­
cantly elevated in seminal plasma of men with 
decreased sperm motility.30 In contrast, high levels 
of IL-IO have been observed in the seminal plasma 
of fertile men when compared with iniertile men 
with or without leucocytospermia.31 However. In 
their study the classification cd infertile groups was 
solely based on leucocytospermia.
In our study, we found significant correlations 
between 1L-10 and other proinflaminatory cytokines 
in the oligospcrmic. asthenospennic. oligoasthcno- 
spermic and azoospennic gn>u[>s. Raised levels of IL- 
IO were found along with raised levels of IL-6. IL-g 
and TNF-a in the azoospermic obstructive group and 
raised levels of 1L-10 was lound along with raised 
levels of IL-6 fr IL-8 in the asthenospennic group. 
IL-IO Is an anti-lnfiammatorv cytokine with Irmmi- 
noregulaiory functions and inhibits the production 
of several proinllammatory cytokines including IL-8 
by altering the accessory cell function of macrophag­
es.3* Hence it is possible that the raised levels of IL- 
IO observed in this study was in direct response to 
suppress the proinllammatory cytokines such as IL6, 
IL-8 fr IFN-y. In contrast. IL-IO levels have been 
shown to he significantly decreased In the seminal 
plasma of oligo-reratozoospermia and asthenoteraro- 
zixispermic pariems with genital infection when 
compared with fertile, azoospermic or oligo-tcrato- 
asthcnozoospermic patients without infection.31
Amok*! at t immuneAtg* 43
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Previously, increased levels of IL-11 wrre found in 
men with male accessory gland infection when com­
pared with normal men. but IL-II levels did nor 
show any significant difference between normal 
men ami those with abnormal spermiograms.34 Our 
study, did nor find any statistically significant dilfer- 
cnec in the levels of IL-11 amongst the various sub 
groups of sublertile men in comparison with normo- 
spermic group. This would suggest that this cytokine 
may nor be influencing spermatogenesis.
Tim study demonstrated no significant dilfeience 
In the IL-T2 levels between the normospennic and 
siibfertlle sub groups. This is In agreement with 
other siudies.34'1'
Elevated levels of TNF-a and IFN-y have been 
identified in the oligospcrmic and azoospermic 
groups."* TNF-a levels in seminal plasma have been 
shown to be negatively correlated with the number 
of progressively motile spenn in the ejaculate, but 
there was no correlation with total spenn counts, 
viability, morphological alterations etc.3'’ TNF-a lev­
els were significantly elevated in seminal plasma of 
men with decreased spenn motility.30 Significantly 
Increased levels of TNF-a were found in the oligoas- 
thenozoospennie and the a/onspcrmic groups when 
compared with the normospennic group.37 However, 
the azoospermic group was not subdivided Into 
obstructive and non-obstructive. In direct contrast, 
there was no relationship between TNF-a levels In 
seminal plasma and semen <)uality or parameters of 
sperm functional capacity.4* However. In this study, 
the azoospennic men were excluded. IFN-y is 
thought to stimulate the production ol TNF-a and it 
is reponed that there is a significant overproduction 
of IFN-y levels in the seminal plasma of iniertile 
men and a significant negative correlation with 
sperm count and motility,4* IFN-y levels were signifi­
cantly elevated In seminal plasma of men with 
decreased sperm motility,40
In our study, the TNF-a ft IFN-y levels were signif­
icantly increased (P < 0.0S) in the azoospermic 
obstructive group only. This would suggest that the 
testis is unlikely to be the site ol production of these 
cytokines. Although some of the median values in 
the TNF-a measurement are 0 as it was the most fre­
quently occurring number, looking at the mean val­
ues, the TNF-a levels In the obstructive azoospermic 
group was 27.8 In comparison with other groups 
where the mean values ranged from 0-5.1. Our 
study would support the finding ot another 
study that TNF-a docs not affect sperm numbers or
379
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motiUiy." Prominent c>-tokincs associated with T 
cell (unction, such as IL-IO. IL-I2 and IFN-7. were 
detected at km concentration t< 100 in only
a lew samples ©I normal men. This is similar to our 
normospermic jiunip values. This suggests that cellu­
lar immune activity Is low in the genital tract of nor­
mal men.'0 This cell mediated immunity could be up 
regulated by genital tract infection and lead to an 
increase in the levels of these cytokines.'1
As increased levels of cytokines were found in the 
obstructive aroospemtk group, the measured levels 
must he coming from either the seminal veskles or 
the prostate. Although unlikely, there may even be 
a small contribution from the epididymis. The only 
definitive way to prove that the cytokines are not 
originating (nun the testis Is to measure the cytokine 
levels from testicular sperm extraction samples.
The pathophysiological significance of the cyto­
kines in sperm function is still unclear and contro­
versial. Cytokines rarely act in isolatkm. but rather 
In a network ol other cytokines (e g.) elevated levels 
of 11-6. 11-8 and II-11 were found In the seminal 
plasma ol infertile men with Infection and ollgtv te- 
rato-asthenoAx>spemua-u Hence we wanted to see 
If there was a significant correlation between the dil- 
ferent cytokines in subfenile men. This study shows 
that there is an intricate cytokine network that exists 
in seminal plasma which may influence sperm func­
tion directly or indirectly. However, as the range of 
cytokine levels In out study Is too large. It hi difficult 
to define a cut-off value and thus suggest a clinical 
use for routine measurement of cytokine levels in 
subfenile men. Our study suggests the possible effect 
ol the individual cytokines on spenn motility. It is 
possible that they affect the reproductive system dil- 
fercntly through their soluble receptors.1 * Prointlam- 
matory cytokines such as IL-6. IL-8. and TNFz 
modulate pro-oxidant and antioxidant activities in 
tin* semen and thus may directly Influence semen 
parameters.*4 However, funlu-r studies are tequired 
to assess the role of this cytokine network and Im- 
munomodulation in sperm function and transport. 
The measurement of each cylokine separately in the 
seminal plasma ol subfenile men. despite significant 
dilierenccs. does not have a diagnostic value in male 
Infertility. However, an assay of selective cytokines 
and leucocytes In the semen of men may prove to 
he of clinical value In the diagnosis of male accessory 
gland infection and facilitate treatment.
There are a few limitations to our study. The 
number of patients in each group is small. Hence
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statistical significance may not correlate with clini­
cal significance. In our study, we have not excluded 
patients who smoke and consume akohol as none 
of them were heavy smokers t>20 cigarettes-<kw i 
or chronic alcoholics. Controversy exists about the 
role of smoking and male infertility. Some studies 
have shown that smoking has a detrimental efk-ct 
on sperm quality. However, other studies have not 
found an association between smoking and sperm 
quality, sperm (unctions, or sperm nuclear DNA 
damage. Standard semen parameters were not dil- 
ferent between infertile men who smoked and 
those who dkl not smoke In another studs, 
heavy smoking was associated with a decrease in 
semen concentrathw.'*’ It is likely that some 
authors may not agree with tiv due to the fact that 
smoking may increase the seminal leucocyte count 
and thus Increase the seminal oxidative stress. Alco­
hol is known to alter cytokine levels in a variety ol 
tissues including plasma, lung liver, and brain. 
Studies on human monocyte responses revealed 
that chronic alcohol use alters Inflammatory cyto­
kine production.'7 Chronic alcohol consumption (6 
units a day for more than 5 day's a week) has 
shown to aflect male reproductive hormones and 
semen quality.1*
Although we have endeavoured to dassily our 
patient sub groups in reference to the WHO manual, 
some conventional authors may not agree with the 
quoted reference ranges of semen parameters. The 
measurement of seminal plasma leucocytes during 
male genital tract inflammation without an associ­
ated contribution of cytokines may have little prog­
nostic value in the evaluation of male iniertility. 
Hence seminal leucocyte concentrations were also 
measured in these sub groups. The median and the 
ranges ol the total CD 45 amongst the various study 
groups are presented. The total CD45 counts 
between the normospermic group |5.9 (V9-I6.7)) 
and the other sub groups of subfenile men (oligo­
spermia (8.4 (4-26.1) PeO^Q). asthenospermia 
(12.1 (9.6-18.4) P<0.59). olignasthcnospermia
(7.75 (4.1-12.4) P< 0.945) and azoospermia <5.5 
(2.6-11.1) P < 0.57)1 to our study were not found to 
be statistically different. It is of dinical relevance in 
this setting and our study concurs with the findings 
of a recent study where none of the cytokines 
involved In our study was assodated with increased 
cellularity in the semen.20 II.-1 was not studied in 
our study as it has been studied extensively in the 
(vast and furthermore, has three members in the
Am«rK4J« ol ^pnjduCtN* tonumtafv *2 tfOO*
t> 3009 k-f*i Witt, 1 SttK AjS
CYTOKINES AND MALE SUBFERTILITY
lamily. two of which arc prointlamnvatorv and third 
lias an anti-inlUmmatory cfltxt.
To the t'CM of our knowledge, no previotw studio* 
have concum-mlv anal>,sed ti*e simuhanetHis 
expression •»( these seven cvisskines in the seminal 
plasma of men hi'lonsiny: to tliflerem ^mups of male 
subfertility. The effects of individual cytokine on 
sperm motility and numbers are also confirmed. The 
presence of increased levels of cytokines in the 
obstructed a/oospertnic group suggests that the cyto­
kines may not originate Irom the testis. This study 
also highlights the presence of an intricate cytokine 
network in these sublertile men.
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1 ABSTRACT
2 The role of leucocvtospcrmia in male subfertility is a much debated topic despite being a
3 frequent finding. This study aimed to identify the role of leucocytes, leucocyte subpopulatkms
4 and natural killer cells in male subfertility . 76 subfettile men attending a regional andrology
5 unit were recruited into this prospective study and subdivided into groups based on their
6 semen analysts. The different leucocyte subpopulations were identified using
7 immunocytochemicol staining. Significant levels of CD3 helper T lymphocytes tp<0.00l> tserc
R present in the uligospcrmic. usthenospermie. oligoasihenospermit- and obstructive a/oospermit group
9 eompared to the nocmospemiic group Significant levels of B cells (p<0.05) were present in the
10 asthcnospcrmic. oligoasthcnospcrmic and obstructive azoospcrmic group. The natural killer
11 cells (CD56) were significantly raised in the oligoasthenospemtic and obstructive a/oosperms.'
12 group (p<0.05). Our study suggests that leucocytospermia impairs sperm function through
13 enhanced T helper coll modulation, increased B cell population which leads to increased levels
14 of antisperm antibody and natural killer cells mediated sperm damage. The site of seminal 
13 leucocyte production is not necessarily confined to the vas or the epididymis.
16
17 Key words: leucocytes, sub feitility. sperm count, sperm motility
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2 INTRODUCTION:
3
4 The relationship between leucocytes ami the fertilising potential of an ejaculate remains highly
5 controversial. Leucocyiospermia is a frequent finding in infettile patients and is associated
6 with poor semen quality. The incidence of leucocytes in the seminal fluid among infettile
7 men. ranged from 15 to 28‘3\ whereas in fertile men it is 109 (Zom ct al. 2000). Increased
8 | nolvmornhonuclear IPMN) concentrations are related to decreased percentages of normal
9 forms of spermatozoa and a significant increase in the percentage of midpiece abnormalities
10 (Thomas et al. 1997). Another study showed that, the patient group with lower mean leucocyte
11 concentration (0.5*10'' leucocytes per ml) hud a significantly higher proportion of sperm with
12 normal morphology compared with patients who had a higher mean leucocyte concentration.
13 There was also a significant positive correlation between leucocyte concentration and
14 midpiece defects (Thomas et al. 1997).
15
16 A potential mechanism through which leucocytospcrmia may induce alteration in sperm
17 | function is excessive reactive oxvtcn species (ROS) production by activated granulocytes. It
18 has been debated that oxidative stress may induce alterations in the regulation of
19 spermatogenesis, resulting in structural defects of the sperm (Gil-Guzman et al. 2001:OI!cio et
20 al. 2001). On the subccllular level, it has been shown that leucocytes perm ia and excessive
21 ROS levels are associated with an increase in chromatin alterations and DNA damage in
22 sperm, as defined by the sperm chromatin structure assay (Alvarez et al. 2002). A different
23 study, has shown that a high incidence of sperm tail defects is associated with sperm
24 chromosomal abnormalities (Lewis-Joncs et al. 2003). It is thus conceivable that oxidative
25 genetic damage may have led to a significant increase in the proportion of sperm with tail
26 defects observed in leucocytospcrmic study population.
27
4
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1 However some authors failed to prove this association between sperm morphology and
2 leucocytospermia. One study even demonstrated leucocyiospennia to have a positive
3 association with sperm concentration: acrosome reaction and hypoosmotic swelling (HOS)
4 test scores (Kaleli et al. 2000). Sperm concentration was found to be constantly higher at
5 increasing leucocyte concentrations. Surprisingly, this study was also unable to document any
6 significant effect on sperm motility, even when the leucocyte concentrations increased1. It was
7 even suggested that leucocytes have a role in the removal of abnormal spermatozoa from the
8 ejaculate, thereby increasing the percentage of sperm with normal morphology (Tomlinson et
9 al. 1992). Other studies have not observed sperm damage during leucocytospermia (Kaleli et
10 al. 2000).
11
12 These conflicting findings are likely to be due to the different methods of staining and
13 counting seminal leucocytes, as well as different selection criteria for men representing fertile
14 or infertile groups. These results may also be due to the heterogenous aetiology of
15 leucocytospermia (such as sexual abstinence, inflammation, auto immunity etc). Analysis of
16 the heterogenous aetiology of the leucocyte populations in human semen is useful in the
17 diagnosis and therapeutic monitoring of male genital tract infections and of sexually
18 transmitted diseases or autoimmune disease. Analysis of leucocytes is often difficult due to the
19 low percentage of leucocy tes in semen, the high number of spermatozoa, and the presence of
20 immature sperm cells, often not easily recognizable from the leucocytes because of their
21 similar staining and cytological characteristics. Whether these cells in semen originate from
22 the reproductive tract (testis, epididymis, and vas) and/or the accessory glands will be
23 important to know. The lack of the clinical significance of leucocytospermia reported in some
24 studies is possibly a reflection of the powerful antioxidant properties of the seminal plasma.
25 which may provide protection against leucocyte-mediated oxidative stress (Aitken et a!.1994).
5
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1 Most of the previously performed studies investigated the effects of these products on sperm
2 motility.
3
4 Different hypotheses have been explored recently to explain the relationship between 
3 Icucocytospcnnia and sperm structural damage. The hypotheses that sperm structural damage
6 occurs during spermatogenesis is consistent with the findings of a study which showed that
7 infertile men with and without leucocytospermia had similar sperm concentrations in semen
8 (Aziz et al. 2004). Low sperm concentrations would have been expected if the leucocyte
9 induced damage occurred during spemtiogenesis (proliferative phase). The mechanism
10 through which leucocytospermia may induce the alteration in sperm structure is mu clear.
11 However, one potential explanation is that leucocytospermia could be a marker for an
12 inflammatory process in the testis and in most cases would be related to a subclinkal
13 inflammatory process and not due to an overt epididymoorchitis. The presence of
14 proinflammatory mediators such as cytokines in the testis could lead to alterations in the
15 regulation of spermiogenesis by interfering with Sertoli cell function leading to abnormal
16 spermiogenesis (Cohen PE & Pollard JW 1995).
17
18 The main objective of this study was to try and resolve an important aspect in clinical
19 andrological examination by determining the relationship of a repertoire of leucocyte
20 subpopulalions in the seminal plasma of different subgroups of subfertile men attending a
21 regional andrology clinic. The second objective was to identify the presence if any of
22 leucocytes in seminal plasma of azoospermic men.
23
24
25
6
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1
2
3 MATERIAL & METHODS:
4 S.MKly Ptsfen
5 A prospective cohort study was designed in which semen was collected From men attending
6 the Reproductive Medicine Unit of the Liverpool Women’s Hospital for infertility
7 investigation. The median age of men was 34.5 (range 22 to 49) years. The medium duration
8 of infertility was 5 (range 2 tol3) wars. 38 of the men consumed alcohol on an average of 10-
9 12 units / week. 20 of the men also smoked on an average of 10-20 cigarettes per day. Men
10 were divided into the different subgroups (norntospermic, asthenospermic. oligospermic.
11 oligoasthenospermic. obstructive azoospcrmic and non obstructive azoospermia) according to
12 the results of the seminal analysis on 2 consecutive semen samples. The scminology
13 laboratory at the hospital carried out standard sperm function tests on each sample, including
14 details on sperm number, motility, and the presence of bound anti-sperm antibodies etc. as
15 detailed by W'HO. These men had no other illnesses nor did they take any medication that
16 could have affected their leucocyte subpopulations.
17 Ethical approval was granted by the Liverpool Research Ethics Committee. Written, informed
18 consent was obtained from 76 men attending the Reproductive Medicine Unit. Liverpool
19 Women’s Hospital. Clinical details of both partners were obtained from the case notes.
20 Scmm Sritedtan
21 Semen was obtained by masturbation after 3- 5 days of sexual abstinence. The samples were
22 collected ht a sterile, wide mouthed, non toxic container and processed in the laboratory
23 within 1 hour of ejaculation. Samples did not get exposed to extremes of temperature. They
24 did not come in contact with cither lubricants or latex products. All the samples underwent
25 semen analysis in the laboratory in accordance with the 1999 W'HO laboratory manual for the
7
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1 examination of human semen and the study was done using these reference values) 1999).
2 Men were divided into the diffetent sub groups according to the results of 2 consecutive
3 semen analysis 6 weeks apart. Given the wide variability between ejaculates. 2 samples were
4 taken to confidently define an individual's phenotype. Asthenospermia was defined as a sperm
^ Dieted: lit. ]
5 j motility of <40%. Oligospermia was defined as a sperm count _Severe Oligospermia
b was defined as sperm count <10x10*. Oligoasthenospermia was defined as a sperm count of
7 10-20x10* and motility of <40%. Azoospermia was defined as complete absence of sperm in
8 the semen either due to germ cell failure such as maturation arrest, hypospermatogenesis or
9 sertoli cell only syndrome (non obstructive group) or due to obstruction in the sperm delivery
10 system. The obstructive azoospermic group had all undergone vasectomy. Although testicular
11 biopsy is the definitive test to rule out the non obstructive from the obstructive groups, the
12 presence or absence of active spermatogenesis can be accurately predicted by measuring the
13 testis volume and serum FSH (Matsumiya et al. 1994). Hence the differentiation between
14 germ cell failure azoospermia and obstructive azoospermia was made by the serum follicle
15 stimulating hormone (FSH) levels, karyotyping and testicular volume. The testicular volume
16 in our non obstructive group was reduced K 7 ml) and the FSH levels were ereater then four
17 times the normal. After semen analysis the remaining sample was processed for the
18 measurement of leucocyte subpopulations. The fertile controk had a normal semen analysis
19 and were ASA and infection negative. This fertile group of men was from the IVF study group
20 and was attending the reproductive medicine unit for purely female factor infertility. Female
21 factor infertility can be divided into four categories: ovarian, tubal, pelvic and uterine. The
22 most common cause of female infertility of ovarian origin is anovulation. Tubal infertility
23 could be caused by infection such as Chlamydia, gonococcal infection and tuberculosis, which
24 damage the fallopian tubes. Previous pelvic or abdominal surgery may distort the anatomy of
25 the tubes. There is a possibility that tubal problems may also be congenital, leading to an
8
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1 incomplete development of the fallopian tube. Adhesions that form in the pelvis as a result of
2 an infection or surgery, cause organs or tissues that are normally separate to stick together
3 leading to pelvic infertility. Endometrial polyps and fibroids, if large, may interfere with
4 fertility and cause uterine infertility. Thus isolated conditions of the female are responsible for
5 infertility in 3S% of the cases. All the samples underwent testing for genito-urinary infections
6 such as Ureaplasma, Mycoplasma. Chlamydia. Trichomonas Vaginalis. E.Coli and other
7 organisms such as Enterococcus. Streptococcus etc. The swabs were taken directly from
8 semen and sent to the microbiology laboratory for culture to rule out infection.
9 Preparation of Seminal leucocytes
10 After semen analysis the remainder of the sample underwent immunocytochemical staining.
11 the established method for accurately detecting leucocyte subpopulationst Wolff 1995). The
12 monoclonal antibodies ased were CD2. CD3. CD4 (T helper cells). CDS (T cytotoxic cells).
13 CDI4. CDI6 (Granulocytes). CD20 (B cells), CD 45 (Pan Leucocyte). CD56 (Natural killer
14 cells). CD69 (activated T and B cells) and L243.
15 Semen samples were diluted to 10ml with phosphate buffered saline (PBS), and washed by
16 centrifugation for 10 minutes at 300 g at room temperature. The supernatant was discarded.
17 | The final cellular pellet was re-suspended in 2ml of PBS/BSA (bovine serum albumin)
18 {containing O.ISt BSA). An aliquot of this suspension was mixed 1:1 in Trypan blue (which
19 stains non-viable cells). Using a haemocytomelet, the cellular concentration and percentage
20 viability was assessed. By altering the dilution factor of the suspension, the total round cell
21 concentration (including non-viable cells) was I x 10*7 ml in PBS/BSA. The round cells were
22 leucocytes and germ cells. Constantly mixing to ensure an even suspension of cells. 50wl was
23 applied to each spot on Teflon-coated slides. Slides were air dried overnight, before fixing for
24 10 minutes in acetone. Wrapped in foil, slides were stored at -20° C until staining.
25
9
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1 Slides were removed from the freezer and allowed to reach room temperature. Areas to be
2 stained were marked with a Dako pen to separate adjacent wells. The primary monoclonal
3 antibodies were used as per manufacturer's instructions. Finally, the slides were washed
4 thoroughly in tap water and mounted in Aquamount (BDH. Poole, UK). The number of
5 positively stained (red-pink) leucocytes for each antibody were counted in ten high power
6 fields (HPF = x 320 magnification) using a light microscope fitted with a graticule. Mean
7 values of the ten counts were calculated, and used for an average value per HPF. CD45 binds
8 to a common leucocyte antigen, thus staining all leucocytes. In wells incubated with CD45.
9 both positive and negative (unstained, identified by blue nucleus) cells were counted. This
10 proportion was used to determine the proportion of leucocytes relative to other round cells
11 (immature Germ cells) in the ejaculate. The percentage of CD45 positive cells were
12 determined from the number of CD45 positive cells divided by the sum of both the CD45
13 positive and negative cells. Since all samples were initially diluted to lx l(f/ ml. these results
14 represent total number of leucocytes per ejaculate. The absolute counts of the monoclonal
15 antibodies were used for analysis as some of the monoclonal antibodies can cross react with
16 other cells and hence the medians were used for the analysis rather than expressing them as a
17 percentage of the total round cell count. The specificity of each antibody (the type of leucocyte
18 it binds to. resulting in red-pink staining) was verified on testing the clones obtained from the
19 relevant manufacturers.
20 Statistical analysis
21 Statistical analysis was performed using the statistical package for social sciences (SPSSvl I)
22 software. The Shapiro Wilkes test was used to test for normal distribution. As our data was not
23 normally distributed, statistical analysis was performed using the Mann- Whitney U lest to
24 analyse the difference between cell counts from various groups of patients and sperm
25 parameters. Spearman's rank correlation coefficient was used to determine the correlation
10
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between leucocyte count and sperm parameters. Statistical significance was taken at the 5% 
confidence level (p<0.05). The number of patients is relatively small, as this was aimed to 
be a pilot study and if significant levels of leucocyte subpopulations were found in the 
various subgroups then an adequately powered study will be required to determine both 
the statistical and the clinical significance of these findings.
RESULTS
The CD 45 count in the oligospermic group when compared to the normospemiic was not 
significantly increased as seen in Table I. Only CD3 was significant (p<0.003) as shown in 
Table 2. CD3 was significant in the asthenospermic <p<0.001) group. The major 
histocompatibility complex (MHO class 2 cells (L243) were found in all 3 groups. The 
predominant leucocyte sub group was the granulocytes in the normospcrmic. oligospermic and 
the asthenospermic groups. The CD3 (Fig 1) and the CD20 (Fig 2) levels were significantly 
increased in the asthenospermic group <p<0.01& p<0.02) respectively when compared to the 
normospermic group as shown in Table 2. The T and B cells are significantly increased in the 
oligoasthenospermic group.
Significant correlations between the T and the B cells exist particularly' in the 
oligosathenospermic groups (Fig 3). They were CD2 and CDS (r=0.79). CD3 and CDS 
(r=0.85). CD4 and CDS (r=0.79). CD2 and L243 (r=0.67). CD3 and L243 (r*0.70). CD4 and 
L243 (t=0.73. p <0.01). The CD2 & CD3 correlated with CD20 (r=0.47. p value<0.05>. The 
other correlations seen only in the oligoaMhenospermic group were between CD14, CDI6 and 
L243 r=0.82. and CD20 and L243 (r=0.71. p <0.01).
Other sperm parameters such as morphology were also studied to find out if leucocytospermia 
had an effect and this is represented in Table 3.
II
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1 In obstructive azoospermia, there was an increase in the number of T cells (CD3: px 0.01). B
2 cells (CD 20; p< 0.02). large granular lymphocytes (CD56: p< 0.03) ami activated T and B
3 cells (CD69; P<0.Q3) when compared to the normospermic group. These increased numbers
4 were statistically significant (Table 2). In non obstructive group, there was an increase in the
5 number of T cells (CD3; P= 0.05). Positive correlation was identified between the leucocytes
6 in the non obstructive azoospermic group as shown in Fig 4.
7
8 DISCUSSION:
9 The correlation between leucocyiospermia and mule infertility is controversial; some studies
10 have even failed to find any association (Fedder. Askjaer, & Hjort 1993) (Curi et al. 2003).
11 However, our study shows different leucocyte species infiltrate the human ejaculate to varying
12 extent and with significant correlations.
13 Our study, is in agreement with other studies (Aitken et al. 1992) (Basso), Recio. & de la Cruz
14 1990) in that there were no statistically significant difference in the CD45 count between the
15 oligospcrmic and the normospermic groups. Our study also showed for the first time that
16 significant levels of CD3 T lymphocytes were present in the oligospermic group when
17 compared to the normospermic group. This would suggest an increase in the helper T cell activity
18 in this group. There was no increase in the CD 14 and CD 16 cells in the digospennic group when
19 compared to the normospermic group. This suggests that these leucocy te subpopulations are not a
20 major factor in influencing sperm structure.
21
22 The CD3 were significantly increased in the asthenospermic group when compared to the
23 normospermic group which shows an increase in the helper T cell activity in this group too. CD20
24 levels were significantly increased in the asthenospermic group when compared to the
25 normospermic group. This raises the possibility that an increase in this cell group could alTect sperm
26 motility through an increased ASA production. This ASA could bind to the sperm and decrease its
12
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1 motility. The activation of a resting helper T cell causes it to release cytokines in paftkular
2 | interferon (1FN) which is known to affect sperm motility. Similarly, activation of resting T
3 helper cells could stimulate the activity of B cells (CD20), the latter producing antibodies and
4 thus further decreasing sperm motility. This is the fust study which reports raised T cells (CD
5 3) and B cells (CD 20) in the asthcnospermic group.
6
7 Significantly elevated levels of T cells (CD 3 and CD8). B cells (CD20) and large granular
8 lymphocytes (CD56) were found in the oligoasthenospcrmic group. Most of the previous
9 studies have looked into the total leucocyte count and various sperm parameters. This is the
10 first study that has identified leucocyte sub-type correlations and various sperm parameters.
11 Our study highlights that there is a finely balanced interaction between the T cells and the B
12 cells within the seminal plasma particularly in the oligoasthenospcrmic group. The likely
13 severity of the condition will probably depend of the predominance of the cell group, as the
14 increased T cell activity is more likely to be of a helper in nature, whereas the increased B
15 cells activity might be the cause of decreased motility due to antibody production and the
16 increased CD56 activity could be removing the non functioning sperm.
17
18 We studied the seminal population of leucocytes rather than at the level of the epididymis in
19 both the o/oospermic groups. Our study the first in humans identified significant levels of
20 helper T cells (CD3) in both our azoospermic groups and there was a no significant increase in
21 the cytotoxic cells (CD8) in cither azoospermic groups. However, in direct contrast, a study
22 found that in the epididymis of rats following a vasectomy, there was a decrease in the T
23 helper cells number and an increase in the T cytotoxic cells number (Hooper et al. 1995).
24 CD20. CD 56 and CD69 counts were significantly elevated in the obstructive group. It is
25 thought that T cells arc present in increased numbers as they try to suppress the development of
13
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1 an immune response lo the trapped sperm as a result of an obstruction. This increase in the B
2 cell population in the a/oospermit group may result in increased levels of antisperm antibody
3 being secreted which could lead lo subsequent subfenility even after vasectomy reversal. We
4 don't propose that there is a cause and effect relationship between these cells and azoospermia.
5 but suggest the site of seminal leucocyte production is not necessarily confined to the vas or the
6 epididymis as once thought.
7 There are a few limitations to our study. The numbers of patients in each group arc small.
8 Hence statistical significance may not correlate with clinical significance. In our study we
9 have not excluded patients who smoke and consume alcohol as none of them were heavy
10 smokers 020 cigarettes / day) (may increase the seminal leucocyte count and thus increase
11 the seminal oxidative stress or decrease in semen concentration!Close. Roberts, & Berger
12 1990)) nor chronic alcoholics, (heavy alcohol use was associated with an increase in the
13 seminal leucocytes and chronic alcohol consumption (6 units / day for more than 5 days a
14 week) has shown lo affect male reproductive hormones and semen quality}(Muthu.sami &
15 Chinnaswamy 2005).
16 Although we have endeavoured to classify our patient sub groups in reference to the WHO
17 manual, some conventional authors may not agree with the quoted reference ranges of semen
18 parameters. Some authors may not be agreeing with our selection of markers used to detect
19 leucocyte subpopulations. CD2 is expressed not only on T cells but also on NK cells and B
20 cells. CD 14 is mostly confined to monocytes / macrophages. However, some non immune
21 cells such as choroids plexus cells are also known to express CDI4. Although no significant
22 different levels were detected in our study, some authors would have wanted us to test for the
23 expression of CD 14 by the human germ cells. Correlations between CD 14 and L243 may be
24 considered trivial as monocytes/macrophages express MHC II (clone L243). CD 16 b not
25 restricted to granulocytes and some pro-inflammatory monocytes express CDI4 and
14
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1 CD 16.Our hypothesis could have been strengthened by performing a few testicular biopsies on
2 some of our patients with impaired sperm parameters for the presence of inflammatory
3 infiltrates.
4 The measurement of seminal plasma leucocytes during male genital tract inflammation
3 without an associated contribution of cytokines may have little prognostic value in the
6 evaluation of male infertility. Hence seminal cytokine concentrations were also measured in
7 these sub groups (Seshadri et al. 2009). Significantly higher concentrations of IL-6 (p <0.05).
8 was present in the oligospermic. asthcnospcrmic. oligoasthcnospermic and both azoospcrmic
9 groups when compared to the normospermic group. Significantly higher concentrations of IL-
10 8 (p <0.05). was present in the asthenospermic group when compared to the normospermic
11 group. Significantly higher concentrations of 1L-I0 (p <0.05). was present in the
12 asthenospermic. oligoasihenospcnnic and azoospcrmic obstructive group when compared to
13 the normospermic group. Furthermore IL-6. IL-10. TNF-ot and IFN-y were significantly
14 increased in the obstructive azoospcrmic group when compared to the normospermic group. A
15 significant correlation was found between IL-10 and IL-11 in the oligospermic (p<0.05) and
16 obstroctive azoospennic (p<0.01) groups. A significant correlation (p<0.01) was found
17 between IL-10 and IL-11 and between IL-10 and IFN-y in the oligoasthenospermic group
18
19 IL-6 positively correlated with L243 in the oligospermic group (r=0.83. p va1ue< 0.01) and
20 IFN-y negatively correlated with CD20 in the severe oligospermic group (r=-0.74. p<0.05).
21 IL-10 positively correlated with CD69 and IFN-y positively correlated with CD69 and L243 in
22 the asthenospermic group. IFN-y correlation between the various leucocyte subpopulations in
23 different subferile men could suggest that IFN-y. could lead to increased sperm membrane
24 lipid peroxidation. ROS (generated by leucocytes) acts syncrgistically with pro-inflammatory
25 cylokines to exacerbate the destructive environment for the spermatozoa. We were unable to
15
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1 detect any significant correlations between the various leucocyte subpopulations and the
2 cytokines 1L-10. 1L-11 & 1L-12 in the various subfettile group studied. This would strongly
3 suggest that these cytokines do not influence spermatogenesis. In the abscence of infection we
4 were unable to detect any correlation between IL-fl or TNF- a expression and the leucocyte
5 subpopulations studied.
6
7 The significantly higher frequency of sperm morphological defects in infertile men may
8 suggest that leucocytospcrmia as an independent variable has a detrimental effect on sperm
9 morphology. This damage could be due to both defective Sertoli cell function and
10 disorganized spermiation or due to alteration in the maturation process that the sperm undergo
11 while transient in the epididymis. Thus, leucocytospcrmia induced sperm damage may
12 commence during spermiogencsis and continues through spermiation and cpididymul
13 migration.
14
15 Our study has made an attempt to clarify the possible fertility-reducing effect of leucocytes,
16 the relationship between various sperm characteristics particularly sperm morphology and
17 motility. Our study suggests that sperm structural defects in leucocytospermic men may have
18 been acquired at different stages of spermiogencsis. This could be mediated cither through
19 cytokines which have an influence on the sertoli cell function or by the peroxidative damage
20 of ROS released by the activated granulocytes. To the best of our knowledge there have been
21 no studies testing this extent of leucocyte subpopulations using monoclonal antibodies in the
22 different subsets of male subfeitility.
23
24 CONCLUSION
16
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1 This is the first study to have identified significant levels of CD3 T lymphocytes and B cells in
2 the various subfetlilc groups. Our findings suggest that leucocytospermia could impair sperm
3 function through enhanced T helper cell modulation. An increase in the B cell population in
4 the groups may result in increased levels of antisperm antibody being secreted which could
5 impair sperm numbers and function which would result in subfertility. The presence of various
6 leucocyte subpopulations in the obstructive a/oospermic group suggests that the site of
7 seminal leucocyte production is not necessarily confined to the vas or the epididymis as
8 previously thought. Natural killer cells could be responsible for mediating sperm damage
9 especially in the oligoasthenospermic group. The presence of increased level of lymphocytes 
10 in the reproductive tract could be as a result of an immunological reaction.
17
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Fig 1: CD 3 cells (stained pink) in the Asthcnospermic sample
■
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Fig 2: CD 20 cells in the Asthenospermic sample
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CD4 CD 14 L 243
Fig 4: Correlation matrix showing the positive correlations (CD4 and L243 r=0.90. CD14 
and CD4 r=0.86. CD 14 and L243 r=0.97. p values <0.01) between the leucocytes in the 
non obstructive azoospermic group.
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Table 1: Median and ranges of the Leucocytes (expressed as cells per 10 hpf) in all our 
various study groups.
N»I4
Median / Ranees
N-13
Median / Ranges
N*I8
Median / Ranges
Axoospennic
Obatnictive
Na 10
Median / Ranges
Non Obstrarthr
Malt
Median / Ranges
N»I4
Median / Ranges
CO 45* 63 (553-761 76(66-89) 76.7(69-79) 79 (66-88) 93 (83-97) 80(64-96)
CO 45 5.9(3.9-16.7) 93(43-133) 123(9.6-18.4) 73 (4-12.4) 665 (3.6-8 4) 535(23-11.1)
CO 2 0.7 (0.3-1.9) 1.60.1-2.2) 1.6 (M) 1.90-2.9) 13(07-23) 0.9(03-13)
CD 3 03(0.3-13) 1.7(13-23) 235 (0.9-5) 1A (09-53) 135 0-23) 0.85 (0.6-25)
CD 4 1 (0i6-2.2) 130.1-2) 2.15(1-3) 2 (08-3.2) 2.05(13-3) 1.65 03-3.9)
CDS 06(0.2-1.1) 0.7 (0.4-09) 0.95 (0.9-33) 1 (0.7-23) 1(05-1.7) 0.35(0.3-2.1)
CD 14 13(0.5-2.8) 13(0.7-1.9) 3.25(1.8-4 5) 2.1 (08-4.7) 315 03-33) 105 (0.7-25)
CD 1* 23(1.5-5.7) 2.6 (0.7-S.6) 3.85 0.6-53) 23(13-73) 2.8(32-33) 1.7 (1.4-3)
CD 20 0.4 (0.2-1) 0.8(03-1.1) 1.85 0-5.4) 1 (04-2.4) 1.45(07-33) 0.6(03-1.1)
CD 54 0.4 (0.3-03) 0.6(03-09) 0.4(01-0.8) 0.6(03-1.9) 03(03-1.4) 05(0.1-33)
CD 49 03 (0.2-13) 13(0.4-1,8) 1.75(0.7-3.1) I I (03-23) 1.60-2.4) 0.65(0.4-1.6)
L243 2.4(1.7-53) 23(1.7-2.9) 2.8 0.7-6.4) 2.2 0.6-4.4) 23 0.7-5) 2 033.1)
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Table 2: P values of the different leucocyte subpopulations from the various subfeitile 
groups when compared to the normospermic group (*signiflcance at 5% level, 
♦♦significance at the 1% level)
OMgmprrmic
P value
NonmMprraic vs
AMhnMaprrmk
P value
Nsnnm|wnni( w
AmMpmnk OOstrartivt
P valur
Ora rrfl faihirr
P talur
OUftMstbcimapcTiitic
Rvalue
CD 45% 0.43 0.14 0.07 0.001** 0.1
CD 45 0M 0.39 0.945 0.82 0.47
CD 2 0.21 0.15 0.09 0.45 0.72
CD 5 0.003** 0.001* 04)04** 0.01* •MS*
CD 4 0.34 0.19 0.2 0.22 an
CD 8 0.39 0.06 0.02* 0.1 0.82
CD 14 0.87 0.08 0.22 0.11 0.72
CD 1* 0.71 &S2 0.94 0.96 0.44
CD 20 0.47 0.02 * 0J2* 04)2* 033
CD 54 0.52 0.8 •MS' 0.03* 0.47
CD 45 0.18 0JB7 at 0.03* 0.45
1.245 080 0.93 06 096 068
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Table 3: Median and ranges of the sperm parameters in the various subfertile groups are 
shown in comparison to the normospermic group.
Sperm Pant meters Normospermic (ao|4) Oligospermic
(n-13)
AsUmospcrmic lo-IO)
Sperm count
10*/ml 43 (28-75) 10(5-11) 46.5 (34-83) 5(2-15)
Motility % 25 <20-4O> 27J (25-30) 13.75 (2.5-17.5) 5 (2.5-15)
oe » «  mjnorpnoiogy iv
normal forms 28(18-32) 18(12-22) 10(9-12) 11(8-16)
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